<html lang="en"><head>
	<!-- Required meta tags -->
	<meta charset="utf-8">
	<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
	<!-- Check Browser, as well as Hostname and set JS, CSS, Favicon path based on that-->

	<!-- Favicon -->
	<!-- cpcommit -->
	<!-- <link rel="shortcut icon" type="image/x-icon" href="https://www.sec.gov/favicon.ico"> -->

	<script>
		(function () {
			var hostName = window.location.hostname;

			var browserAccepted = function () {

				var ua = window.navigator.userAgent;
				var trident = ua.indexOf('Trident/'); //IE 11;
				var msie = ua.indexOf('MSIE '); // IE 10 or older
				if (msie > 0) {
					return false;
				}
				return true;
			}();

			var pathToLibs = './js';
			var pathToError = './';
			// uncomment following lines only when running ix symlink to ix.xhtml on *.sec.gov
			/* commented out for running ix redirector script
			if (hostName === 'www-test.sec.gov' || hostName === 'www.sec.gov') {
				pathToLibs = './ixviewer/js';
				pathToError = '/ixviewer/';
			}
			*/
			if (browserAccepted) {

				// css
				document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/css/custom-bootstrap.css>');
				document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/lib/fontawesome/css/all.min.css>');
				document
					.write('<link rel="stylesheet" href=' + pathToLibs + '/css/app.css>');

				// js
				document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/jquery-3.7.1.slim.min.js"><\/script>');
				document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/popper.min.js"><\/script>');
				document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/bootstrap.min.js"><\/script>');
				document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/moment.js"><\/script>');
				document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/vanilla-picker.min.js"><\/script>');
				document
					.write('<script type="text/javascript" src="' + pathToLibs + '/lib/he.js"><\/script>');

				var date = new Date();
				var todaysDate = date.getDate() + '-' + (date.getMonth() + 1) + '-'
					+ date.getFullYear();
				document.write('<script type = "text/javascript" defer=true src="'
					+ pathToLibs + '/production.min.js?d=' + todaysDate
					+ '"><\/script>');
			} else {
				// user us on a browser that we do not support
				var currentUrl = window.location.href.split('?')[0];
				var browserError = currentUrl.substring(0, currentUrl
					.lastIndexOf('/'));
				browserError += pathToError + 'browser-error.html?url='
					+ encodeURIComponent(window.location.href);
				window.location.href = browserError;
			}
		})();
	</script><link rel="stylesheet" href="./js/css/custom-bootstrap.css"><link rel="stylesheet" href="./js/lib/fontawesome/css/all.min.css"><link rel="stylesheet" href="./js/css/app.css"><script type="text/javascript" src="./js/lib/jquery-3.7.1.slim.min.js"></script><script type="text/javascript" src="./js/lib/popper.min.js"></script><script type="text/javascript" src="./js/lib/bootstrap.min.js"></script><script type="text/javascript" src="./js/lib/moment.js"></script><script type="text/javascript" src="./js/lib/vanilla-picker.min.js"></script><style>.picker_wrapper.no_alpha .picker_alpha{display:none}.picker_wrapper.no_editor .picker_editor{position:absolute;z-index:-1;opacity:0}.picker_wrapper.no_cancel .picker_cancel{display:none}.layout_default.picker_wrapper{display:-webkit-box;display:flex;-webkit-box-orient:horizontal;-webkit-box-direction:normal;flex-flow:row wrap;-webkit-box-pack:justify;justify-content:space-between;-webkit-box-align:stretch;align-items:stretch;font-size:10px;width:25em;padding:.5em}.layout_default.picker_wrapper input,.layout_default.picker_wrapper button{font-size:1rem}.layout_default.picker_wrapper>*{margin:.5em}.layout_default.picker_wrapper::before{content:'';display:block;width:100%;height:0;-webkit-box-ordinal-group:2;order:1}.layout_default .picker_slider,.layout_default .picker_selector{padding:1em}.layout_default .picker_hue{width:100%}.layout_default .picker_sl{-webkit-box-flex:1;flex:1 1 auto}.layout_default .picker_sl::before{content:'';display:block;padding-bottom:100%}.layout_default .picker_editor{-webkit-box-ordinal-group:2;order:1;width:6.5rem}.layout_default .picker_editor input{width:100%;height:100%}.layout_default .picker_sample{-webkit-box-ordinal-group:2;order:1;-webkit-box-flex:1;flex:1 1 auto}.layout_default .picker_done,.layout_default .picker_cancel{-webkit-box-ordinal-group:2;order:1}.picker_wrapper{box-sizing:border-box;background:#f2f2f2;box-shadow:0 0 0 1px silver;cursor:default;font-family:sans-serif;color:#444;pointer-events:auto}.picker_wrapper:focus{outline:none}.picker_wrapper button,.picker_wrapper input{box-sizing:border-box;border:none;box-shadow:0 0 0 1px silver;outline:none}.picker_wrapper button:focus,.picker_wrapper button:active,.picker_wrapper input:focus,.picker_wrapper input:active{box-shadow:0 0 2px 1px dodgerblue}.picker_wrapper button{padding:.4em .6em;cursor:pointer;background-color:whitesmoke;background-image:-webkit-gradient(linear, left bottom, left top, from(gainsboro), to(transparent));background-image:-webkit-linear-gradient(bottom, gainsboro, transparent);background-image:linear-gradient(0deg, gainsboro, transparent)}.picker_wrapper button:active{background-image:-webkit-gradient(linear, left bottom, left top, from(transparent), to(gainsboro));background-image:-webkit-linear-gradient(bottom, transparent, gainsboro);background-image:linear-gradient(0deg, transparent, gainsboro)}.picker_wrapper button:hover{background-color:white}.picker_selector{position:absolute;z-index:1;display:block;-webkit-transform:translate(-50%, -50%);transform:translate(-50%, -50%);border:2px solid white;border-radius:100%;box-shadow:0 0 3px 1px #67b9ff;background:currentColor;cursor:pointer}.picker_slider .picker_selector{border-radius:2px}.picker_hue{position:relative;background-image:-webkit-gradient(linear, left top, right top, from(red), color-stop(yellow), color-stop(lime), color-stop(cyan), color-stop(blue), color-stop(magenta), to(red));background-image:-webkit-linear-gradient(left, red, yellow, lime, cyan, blue, magenta, red);background-image:linear-gradient(90deg, red, yellow, lime, cyan, blue, magenta, red);box-shadow:0 0 0 1px silver}.picker_sl{position:relative;box-shadow:0 0 0 1px silver;background-image:-webkit-gradient(linear, left top, left bottom, from(white), color-stop(50%, rgba(255,255,255,0))),-webkit-gradient(linear, left bottom, left top, from(black), color-stop(50%, rgba(0,0,0,0))),-webkit-gradient(linear, left top, right top, from(gray), to(rgba(128,128,128,0)));background-image:-webkit-linear-gradient(top, white, rgba(255,255,255,0) 50%),-webkit-linear-gradient(bottom, black, rgba(0,0,0,0) 50%),-webkit-linear-gradient(left, gray, rgba(128,128,128,0));background-image:linear-gradient(180deg, white, rgba(255,255,255,0) 50%),linear-gradient(0deg, black, rgba(0,0,0,0) 50%),linear-gradient(90deg, gray, rgba(128,128,128,0))}.picker_alpha,.picker_sample{position:relative;background:url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E") left top/contain white;box-shadow:0 0 0 1px silver}.picker_alpha .picker_selector,.picker_sample .picker_selector{background:none}.picker_editor input{font-family:monospace;padding:.2em .4em}.picker_sample::before{content:'';position:absolute;display:block;width:100%;height:100%;background:currentColor}.picker_arrow{position:absolute;z-index:-1}.picker_wrapper.popup{position:absolute;z-index:2;margin:1.5em}.picker_wrapper.popup,.picker_wrapper.popup .picker_arrow::before,.picker_wrapper.popup .picker_arrow::after{background:#f2f2f2;box-shadow:0 0 10px 1px rgba(0,0,0,0.4)}.picker_wrapper.popup .picker_arrow{width:3em;height:3em;margin:0}.picker_wrapper.popup .picker_arrow::before,.picker_wrapper.popup .picker_arrow::after{content:"";display:block;position:absolute;top:0;left:0;z-index:-99}.picker_wrapper.popup .picker_arrow::before{width:100%;height:100%;-webkit-transform:skew(45deg);transform:skew(45deg);-webkit-transform-origin:0 100%;transform-origin:0 100%}.picker_wrapper.popup .picker_arrow::after{width:150%;height:150%;box-shadow:none}.popup.popup_top{bottom:100%;left:0}.popup.popup_top .picker_arrow{bottom:0;left:0;-webkit-transform:rotate(-90deg);transform:rotate(-90deg)}.popup.popup_bottom{top:100%;left:0}.popup.popup_bottom .picker_arrow{top:0;left:0;-webkit-transform:rotate(90deg) scale(1, -1);transform:rotate(90deg) scale(1, -1)}.popup.popup_left{top:0;right:100%}.popup.popup_left .picker_arrow{top:0;right:0;-webkit-transform:scale(-1, 1);transform:scale(-1, 1)}.popup.popup_right{top:0;left:100%}.popup.popup_right .picker_arrow{top:0;left:0}</style><script type="text/javascript" src="./js/lib/he.js"></script><script type="text/javascript" defer="true" src="./js/production.min.js?d=22-4-2024"></script>
	<title>Inline XBRL Viewer</title>
<style type="text/css" id="customized-styles"> #dynamic-xbrl-form [enabled-taxonomy="true"][continued-taxonomy="false"]{border-top:2px solid #FF6600;border-bottom:2px solid #FF6600;display:inline;} #dynamic-xbrl-form [enabled-taxonomy="true"][continued-main-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #FF6600, 2px 0px 0px 0px #FF6600;} #dynamic-xbrl-form [enabled-taxonomy="true"][text-block-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #FF6600, 2px 0px 0px 0px #FF6600;border-top:none;border-bottom:none;} #dynamic-xbrl-form [highlight-taxonomy="true"]{background-color:#FFD700 !important;} #dynamic-xbrl-form [highlight-taxonomy="true"] > *{background-color:#FFD700 !important;} #dynamic-xbrl-form [selected-taxonomy="true"][continued-main-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #003768, 2px 0px 0px 0px #003768;} #dynamic-xbrl-form [selected-taxonomy="true"][text-block-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #003768, 2px 0px 0px 0px #003768;} #dynamic-xbrl-form [selected-taxonomy="true"][continued-taxonomy="false"]{border:3px solid #003768 !important;display:inline;} #dynamic-xbrl-form [hover-taxonomy="true"]{background-color:rgba(255,0,0,0.3);} #dynamic-xbrl-form .text-block-indicator-left{border-left:.75rem solid ##003768;} #dynamic-xbrl-form .text-block-indicator-right{border-right:.75rem solid ##003768;} .tagged-data-example-1{border-top:2px solid #FF6600;border-bottom:2px solid #FF6600;} .search-results-example-1{background-color:#FFD700;} .tag-shading-exmple-1:hover{background-color:rgba(255,0,0,0.3);} .selected-fact-example-1{border:3px solid #003768 !important;}</style></head>

<body>
	<noscript>This application relies heavily on JavaScript, you
		will need to allow JavaScript to use this application.</noscript>
	<nav class="reboot navbar navbar-expand-md navbar-dark navbar-height bg-sec fixed-top w-100 pl-0">
		<button class="reboot navbar-toggler ml-1" type="button" data-test="" data-toggle="collapse" data-target="#main-navbar" aria-controls="main-navbar" aria-expanded="false" aria-label="Toggle navigation">Inline Viewer</button>
		<div class="reboot navbar-height collapse navbar-collapse bg-sec w-100" data-test="main-navbar" id="main-navbar">
			<ul class="reboot navbar-nav mr-auto bg-inherit">
				<li class="reboot nav-item dropdown my-auto ml-1">
					<a id="menu-dropdown-link" data-test="menu-dropdown-link" class="reboot nav-link dropdown-toggle click disabled" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" tabindex="1" accesskey="1">
						<i class="reboot nav-loading fas fa-bars" title="Menu"></i>
						<span class="reboot d-md-none d-lg-inline">Menu</span>
						<span class="reboot sr-only sr-only-focusable">Menu</span>
					</a>
					<div class="reboot dropdown-menu">
						<a id="menu-dropdown-information" data-test="menu-dropdown-information" class="reboot dropdown-item click text-body" tabindex="1">Information</a>
						<a id="form-information-instance" data-test="form-information-instance" class="reboot dropdown-item click text-body" target="_blank" tabindex="1">Save XBRL
							Instance</a>
						<a id="form-information-zip" data-test="form-information-zip" class="reboot dropdown-item click text-body" target="_blank" tabindex="1">Save XBRL Zip
							File</a>
						<a id="form-information-html" data-test="form-information-html" class="reboot dropdown-item click text-body" target="_blank" tabindex="1">Open as HTML</a>
						<a id="menu-dropdown-settings" data-test="menu-dropdown-settings" class="reboot dropdown-item click text-body" tabindex="1">Settings</a>
						<a id="form-information-help" data-test="form-information-help" class="reboot dropdown-item click text-body" tabindex="1">Help</a>
						<span id="form-information-version" class="reboot dropdown-item-text text-body" tabindex="1"></span>
					</div>
				</li>
				<li class="reboot nav-item my-auto ml-1">
					<a id="sections-dropdown-link" data-test="sections-dropdown-link" class="reboot nav-link click disabled meta-required" tabindex="2" accesskey="2">
						<i class="reboot fas fa-layer-group" title="Sections"></i>
						<span class="reboot d-md-none d-lg-inline">Sections</span>
						<span class="reboot sr-only sr-only-focusable">Sections</span>
					</a>
				</li>
				<li class="reboot nav-item my-auto ml-1 mr-1">
					<form id="global-search-form" data-test="global-search-form" class="reboot my-2 my-lg-0 input-group disabled" novalidate="">
						<div class="reboot input-group-prepend">
							<button data-name="global-search-options" class="reboot dropdown btn btn-outline-light disabled" type="button" data-toggle="dropdown" tabindex="3">
								<i class="reboot nav-loading fas fa-cog" title="Additional Search Options">
									<span class="reboot sr-only sr-only-focusable">Additional
										Search Options</span>
								</i>
							</button>
							<div class="reboot dropdown-menu px-2">
								<div class="reboot form-check">
									<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="1" checked="" tabindex="3">
									<label class="reboot form-check-label mb-0">
										<span class="reboot">Include Fact Name</span>
									</label>
								</div>
								<div class="reboot form-check">
									<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="2" checked="" tabindex="3">
									<label class="reboot form-check-label mb-0">
										<span class="reboot">Include Fact Content</span>
									</label>
								</div>
								<div class="reboot form-check">
									<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="3" checked="" tabindex="3">
									<label class="reboot form-check-label mb-0">
										<span class="reboot">Include Labels</span>
									</label>
								</div>
								<div class="reboot form-check">
									<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="4" tabindex="3">
									<label class="reboot form-check-label mb-0">
										<span class="reboot">Include Definitions</span>
									</label>
								</div>
								<div class="reboot form-check">
									<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="5" tabindex="3">
									<label class="reboot form-check-label mb-0">
										<span class="reboot">Include Dimensions</span>
									</label>
								</div>
								<div class="reboot bg-light border p-1">
									<span class="reboot dropdown-item-text">Reference
										Options</span>
									<div class="reboot form-check">
										<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="6" tabindex="3">
										<label class="reboot form-check-label mb-0">
											<span class="reboot">Include Topic</span>
										</label>
									</div>
									<div class="reboot form-check">
										<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="7" tabindex="3">
										<label class="reboot form-check-label mb-0">
											<span class="reboot">Include Sub-Topic</span>
										</label>
									</div>
									<div class="reboot form-check">
										<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="8" tabindex="3">
										<label class="reboot form-check-label mb-0">
											<span class="reboot">Include Paragraph</span>
										</label>
									</div>
									<div class="reboot form-check">
										<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="9" tabindex="3">
										<label class="reboot form-check-label mb-0">
											<span class="reboot">Include Publisher</span>
										</label>
									</div>
									<div class="reboot form-check">
										<input disabled="" class="reboot form-check-input meta-required" type="checkbox" name="search-options" value="10" tabindex="3">
										<label class="reboot form-check-label mb-0">
											<span class="disabled">Include Section</span>
										</label>
									</div>
								</div>
								<div class="reboot form-check">
									<input class="reboot form-check-input" type="checkbox" name="search-options" value="11" tabindex="3">
									<label class="reboot form-check-label mb-0">
										<span class="reboot">Match Case</span>
									</label>
								</div>
							</div>
						</div>
						<input type="text" class="reboot form-control disabled" id="global-search" data-test="global-search" placeholder="Search Facts" disabled="" aria-label="Search all Facts and highlight them accordingly." tabindex="4">
						<div class="reboot input-group-append">
							<button id="search-btn-clear" data-name="global-search-clear" class="reboot btn btn-outline-light disabled" type="button" tabindex="5">
								<i class="reboot nav-loading fas fa-times-circle" title="Clear Search"></i>
								<span class="reboot sr-only sr-only-focusable">Clear
									Search</span>
							</button>
							<button class="reboot btn btn-outline-light disabled" type="submit" tabindex="6">
								<i class="reboot nav-loading fas fa-search" title="Submit Search"></i>
								<span class="reboot sr-only sr-only-focusable">Submit
									Search</span>
							</button>
						</div>
					</form>
				</li>
				<li class="reboot nav-item dropdown my-auto ml-1">
					<a href="#" id="nav-filter-data" data-test="nav-filter-data" class="reboot nav-link dropdown-toggle disabled click" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" tabindex="7" accesskey="3">
						<i class="reboot nav-loading fas fa-list-alt" title="Data"></i>
						<span class="reboot d-md-none d-lg-inline">Data</span>
						<span class="reboot sr-only sr-only-focusable">Data</span>
					</a>
					<div class="reboot dropdown-menu">
						<form id="nav-filter-dropdown" data-name="data-dropdown" class="reboot px-2">
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="data-radios" value="0" checked="" tabindex="7">
								<label class="reboot form-check-label mb-0">All</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="data-radios" value="1" tabindex="7">
								<label class="reboot form-check-label mb-0">
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span class="reboot">Amounts Only</span>
								</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="data-radios" value="2" tabindex="7">
								<label class="reboot form-check-label mb-0">
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span class="reboot">Text Only</span>
								</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input meta-required" type="radio" name="data-radios" value="3" disabled="" tabindex="7">
								<label class="reboot form-check-label mb-0">
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span class="reboot">Calculations Only</span>
								</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="data-radios" value="4" tabindex="7">
								<label class="reboot form-check-label mb-0">
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span class="reboot">Negatives Only</span>
								</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="data-radios" value="5" tabindex="7">
								<label class="reboot form-check-label mb-0">
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span class="reboot">Additional Items Only</span>
								</label>
							</div>
						</form>
					</div>
				</li>
				<li class="reboot nav-item dropdown my-auto ml-1">
					<a href="#" id="nav-filter-tags" data-test="nav-filter-tags" class="reboot nav-link dropdown-toggle disabled click" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" tabindex="8" accesskey="4">
						<i class="reboot nav-loading fas fa-tags" title="Tags"></i>
						<span class="reboot d-md-none d-lg-inline">Tags</span>
						<span class="reboot sr-only sr-only-focusable">Tags</span>
					</a>
					<div class="reboot dropdown-menu">
						<form id="nav-filter-tags-dropdown" data-name="tags-dropdown" class="reboot px-2">
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="tags-radios" value="0" aria-label="Radio Button for All Tag Types" checked="" tabindex="8">
								<label class="reboot form-check-label mb-0">All</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input" type="radio" name="tags-radios" value="1" aria-label="Radio Button for Standard Only Tag Types" tabindex="8">
								<label class="reboot form-check-label mb-0">
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span>Standard Only</span>
								</label>
							</div>
							<div class="reboot form-check">
								<input class="reboot form-check-input meta-required" type="radio" name="tags-radios" value="2" disabled="" aria-label="Radio Button for Custom Only Tag Types" tabindex="8">
								<label class="reboot form-check-label mb-0">
									<i title="Facts whose tags are outside the realm of DEI, US-GAAP, etc." class="reboot far fa-question-circle"></i>
									<i title="The first time choosing this will take a few moments." class="reboot far fa-clock d-none performance-concern"></i>
									<span class="reboot">Custom Only</span>
								</label>
							</div>
						</form>
					</div>
				</li>
				<li class="reboot nav-item dropdown my-auto ml-1">
					<a href="#" id="nav-filter-more" data-test="nav-filter-more" class="reboot nav-link dropdown-toggle disabled click" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" tabindex="9" accesskey="5">
						<i id="loading-more-filters" class="reboot nav-loading fas fa-filter" title="More Filters"></i>
						<span class="reboot d-md-none d-lg-inline">More Filters</span>
						<span class="reboot sr-only sr-only-focusable">More Filters</span>
						<span title="Total active filters." class="reboot badge badge-warning"></span>
					</a>
					<div class="reboot dropdown-menu dropdown-menu-width">
						<label class="reboot dropdown-item-text d-none performance-concern">
							Selecting any of the below will take a few moments.</label>
						<div class="reboot accordion" id="more-filters-accordion">
							<form class="reboot" data-test="more-filters-form">
								<div class="reboot mx-1">
									<div class="reboot px-0 py-0">
										<a href="#" data-test="Period" data-target="#user-filters-periods" data-toggle="collapse" class="reboot d-flex justify-content-between align-items-center w-100 click text-primary" tabindex="9">
											<span class="reboot">Periods</span>
											<span data-test="Period-count" id="filters-periods-count" class="reboot badge badge-secondary">
												<i class="reboot fas fa-spinner fa-spin"></i>
											</span>
										</a>
									</div>
									<div id="user-filters-periods" class="reboot collapse height-200 overflow-y-auto" data-parent="#more-filters-accordion">
										<!-- Below is populated dynamically VIA JS -->
										<div class="reboot list-group list-group-flush"></div>
									</div>
								</div>
							</form>
							<form>
								<div class="reboot mx-1">
									<div class="reboot px-0 py-0">
										<a href="#" data-test="Measures" data-target="#user-filters-measures" data-toggle="collapse" class="reboot d-flex justify-content-between align-items-center w-100 click text-primary" tabindex="9">
											<span class="reboot">Measures</span>
											<span data-test="Measures-count" id="filters-measures-count" class="reboot badge badge-secondary">
												<i class="reboot fas fa-spinner fa-spin"></i>
											</span>
										</a>
									</div>
									<div id="user-filters-measures" class="reboot collapse height-200 overflow-y-auto" data-parent="#more-filters-accordion">
										<!-- Below is populated dynamically VIA JS -->
										<div class="reboot list-group list-group-flush"></div>
									</div>
								</div>
							</form>
							<form>
								<div class="reboot mx-1">
									<div class="reboot  px-0 py-0">
										<a href="#" data-test="Axis" data-target="#user-filters-axis" data-toggle="collapse" class="reboot d-flex justify-content-between align-items-center w-100 click text-primary" tabindex="9">
											<span class="reboot">Axis</span>
											<span data-test="Axis-count" id="filters-axis-count" class="reboot badge badge-secondary">
												<i class="fas fa-spinner fa-spin"></i>
											</span>
										</a>
									</div>
									<div id="user-filters-axis" class="reboot collapse height-200 overflow-y-auto" data-parent="#more-filters-accordion">
										<div class="reboot list-group list-group-flush d-none">
											<div class="reboot d-flex justify-content-between align-items-center w-100 px-1">
												<div class="reboot form-check">
													<input id="axes-all-0" title="Select/Deselect all options below." class="reboot form-check-input" type="checkbox" tabindex="9">
													<label class="reboot form-check-label mb-0">
														<a class="reboot" href="#axes-filters-accordion-0" data-toggle="collapse" tabindex="9">Explicit</a>
													</label>
												</div>
												<span class="reboot badge badge-secondary" id="axis-explicit-count"></span>
											</div>
										</div>
										<!-- Below is populated dynamically VIA JS -->
										<div class="reboot list-group list-group-flush d-none">
											<div class="reboot d-flex justify-content-between align-items-center w-100 px-1">
												<div class="reboot form-check">
													<input id="axes-all-1" title="Select/Deselect all options below." class="reboot form-check-input" type="checkbox" tabindex="9">
													<label class="reboot form-check-label mb-0">
														<a class="reboot" href="#axes-filters-accordion-1" data-toggle="collapse" tabindex="9">Typed</a>
													</label>
												</div>
												<span class="reboot badge badge-secondary" id="axis-typed-count"></span>
											</div>
										</div>
									</div>
								</div>
							</form>
							<form>
								<div class="reboot mx-1">
									<div class="reboot px-0 py-0">
										<a href="#" data-test="Members" data-target="#user-filters-members" data-toggle="collapse" class="reboot d-flex justify-content-between align-items-center w-100 click text-primary" tabindex="9">
											<span class="reboot">Members</span>
											<span data-test="Members-count" id="filters-members-count" class="reboot badge badge-secondary">
												<i class="reboot fas fa-spinner fa-spin"></i>
											</span>
										</a>
									</div>
									<div id="user-filters-members" class="reboot collapse height-200 overflow-y-auto" data-parent="#more-filters-accordion">
										<div class="reboot list-group list-group-flush d-none">
											<div class="reboot d-flex justify-content-between align-items-center w-100 px-1">
												<div class="reboot form-check">
													<input id="members-all-0" title="Select/Deselect all options below." class="reboot form-check-input" type="checkbox" tabindex="9">
													<label class="reboot form-check-label mb-0">
														<a class="reboot" href="#members-filters-accordion-0" data-toggle="collapse" tabindex="9">Explicit</a>
													</label>
												</div>
												<span class="reboot badge badge-secondary" id="members-explicit-count"></span>
											</div>
										</div>
										<!-- Below is populated dynamically VIA JS -->
										<div class="reboot list-group list-group-flush d-none">
											<div class="reboot d-flex justify-content-between align-items-center w-100 px-1">
												<div class="reboot form-check">
													<input id="members-all-1" title="Select/Deselect all options below." class="reboot form-check-input" type="checkbox" tabindex="9">
													<label class="reboot form-check-label mb-0">
														<a class="reboot" href="#members-filters-accordion-1" data-toggle="collapse" tabindex="9">Typed</a>
													</label>
												</div>
												<span class="reboot badge badge-secondary" id="members-typed-count"></span>
											</div>
										</div>
									</div>
								</div>
							</form>
							<form>
								<div class="reboot mx-1">
									<div class="reboot px-0 py-0">
										<a href="#" data-test="Scale" data-target="#user-filters-scales" data-toggle="collapse" class="reboot d-flex justify-content-between align-items-center w-100 click text-primary" tabindex="9">
											<span class="reboot">Scale</span>
											<span data-test="Scale-count" id="filters-scales-count" class="reboot badge badge-secondary">
												<i class="reboot fas fa-spinner fa-spin"></i>
											</span>
										</a>
									</div>
									<div id="user-filters-scales" class="reboot collapse height-200 overflow-y-auto" data-parent="#more-filters-accordion">
										<!-- Below is populated dynamically VIA JS -->
										<div class="reboot list-group list-group-flush"></div>
									</div>
								</div>
							</form>
							<form>
								<div class="reboot mx-1">
									<div class="reboot px-0 py-0">
										<a href="#" data-test="Balance" data-target="#user-filters-balances" data-toggle="collapse" class="reboot d-flex justify-content-between align-items-center w-100 click text-primary" tabindex="9">
											<span class="reboot">Balance</span>
											<span data-test="Balance-count" id="filters-balances-count" class="reboot badge badge-secondary">2</span>
										</a>
									</div>
									<div id="user-filters-balances" class="reboot collapse height-200 overflow-y-auto" data-parent="#more-filters-accordion">
										<div class="reboot d-flex justify-content-between align-items-center w-100 px-2">
											<div class="reboot form-check">
												<input id="user-filters-balances-debit" title="Select/Deselect this option." class="reboot form-check-input" type="checkbox" tabindex="9">
												<label class="reboot form-check-label mb-0">Debit</label>
											</div>
										</div>
										<div class="reboot d-flex justify-content-between align-items-center w-100 px-2">
											<div class="reboot form-check">
												<input id="user-filters-balances-credit" title="Select/Deselect this option." class="reboot form-check-input" type="checkbox" tabindex="9">
												<label class="reboot form-check-label mb-0">Credit</label>
											</div>
										</div>
									</div>
								</div>
							</form>
						</div>
					</div>
				</li>
				<li id="current-filters-reset" data-test="current-filters-reset" class="reboot nav-item d-none my-auto ml-1">
					<a href="#" id="current-filters-reset-all" data-name="current-filters-reset" class="reboot nav-link dropdown-toggle text-danger disabled click" tabindex="11" accesskey="7">
						<i class="reboot nav-loading fas fa-redo"></i>
						<span class="reboot d-md-none d-lg-inline">Reset All
							Filters</span>
					</a>
				</li>
				<li id="links-dropdown" data-test="links-dropdown" class="reboot nav-item dropdown d-none my-auto ml-1">
					<a href="#" id="additional-links-dropdown" class="reboot nav-link dropdown-toggle disabled click" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" tabindex="12" accesskey="8">
						<i class="reboot nav-loading fas fa-link"></i>
						<span class="reboot d-md-none d-lg-inline">Links</span>
					</a>
					<div id="links-dropdown-content" class="reboot dropdown-menu dropdown-menu-width w-auto"></div>
				</li>
			</ul>
			<ul class="reboot navbar-nav pull-right bg-inherit">
				<li class="reboot nav-item my-auto ml-1">
					<a id="facts-menu" data-test="facts-menu" class="reboot nav-link click" tabindex="13" accesskey="9">
						Facts
						<span class="reboot taxonomy-total-count badge badge-light"><i class="fas fa-spinner fa-spin"></i></span>
					</a>
				</li>
			</ul>
		</div>
	</nav>
	<div class="reboot main-container">
		<div id="error-container" data-test="error-container" class="reboot px-0"></div>
		<div id="xbrl-form-loading" data-test="xbrl-form-loading" class="reboot jumbotron h-100 d-none">
			<h2 class="reboot display-4 text-center">
				<i class="reboot fas fa-spinner fa-spin"></i>
				Loading Inline Form.
			</h2>
		</div>
		<div id="sections-menu" data-test="sections-menu" class="reboot left-sidenav col-sm-3 bg-light overflow-x-auto invisible">
			<div class="reboot mb-2">
				<span class="reboot lead">Tagged Sections</span>
				<a id="sections-menu-toggle" class="reboot float-right click color-inherit" tabindex="2">
					<i class="reboot fas fa-times-circle mt-2 text-dark"></i>
				</a>
			</div>
			<form id="sections-menu-search-submit" data-name="sections-menu-search" class="reboot my-2 my-lg-0 input-group" novalidate="">
				<div id="sections-search-additional" class="reboot input-group-prepend d-none">
					<button class="reboot dropdown btn btn-sec" type="button" data-toggle="dropdown" tabindex="2">
						<i class="reboot nav-loading fas fa-cog"></i>
					</button>
					<div class="reboot dropdown-menu px-2">
						<div class="reboot form-check">
							<input class="reboot form-check-input" type="radio" name="sections-search-options" value="1" checked="" tabindex="2">
							<label class="reboot form-check-label">Search in All.</label>
						</div>
						<div class="reboot form-check">
							<input class="reboot form-check-input" type="radio" name="sections-search-options" value="2" tabindex="2">
							<label class="reboot form-check-label">Search in Internal
								Sections Only.</label>
						</div>
						<div class="reboot form-check">
							<input class="reboot form-check-input" type="radio" name="sections-search-options" value="3" tabindex="2">
							<label class="reboot form-check-label">Search in External
								Sections Only.</label>
						</div>
					</div>
				</div>
				<input type="text" class="reboot form-control" id="sections-search" data-test="sections-search" placeholder="Search Sections" aria-label="Search all Sections by their associated label." name="search-sections" tabindex="2" required="">
				<div class="reboot input-group-append">
					<button id="section-menu-search-btn-clear" data-name="sections-menu-search-clear" class="reboot btn btn-sec" type="button" tabindex="2">
						<i class="nav-loading fas fa-times-circle" title="Clear Sections Search"></i>
						<span class="reboot sr-only sr-only-focusable">Clear
							Sections Search</span>
					</button>
					<button class="reboot btn btn-sec" type="submit" tabindex="2">
						<i class="reboot nav-loading fas fa-search" title="Submit Sections Search"></i>
						<span class="reboot sr-only sr-only-focusable">Submit
							Sections Search</span>
					</button>
				</div>
			</form>
			<hr>

			<div class="reboot accordion" id="tagged-sections">
				<!-- Below is populated dynamically VIA JS -->
			</div>
		</div>



		<div id="help-menu" data-test="help-menu" class="reboot left-sidenav col-sm-3 bg-light overflow-x-auto invisible">

			<div class="reboot mb-2">
				<span class="reboot lead">Help</span> <a id="help-menu-close" data-test="help-menu-close" class="reboot float-right click"> <i class="reboot fas fa-times-circle mt-2"></i>
				</a>
			</div>
			<div class="reboot accordion" id="help-sections">
				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-getting-started">
								<span class="reboot font-size-1 ">Getting Started</span>
							</button>
						</h5>
					</div>
					<div id="help-getting-started" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">The Inline XBRL viewer allows a user
							to quickly and easily review details of the tagged information in
							an Inline document by automatically placing a top and bottom
							highlight border around each tagged numeric fact and left and
							right border for each block tagged fact. Hovering over a tagged
							fact will highlight (shade) all content related to the tagged
							fact, and clicking on a tagged fact will reveal its tagging
							details in the Fact Review Window. Navigation, search and filter
							options are also provided to easily refine and identify specific
							types of tagged information.</p>
					</div>
				</div>
				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-fact-review-window">
								<span class="reboot font-size-1">Fact Review Window</span>
							</button>
						</h5>
					</div>
					<div id="help-fact-review-window" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">The Fact Review Window shows the tagging
							details for the currently selected fact, which is highlighted
							with a solid blue border. There are four categories of fact detail
							which can be viewed; an "N/A" value indicates there is no
							available information for the item within the given category:</p>
						<ul class="reboot">
							<li class="reboot">Attributes - All primary information (as
								applicable) describing the tagged fact including period, sign,
								decimals, dimensional detail (axes and members), scale, measure
								and data type.</li>
							<li class="reboot">Labels - Detailed documentation
								(definition) for the tag used, and other labels.</li>
							<li class="reboot">References - Authoritative reference
								information (as applicable) for the selected tag.</li>
							<li class="reboot">Calculation - Balance and calculation
								hierarchy details (numeric non-dimensioned items only).</li>
						</ul>
					</div>
				</div>
				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-search">
								<span class="reboot font-size-1">Searching</span>
							</button>
						</h5>
					</div>
					<div id="help-search" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">There are two ways to search the
							document: FACTS AND SECTIONS. To search information, enter a
							keyword in a search box and select the magnifying glass icon to
							return matching results. Search operators "and" (via "AND" or
							"&amp;") and "or" (via "OR" or "|") are available to further refine a
							search.</p>
						<p class="reboot m-2">
							<strong>FACTS</strong>
						</p>
						<p class="reboot m-2">The Search Facts box can be used to find
							tagged facts matching entered keywords. By default, tag name, tag
							labels, and tagged content are included in Search. Tagged facts
							matching the search criteria are shown with a yellow-colored
							(default) shading on the page and appear in the Facts List.
							Select the "X" button to the left of the magnifying glass icon to
							clear the search.</p>
						<p class="reboot m-2">The content included in Search can be increased to
							included tag definitions, dimensions, and authoritative
							references by selecting the cog / wheel icon to the left of the
							search box. See Settings for more information.</p>

						<p class="reboot m-2">
							<strong>SECTIONS</strong>
						</p>
						<p class="reboot m-2">The Search Sections box can be used to
							filter the tagged sections of the financial statements.</p>
					</div>
				</div>
				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-filter">
								<span class="reboot font-size-1">Filters</span>
							</button>
						</h5>
					</div>
					<div id="help-filter" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">Filters change the number of highlighted
							facts and items in the fact list by providing several ways to
							review and pinpoint certain tagged information. Multiple filters
							can be used at once.</p>
						<p class="reboot m-2">
							<strong>DATA FILTERS</strong>
						</p>
						<p class="reboot m-2">These filter options allow the user to
							refine the highlighted tagged facts by data type:</p>
						<ul class="reboot">
							<li class="reboot">All - Displays all tagged data (default)</li>
							<li class="reboot">Amounts Only - Numeric facts only</li>
							<li class="reboot">Text Only - Textual facts only</li>
							<li class="reboot">Calculations Only - Numeric facts
								participating in a calculation only</li>
							<li class="reboot">Negatives Only - Negative Numeric amounts
								only</li>
							<li class="reboot">Additional Items Only - Tagged facts
								without a corresponding HTML presentation (i.e., hidden facts)
								only</li>
						</ul>
						<p class="reboot m-2">
							<strong>TAGS FILTER</strong>
						</p>
						<p class="reboot m-2">These filters allow the user to refine
							the highlighted facts by tag type:</p>
						<ul class="reboot">
							<li class="reboot">All - Displays all tagged data (default)</li>
							<li class="reboot">Standard Only- Facts with standard tags
								from a common taxonomy (e.g., US_GAAP, IFRS, DEI).</li>
							<li class="reboot">Custom Only - Facts with extension
								"custom" tags unique to the entity's document.</li>
						</ul>
						<p class="reboot m-2">
							<strong>MORE FILTERS</strong>
						</p>
						<p class="reboot m-2">Additional filters that allow user to
							further refine the highlighted facts:</p>
						<ul class="reboot">
							<li class="reboot">Periods - List of all used context years
								and reporting periods</li>
							<li class="reboot">Measures - List of all used units of
								measure (e.g., US Dollars); as applicable</li>
							<li class="reboot">Axis - List of all used axis
								(dimensions); as applicable (dimensions); as applicable</li>
							<li class="reboot">Scale - List of all used scaled options
								(e.g., thousands, millions); as applicable</li>
							<li class="reboot">Balance - Debit, credit; as applicable</li>
						</ul>
						<p class="reboot m-2">Multiple filters work in conjunction
							with each other. For example, selecting the "Amounts Only" Data
							filter and "Custom Only" Tags filter will highlight only numeric
							tagged facts using custom tags and list them in the fact list.
							Active filters are displayed in the Filter toolbar as they are
							selected. Active filters can be removed individually by
							unchecking or selecting ALL option for each filter, or all at
							once via the "Reset All Filters" option.</p>
					</div>
				</div>
				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-facts-results-list">
								<span class="reboot font-size-1">Facts List (Results)</span>
							</button>
						</h5>
					</div>
					<div id="help-facts-results-list" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">On the toolbar, select the "count" to
							the right of the word Facts (e.g., Facts 234) to reveal the Facts
							List results - a navigable listing of all currently highlighted
							tagged facts. The count represents the current number of facts.</p>
						<p class="reboot m-2">By default, all tagged facts are
							displayed in the Fact List Results. The list content and count
							reflects the currently highlighted facts (i.e., both Filters and
							Search criteria refine the list to match the highlighted tagged
							facts). Navigation controls are available to move through the
							list as well as move the current view to the corresponding
							highlighted fact location automatically. When a fact in the Facts
							Results List is selected, it will reveal the Fact Review Window.</p>
						<p class="reboot m-2">Certain letters may appear to the right
							of an item in the Fact Result list to indicate a certain
							property. If the letter "A" appears for a fact, it indicates the
							fact is additional data (i.e., hidden with potentially no
							corresponding HTML presentation). If the letter "C" appears, the
							fact is tagged with a custom tag. If the letter "D" appears, the
							fact is tagged with dimensional information.</p>
					</div>
				</div>
				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-tagged-sections">
								<span class="reboot font-size-1">Sections</span>
							</button>
						</h5>
					</div>
					<div id="help-tagged-sections" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">The SECTIONS toolbar item provides a
							listing of the tagged sections of the Inline document. Sections
							are divided into three groups:</p>
						<ul class="reboot">
							<li class="reboot">Document &amp; Entity Information</li>
							<li class="reboot">Financial Statements</li>
							<li class="reboot">Notes to the Financial Statements</li>
						</ul>
						<p class="reboot m-2">By expanding a group and selecting a
							section item in the listing, Inline XBRL viewer will navigate to that section.
							When the Tagged Sections feature is open, the Search Sections box
							will additionally filter the list of sections to only those
							sections that match the entered criteria.</p>
					</div>
				</div>

				<div class="reboot card">
					<div class="reboot card-header px-0 py-0">
						<h5 class="reboot mb-0">
							<button class="reboot btn btn-link d-flex justify-content-between align-items-center w-100" type="button" data-toggle="collapse" data-target="#help-tagged-menu">
								<span class="reboot font-size-1">Menu</span>
							</button>
						</h5>
					</div>
					<div id="help-tagged-menu" class="reboot collapse" data-parent="#help-sections">
						<p class="reboot m-2">
							<strong>Information</strong>
						</p>
						<p class="reboot m-2">The Information menu item provides
							additional detail about the current Inline document and
							customizable viewer settings.</p>
						<ul class="reboot">
							<li class="reboot">Company and Document - Basic company and document
								information</li>
							<li class="reboot">Tags - Fact and tag (standard and custom)
								information</li>
							<li class="reboot">Files - Files used</li>
							<li class="reboot">Additional Items - Additional hidden data
								that's been tagged but potentially does not have a corresponding
								location in the HTML</li>
						</ul>
						<p class="reboot m-2">
							<strong>Save XBRL Instance</strong>
						</p>
						<p class="reboot m-2">The Save XBRL Instance menu item allows
							an XBRL instance document (*.xml) that is extracted from the
							Inline document to be saved locally for use by software
							supporting the XBRL format.</p>
						<p class="reboot m-2">
							<strong>Save XBRL Zip</strong>
						</p>
						<p class="reboot m-2">The Save XBRL Zip menu item allows a zip
							file (*.zip) that contains the as-provided XBRL instance document
							and related custom taxonomy files to be saved locally.</p>
						<p class="reboot m-2">
							<strong>Settings</strong>
						</p>
						<p class="reboot m-2">The Settings menu item provides the
							ability to customize Viewer features.</p>
						<p class="reboot m-2">
							<strong>Tagged Fact Hover</strong>
						</p>
						<ul class="reboot">
							<li class="reboot">On - Displays the hover fact review
								window for any tagged fact*</li>
							<li class="reboot">Off - Hides the hover fact review window
								for any tagged fact (default)</li>
						</ul>
						<p class="reboot m-2">* May impact performance with certain
							web browsers.</p>
						<p class="reboot m-2">
							<strong>Auto Scrolling Position </strong>(This setting will have
							no effect on IE 10 or Safari)
						</p>
						<ul class="reboot">
							<li class="reboot">Top - Selecting a fact from the Sections
								Menu or the Fact Menu will automatically scroll that element to
								the Top of the Inline XBRL viewer window (default)</li>
							<li class="reboot">Center - Selecting a fact from the
								Sections Menu or the Fact Menu will automatically scroll that
								element to the middle of the Inline XBRL viewer window</li>
						</ul>
						<p class="reboot m-2">
							<strong>Highlight Colors</strong> (Use the save and reset buttons
							to save the selected setting or reset to default)
						</p>
						<ul class="reboot">
							<li class="reboot">Tagged Data - Change the highlight color
								of the tagged fact border</li>
							<li class="reboot">Search Results - Change the background
								color of tagged items matching the Search results</li>
							<li class="reboot">Selected Fact - Change the color of
								highlight border used to identify the currently selected fact</li>
							<li class="reboot">Tag Shading (hover) - Change the color of
								the shading applied to tagged data on hover</li>
						</ul>
						<p class="reboot m-2">
							<strong>Search Options</strong>
						</p>
						<ul class="reboot">
							<li class="reboot">Match Case - Matches the specific case of
								the entered Search keyword</li>
							<li class="reboot">Include Labels - Extends Search to
								include tag labels</li>
							<li class="reboot">Include Definitions - Extends Search to
								include tag definitions</li>
							<li class="reboot">Include Dimensions - Extends Search to
								include dimensional detail</li>
							<li class="reboot">Include References - Extends Search to
								include authoritative reference information. Optionally specify
								the reference parts to include in the search (e.g., topic,
								subtopic, section)</li>
						</ul>
						<p class="reboot m-2">
							<strong>Help</strong>(this content)
						</p>
						<p class="reboot m-2">
							<strong>Version</strong>
						</p>
						<p class="reboot m-2">Indicates the current build of the Inline XBRL viewer
							application.</p>
					</div>
				</div>

			</div>
		</div>



		<div data-test="taxonomies-menu" id="taxonomies-menu" class="reboot right-sidenav col-sm-3 bg-light invisible">
			<div class="reboot d-flex flex-column flex-fill h-100">
				<div class="reboot mb-2">
					<span class="reboot lead">Facts</span>
					<a id="taxonomy-menu-secondary-toggle" data-test="taxonomy-secondary-toggle" class="reboot float-right click">
						<i class="reboot fas fa-times-circle mt-2"></i>
					</a>
				</div>
				<div id="taxonomies-menu-list-pagination" class="reboot d-flex flex-column flex-fill h-100 w-100">
					<div class="reboot pagination"></div>
					<div class="reboot form-group">
						<select id="taxonomies-menu-page-select" class="reboot form-control" aria-label="Quickly jump to a page in the Fact Menu." tabindex="13">
							<option class="reboot">Select Page</option>
						</select>
					</div>
					<div class="reboot list-group list-group-flush overflow-x-auto w-100"><span class="text-center py-5">Loading.</span></div>
				</div>
			</div>
		</div>
		<div id="back-to-top" class="reboot d-none">
			<button id="back-to-top-btn" type="button" class="btn btn-sm btn-primary">
				<i class="reboot fas fa-arrow-up"></i>
			</button>
		</div>

		<div id="dynamic-xbrl-form" class="position-relative"><!--?xml version="1.0" ?--><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:f13e9c90-b7ad-4a07-b03e-2f706f72d1ff,g:bdda9bd7-5e35-4d0a-ad16-b8c27a8416e4,d:901bb95f381d40f69da02b9fef764f5e--><meta http-equiv="Content-Type" content="text/html">


<title>abt-20230331</title><div style="display:none"><ix:header><ix:hidden><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80L2ZyYWc6Njg1NDhmZTQ2NTY3NDI3MGIyNzhkY2ZmZjI4N2JiMjcvdGFibGU6NDg1NmY3MGQ3OGYwNDU5NmE1ZTRiMGQxZjdmNDU3YWYvdGFibGVyYW5nZTo0ODU2ZjcwZDc4ZjA0NTk2YTVlNGIwZDFmN2Y0NTdhZl8yLTEtMS0xLTUxODA5_409429eb-4c05-4b49-8a6a-01836fcaee72">0000001800</ix:nonnumeric><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80L2ZyYWc6Njg1NDhmZTQ2NTY3NDI3MGIyNzhkY2ZmZjI4N2JiMjcvdGFibGU6NDg1NmY3MGQ3OGYwNDU5NmE1ZTRiMGQxZjdmNDU3YWYvdGFibGVyYW5nZTo0ODU2ZjcwZDc4ZjA0NTk2YTVlNGIwZDFmN2Y0NTdhZl8zLTEtMS0xLTUxODA5_e9b7aecc-6628-4dfe-aacd-7cce5baaff82">12-31</ix:nonnumeric><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80L2ZyYWc6Njg1NDhmZTQ2NTY3NDI3MGIyNzhkY2ZmZjI4N2JiMjcvdGFibGU6NDg1NmY3MGQ3OGYwNDU5NmE1ZTRiMGQxZjdmNDU3YWYvdGFibGVyYW5nZTo0ODU2ZjcwZDc4ZjA0NTk2YTVlNGIwZDFmN2Y0NTdhZl80LTEtMS0xLTUxODA5_31c65e14-df47-48d3-a7b2-b7881b4db617">2023</ix:nonnumeric><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80L2ZyYWc6Njg1NDhmZTQ2NTY3NDI3MGIyNzhkY2ZmZjI4N2JiMjcvdGFibGU6NDg1NmY3MGQ3OGYwNDU5NmE1ZTRiMGQxZjdmNDU3YWYvdGFibGVyYW5nZTo0ODU2ZjcwZDc4ZjA0NTk2YTVlNGIwZDFmN2Y0NTdhZl81LTEtMS0xLTUxODA5_fa85f318-9f58-4383-bc15-0952a28b2d9b">Q1</ix:nonnumeric><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80L2ZyYWc6Njg1NDhmZTQ2NTY3NDI3MGIyNzhkY2ZmZjI4N2JiMjcvdGFibGU6NDg1NmY3MGQ3OGYwNDU5NmE1ZTRiMGQxZjdmNDU3YWYvdGFibGVyYW5nZTo0ODU2ZjcwZDc4ZjA0NTk2YTVlNGIwZDFmN2Y0NTdhZl82LTEtMS0xLTUxODA5_3cdb9243-8ea6-457b-8df1-c3b7adf3c316">false</ix:nonnumeric><ix:nonnumeric contextref="iaf806062f75b4ffea296eff43c880913_D20230101-20230331" name="abt:MinimumLengthOfTimeHedgedInCashFlowHedge" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfNjQ1_32bee6dc-b03d-416a-a3d9-73785c6a1ebe">P12M</ix:nonnumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaref xlink:type="simple" xlink:href="abt-20230331.xsd"></link:schemaref></ix:references><ix:resources><xbrli:context id="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i148947114aa14878885e1618d2a6a2b2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idabffd4f066349768e68ed96ec926cc1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3958ddc5550840698e906a82b841f72e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i1e8d671828e34662996906aee71f388b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitnumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitnumerator><xbrli:unitdenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitdenominator></xbrli:divide></xbrli:unit><xbrli:context id="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43eddea1184d4003aac2ecaff3210d11_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e92df34460247c3950795525eb078de_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4bec63752274c1696da3054faa991f6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8046febe850b4d36b2eb7de786797a11_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i74b557ae093047c7a2f8bc65d003b8fd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50f0c53ec1ef4f159496a8a90a6f3d67_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie504d88db6094c919c42dcbb98ea5944_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9101b120ca64fcaad1fa5a432872701_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e1b93b791e347b282f9ad3d01ca3f77_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibb3e94d343f04f94b616bdda585a929b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4472410f7f314df1aedd4ce4e47115d9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0569afe73985405fbfca5dcfaa7ae9cf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ab1ef85c672448dbefc61a84290a420_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5eeacf7e4c844ed9e9f099d77a2073b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2af66263295490e83a3a9ab4083256c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i82a7d1bae2e84fcd8e4d18bcca11c40f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i33a00ded9e034d1abe17611ca3b7736c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i460413cfb141475ebe1cf8057dcfde5a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i730c05ab0d5741d8b302d3a08fdd113b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f5acff3249c49e0808b54ebd4b534a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49054d032e5341de91083793555ef1fa_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i94ceff5b3d2848a1a71c2469485a57db_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1c5466b14a304db8a8dafbe006b39ebe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e0b4d14502b460482bc611016663f26_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0213423de94c44019ccc40bc4245a721_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26c0630aef8d43e798c3908df7261016_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecd567dd0d2341e1b29ddcc54c8b7e37_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i035b6168fc8940d2a0449111f396e365_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6c8dee5dd03d4406bc9a1462f0cd0d7e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35351e662b3946778b8bae2908181909_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0924ac0b390a4722af2911303350de7d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a77a23aa91644df95f9c0ffd757fc02_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>abt:segment</xbrli:measure></xbrli:unit><xbrli:context id="i59aba7288ea94e71a5550948cf3e31eb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9ebdacacb92d4e94b4cfa166efd1d8d8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib26333f4c7384ba6a6263ea856ba7765_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5a5715bd39984cc38dbbf68c7154d5b1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifb6f3a80bcfa41d3b2cd6dd9a97f792e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i30f22b73125a44ab88d22c12d20522ae_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:KeyEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3b6fcc89d8194f59a089ccc16fefab41_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7360b44cf13f40e0a18509a59252c1c3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7a82a5ed689848d58d60cfdcd48dd69e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5e1af9d41a3b4ab3a342a1fea73b47e2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i97fccd3d75e147b282b47e4840f28fb3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i134eab6540ec4f4dbf357b01a219b399_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:OtherEmergingMarketsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9e992b933fea4842b103bf588bd86bea_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="icdfc4731de9044a893c37ae5d01c48ad_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i80bdac464a5b478e812274849ec5223a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idf18a527939248739098008e4b29a407_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8fffe02d8f274fd18cf1771ff7523607_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i87c128ad7cdf41f2a4540feb49690207_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0094b23597384c8cbdaf0944852119ce_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic4e5e153b4814125a3065aee911a458d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if34e8c727bb144df8c609d76bd5a03cf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6806781b344a49b0a0c5d16d2a0b6a64_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i65005762efa1479cb3214e5da1ff85f9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibe4683432ae543a0b29600f79845855e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PediatricNutritionalsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia74f7b68d81c49f595a77babb4b32b59_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8aebe0cb600744b9b428d851205dfe9a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3cc39e67e0a941cbb6ea0cd7c05a973a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib19245edea6545c69a5a060ee055e6cf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0933f550888544758127f3bbb77e8514_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i304ed4ed6b784fea9c983fea52ceab58_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:AdultNutritionalsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1a3ee799596543719e38577d55a2b71f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia0047b1773f449f99652fd15a3986991_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if64f8bcdd1344462b07f0f7628dc9c4a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i06e8771634214f839f213274ebcbe975_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iadeda33da14441c3be8a37bc0f849cb8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iad19be6b48f74f50897a26a787246f32_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6167e462fff04de986cb20fd88562feb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i281689992ca54db180c68fa0228e88f2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7b258789836648d7a2f5e3be11622347_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if0332618caa140a8958a26f8c46d6e98_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i14150977ccca4670bd894d440b922297_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i592812b741174076b7c80a521a491695_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:CoreLaboratoryMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib0120d48d28243cfb5d5a31669316bf0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idcae26082e684fdcb5cfe8675fd7d48e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib90060698b8740759ab704f1b607027b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i52fd3e63b10f4ad8a02bf89b5f5ece92_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5550e3bd258f4bd9bc46dd449ca1f750_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1c030b14d2ed4dafa4e017d1c3ad73ae_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:MolecularMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie56024caffd9449b9ca89a72fd10841e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i387286629b6a434190f677743d3ab5af_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i143a3624c7c24e5781b2305a929c1a8c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9d6c41d34faf4b89956fc0655e23f9f7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4de327650d0a49f6a32a9a2fcb9f1d73_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0b802995d3a74eceb6ff50800caf206d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:PointOfCareMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib58fc5fa176e47f58a635219f5d00bd6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4387a4d73657496899800472d96ffcca_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifc37260ce3e44c7588f25a0ffddc87ce_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib0446f2175664fd8847cc0c6ddbf5ec1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6bb810c4f1e14b8fba5fd14365fecb74_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9e667177b5274ac2b66f3f4984d8aaee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4e2cd9411b4547259f234f3d37d3bca1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i44bd8c3ccdae427ab72707bf761d1ff2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6ccaf9e4adbc467aa509133f505b80f3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7d206d9d2dea4f5090681ce6bd95fc8a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i49785b34f77f4d9a8a9c75323d922c59_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iccded785322744b594d6e95a5da23cce_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iffe98fb9bd35435daf251e4efdc4b53b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i629ad9f792aa4fa49fb18992fd403311_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if438dbd694e14134b8ee4662274142dd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic7f8ccb50f8f41248e43ce7e269bda9f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i01ca6ce2ed294098accc68795b89cb80_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9dee10034a194d35b58557d7a4a45803_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RhythmManagementMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i278cae30cfa04edf96da4117c92b3bf7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i95ae93b460414c0890cd72e01cf0a8af_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie7bb5920d33e4f59919844e3fa1c033a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie8dd2b4a668844859f5f04f521e68a5e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie25798391d5c4abfac5364d540963f6c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i35f82eb217ad4a66955ae6d68452ffec_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:ElectrophysiologyMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifca3c9c92061430a9e5012925b5ffa8f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i70f9f63253ad4ea6b0092f253634ea53_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3ea28159eedd440c80b47bf69c2e6ece_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iacd37a9e90d146ebbf3fa932199cd1f8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia4d7158afe7247c5a67c8dfcf660c8b6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1bc2d7b2295746b89599c5881eb06d9e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0d10995fad4f4e68b0b42535f6985da1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0ef6699ffe4b4409bc2c802b16490f1b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3eab75ad790346a5b04b97aca04de241_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ida046084cd8b4327aaf410e813cfbc87_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic8ff6c26944e436080707d429c1fe83c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i47b8849655454b3b9ae6be820fcbc882_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:VascularMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iff5f1c784e284962b8b7c4bc421208e4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9d3904b1d45b48b59ee68e66916ceac9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i786ab705e493445eb34f55b1eb5ddf20_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idfc85f81336044ec99488fdba150b49b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3856ac1965a146daba9616ee78f324df_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie7c15499bb9540cda46fff7ca5ab7e3e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:StructuralHeartMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie51e511274f54fbe8c911836606e333b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i82236fd5a1ca46f199e8dbec45d2de3a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4cca5abdefe246a0a05fbf5b7393e643_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8a4179f516f945238226482679562f8f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie5ce64384838468ca71cfaf072d74f52_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic1b04c8cab9841dd8f219e8458446458_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:NeuromodulationMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib2e0bdc856f44f69bd2e263e7e36dc90_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:DiabetesCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ied48007fb48a477aaa267e8012542fbe_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:DiabetesCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifbe87acf79904f4a9af1462d1f5613d9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:DiabetesCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i003487c6713f4c318b0f09493f097953_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:DiabetesCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ibec0c9c5cbc646d782779493d1b40abc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:DiabetesCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i79e2fa9ad01a4159961b496f38cd1d88_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:DiabetesCareMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ifb84f4ca990746d8a452b63917e79c09_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id96a38e2bc044570a817a5c0ba42831d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i177a8252ee4d4b638b47a978d0522747_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i3825497610b3467f8635e666639656e0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if1f45cd596b047c0ab26ae3215e0e193_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2fbad5ec961c47268cd7ee759ec58b03_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id2d122de90e54253b56ca49a6b721e76_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i509f762913654fcbb109fbfc9799b62a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7029047dc9064ff098b29e87076ce957_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i519bf96b09ae4f1793962f40cf441cbd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i734facbe414049a18242f4d7ba6c2291_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5cf2d116860c4936bd9ccc36e0b34824_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i71d01cbdf0754e8d8ab741a8776b49fa_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i2961f711f2fb4d39865c08a50497fd94_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iad3854f04a58422ca5267adc30e0b611_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic44e3664ddaa40d2b3ec8e93fc77a6d2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idb1e2171349541a5b81da95cde32766f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:HeartFailureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8c5ce2d75f054eb9a1042f3f638183c9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodReclassificationAdjustmentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsegmentsAxis">abt:RapidDiagnosticsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8b699eeae0254fd0b47201e9f19cd838_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:DiagnosticProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc7d17d7f58c4472b5827157f00898fb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:MedicalDevicesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d3805a00f3445b28539df123a4cfdf6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:typedmember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain>2023-04-01</us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain></xbrldi:typedmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="icd6e8cc6801e4ffc8ed77cb2afedfe4c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:typedmember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain>2023-04-01</us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain></xbrldi:typedmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4950353c947435f8a28167dbb179b77_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:typedmember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain>2025-04-01</us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain></xbrldi:typedmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5108fc6f881a4422b13f734c804e80cc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:typedmember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain>2025-04-01</us-gaap:revenueremainingperformanceobligationexpectedtimingofsatisfactionstartdateaxis.domain></xbrldi:typedmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26b45a5d06bf4e98bc964d213c98fcfd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie355518a75604e0da15ec6e9051ddfb4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i0b1d2d67615d43239119edc548f2cd67_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f35fc95a184f259b82549da3bff5c9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie65d4c8bae924c4a81a63f23de909521_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic16ab6c51e434fd08693e117279bd2d7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if914a80751d14e9f8c339ba932064d93_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">abt:StJudeMedicalMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5def2b3772eb4eb9be46d803e62013b7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59a0edfa852f4e538dbd150170f6a956_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d7cdcd3a63a4328ad43f9d17e35fd89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i244422ab50f64c0193508e254b558dd5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i487f0bc874554e53a6fa6076e6071318_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58b2ca6f87a64974a9447f3e5cfe313b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafbd9a2533724636a830035207efcc90_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ied1f76fd93524b358abd3835cd8f3821_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6f81dc76c38c4cf497beb7f57dde7172_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i4561966d0b5348b4803b599bf3e9b5bc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i30ef9ac6448c411b90140bf9eb2d98a9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="if859f647bbea4641a63a5f0475c60ec7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6abf118e0f92461c91fc8118dd251e12_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic903e7c4e980491ebab4dc0ae42affd5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4676364e8eeb483db9ddc8e376318361_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i141ab5fb55224d0b9e671a5085b06dff_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefdc7d9f562a42d5b58bd39a15c39301_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a7ee0bfa68b4f6096f89461b0168802_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43a264a6f390491bad652977df76d77c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:EstablishedPharmaceuticalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9aa4f9893a214cd0aed34ed012e62e6f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida280bcec74742538f374257f20ca0ca_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RestructuringPlanAxis">abt:RestructuringPlan2022StreamlineOfOperationsAndImproveEfficienciesForFourBusinessesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1203f7dfdbbc4e048c4adffc592e6578_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">abt:CostOfGoodsAndServicesSoldMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RestructuringPlanAxis">abt:RestructuringPlan2022StreamlineOfOperationsAndImproveEfficienciesForFourBusinessesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1ad25241e1bd480890c1f6c850441f0b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:RestructuringPlanAxis">abt:RestructuringPlan2022StreamlineOfOperationsAndImproveEfficienciesForFourBusinessesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i7f618d7af5084ff39a1bde7d1d6eee37_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RestructuringPlanAxis">abt:RestructuringPlan2022StreamlineOfOperationsAndImproveEfficienciesForFourBusinessesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5a5f7a9afee4615af611ef4ff744b64_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RestructuringPlanAxis">abt:RestructuringPlan2022StreamlineOfOperationsAndImproveEfficienciesForFourBusinessesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i339e5af605d5441f9250ae0685656b7d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i6ae83cffb65b4863863e8fa97bbb2a59_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">abt:RestrictedStockAwardsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="idcc10e688b78487a8083dfc915a0e318_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="iff57da08c935407fb6ed698c0c11d7c7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide5227ecbb644c8aa728cc6feb96660b_D20220315-20220315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">abt:A255LongTermNotesDue2022Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-03-15</xbrli:startdate><xbrli:enddate>2022-03-15</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i96075db6479749c9b6bcab55f2bcbbc5_I20220315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">abt:A255LongTermNotesDue2022Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8481f7ce10e4885ba9d374c46559537_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1589346f503d4eed8f4857355bd853da_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf806062f75b4ffea296eff43c880913_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ib678f550d770441f847639b178cf7162_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a8fbfa046dd44fdbd60eb9de204aa57_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e21b3a86372457bbb29bacd53de21a4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">abt:FiveYearTermLoanDue2024Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5842560320884b4ca09d1ee717234960_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">abt:FiveYearTermLoanDue2024Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-12-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie652ddad8da44ab7b3257e35e97deacc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">abt:FiveYearTermLoanDue2024Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29316e017ecb4fd9ac8c025fd280f73f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DebtInstrumentAxis">abt:FiveYearTermLoanDue2024Member</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83bfce258f914f0282a0ceacbba11109_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic737d070671843d4b4e94d2dc20e5ae2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i682fcf1581804c00bd53145e30ef97d5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:DeferredIncomeTaxesAndOtherAssetsNoncurrentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i857b08dd304843728a2b4edc9e2adac1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:DeferredIncomeTaxesAndOtherAssetsNoncurrentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if94f09c2f32f40d195fce39b541ed4e4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilitiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80a38e9e75bc4ab99c5bc45ed48fd0dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilitiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c59a71f371048d6b8149957110b0729_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PrepaidExpensesAndOtherReceivablesCurrentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9060369b6314002bd98da0301ffe2ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PrepaidExpensesAndOtherReceivablesCurrentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6d9607924084c2e9ee592b6e86ebe84_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:OtherAccruedLiabilitiesCurrentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08d2fd67dc0247838e1d296020aad581_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:OtherAccruedLiabilitiesCurrentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f6b87f1a44c43999b0843c43f268585_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PrepaidExpenseAndOtherReceivablesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia70cc62a14fc48a4af6f4a094df5c760_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PrepaidExpenseAndOtherReceivablesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibace88747ab645ceb30928a36e8827a3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:OtherAccruedLiabilitiesCurrentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80a3f534c2ca41fba4e80966dcb0c985_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:OtherAccruedLiabilitiesCurrentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13e6528878e0408083556c84d7eabf48_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PrepaidExpenseAndOtherReceivablesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifce8644e0ff04779a198e6d96140ed67_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:PrepaidExpenseAndOtherReceivablesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25a5e508ceaa4ebea2e0f9821d7e70bb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:OtherAccruedLiabilitiesCurrentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd757bdbdf4141aaa446c3b809816bb7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:OtherAccruedLiabilitiesCurrentMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1549e8f60a4d446fb9bba234c7aec8d2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:LongTermDebtExcludingCurrentMaturitiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DebtMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2efe3615243f4d548169acebbd2ada5f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:BalanceSheetLocationAxis">abt:LongTermDebtExcludingCurrentMaturitiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DebtMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00fd463fc60e4769986c725c3e2546a7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">abt:CostOfGoodsAndServicesSoldMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="id5c76d4bbb8d474c9c9cf72dd3a988a4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">abt:CostOfGoodsAndServicesSoldMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9673a64edeb74f94a2da30d9a9d98d48_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ie9b7b52be44b4296a0e398df027b85ce_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:DebtMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i38bd7945f5274d06bb441615ea32b940_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i1e6fc926e07d46cd9a154e136cae40fb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i461bc13197304e459e934cf29a484ca3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied3160c612f04b29956478fa57e5fec7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f37ddf98f7e49a28c4aab1cb538e2e9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i186ce20e309041229664a85b3c0493cf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9e36025d6e949d8bc2a1555cd4ef618_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76fb6d5d675443e8bef64a59f1ee902d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2ebcbddcbdc402b96f02d02939c7313_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3d5d3487ee54862a2d17bc9c8c33841_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherAggregatedInvestmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1648f1c4a921402d87b8daf2f56a458a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i898dd9c510204dc5b25118b6e332d35a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie630ad9b25fd40dab00199e1b0add32a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf5a3ff902f44ab68d0abff8a44f764e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i768adc7924e942e1a5ced688fbdf28ad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40731783197147729ebc7d999fea9ca6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdcbf0e5e0544a539946ac553e1ad902_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ac2b9a95b9b4e838b3e3e9b6198b7ff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3860c46361b4e899d38a0feb173be1a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb49b60ef38446dab1a692e805ebc375_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia517410d985b484bae03d66b28895365_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90903797dbd045c4876732e6152e2a31_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fb068383bf046a1a3b9160d60a024c3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2168e799b254629935c893ee4e1613c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd05d1a66a1d49e6859dfb6ef7567333_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8157806eaebb4a74a10d8a79b40b7ab6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd236f73d0ec46c3a2283cf439977a5f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie651f1bcada8451a9f822de9a86f0970_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7c1d3530e0c475d84f88d994a38b641_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i851a46afc50e4f75995a54d5be04ec0e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia23654808aa54e79b4b5dbb6c3309213_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">abt:LegalProceedingsAndEnvironmentalExposuresMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i698883eb766c454c8f2e05dea484a168_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">abt:LegalProceedingsAndEnvironmentalExposuresMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4640127e23034d04832e15db19017ae6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">abt:LegalProceedingsAndEnvironmentalExposuresMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cb6450851b64b5b87131e6771e96169_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ic06ce61e37914a0aba177ee8c8d0aa99_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i5219a82760434126b153001fe7d898bc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65daf295837843f99c4ef575a76fb9ad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6f76f234e6c4cfaa609a306888b7c66_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i71dce819097046398fee1e1eb1fd6224_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i8f1ac95fbcc84f30b270c838706a1f88_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-01-01</xbrli:startdate><xbrli:enddate>2023-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i776935560ed1406990537cfbfafb2032_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="ia6d8428c497b486fbccee9b4027ea3c4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:StatementBusinessSegmentsAxis">abt:NutritionalProductsMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2022-01-01</xbrli:startdate><xbrli:enddate>2022-03-31</xbrli:enddate></xbrli:period></xbrli:context><xbrli:context id="i9dc04df89731484890459c9dcce08c88_I20230427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">abt:CardiovascularSystemsIncMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i325b9a6ea8f94445a28e2f79fb22141c_D20230427-20230427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000001800</xbrli:identifier><xbrli:segment><xbrldi:explicitmember dimension="us-gaap:BusinessAcquisitionAxis">abt:CardiovascularSystemsIncMember</xbrldi:explicitmember><xbrldi:explicitmember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitmember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startdate>2023-04-27</xbrli:startdate><xbrli:enddate>2023-04-27</xbrli:enddate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i901bb95f381d40f69da02b9fef764f5e_1"></div><div style="min-height:27pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:center"><span><br></span></div></div><div style="margin-top:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></tbody></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8xODQz_9837c303-2454-4cce-8ee5-a991163349b0">10-Q</ix:nonnumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tbody><tr><td style="width:1.0%"></td><td style="width:3.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:700;line-height:114%"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6OTU4MDE0ZGM2NzYyNDM0ZWJlYTMyMDhhNWJkMTRhMDgvdGFibGVyYW5nZTo5NTgwMTRkYzY3NjI0MzRlYmVhMzIwOGE1YmQxNGEwOF8wLTAtMS0xLTUxODA5_1a61e70a-e7cd-4973-bf91-526c98c2d686">x</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></tbody></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8xMDk5NTExNjI5NzAz_ef04b76d-f7c7-4660-9353-f3ac0ee68e66">March 31, 2023</ix:nonnumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.527%"><tbody><tr><td style="width:1.0%"></td><td style="width:3.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:700;line-height:114%"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6NmFiMWMzMGFhOGRlNDE2ZDhiNDY5NmRjOGU4NTU5ZjIvdGFibGVyYW5nZTo2YWIxYzMwYWE4ZGU0MTZkOGI0Njk2ZGM4ZTg1NTlmMl8wLTAtMS0xLTUxODA5_5bd83948-bb45-4c34-9a98-9fad46d06528">o</ix:nonnumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></tbody></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to </span></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No. <ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8xODQ0_292ab13d-0f6a-40d2-bed4-1bb60a361a75">1-2189</ix:nonnumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8xODM4_70ae9e5f-dfde-45b6-9d92-9ca8481ab929">ABBOTT LABORATORIES</ix:nonnumeric></span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tbody><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">An <ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6OTU5NTM0OTQ1ZTNhNDJhNGFmYjYzYTcwMzc3NzJjYjcvdGFibGVyYW5nZTo5NTk1MzQ5NDVlM2E0MmE0YWZiNjNhNzAzNzc3MmNiN18wLTAtMS0xLTUxODA5L3RleHRyZWdpb246YmY3MWYyMzNhM2RmNDVhMWI1ZThkOTQ5Y2VlZjhiOGVfNw_94c9fc8c-4c72-4231-9f0d-0e3561a9dcf6">Illinois</ix:nonnumeric> Corporation</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.R.S. Employer Identification No.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6OTU5NTM0OTQ1ZTNhNDJhNGFmYjYzYTcwMzc3NzJjYjcvdGFibGVyYW5nZTo5NTk1MzQ5NDVlM2E0MmE0YWZiNjNhNzAzNzc3MmNiN18xLTEtMS0xLTUxODA5_eda12226-a82a-4893-b254-94d4832d90cb">36-0698440</ix:nonnumeric></span></td></tr></tbody></table></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8yMzk_f27b03db-933b-4e09-b80e-37e90f206012">100 Abbott Park Road</ix:nonnumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8yNDI_1596d25a-4e72-42de-98d4-e79343d8d7bd">Abbott Park</ix:nonnumeric>, <ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8yNDY_c78aa652-decc-4a72-a2c1-3a7346278725">Illinois</ix:nonnumeric> <ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8yNDk_4722e497-cafc-4714-bdc0-9eaf3c07b7bc">60064-6400</ix:nonnumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Telephone: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8xODM5_e1ba8b25-b704-4784-bf41-e2a96a2fb1ba">224</ix:nonnumeric>) <ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8xODQ1_c181c7bc-2ba7-4c03-b38c-810f97115032">667-6100</ix:nonnumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Securities Registered Pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt;padding-left:3.6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.527%"><tbody><tr><td style="width:1.0%"></td><td style="width:38.808%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.810%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title of Each Class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="i148947114aa14878885e1618d2a6a2b2_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6ODJmZjFkYTdmOGU5NGJiN2I5ODI3OGUzZmNjNzM3OTQvdGFibGVyYW5nZTo4MmZmMWRhN2Y4ZTk0YmI3Yjk4Mjc4ZTNmY2M3Mzc5NF8yLTAtMS0xLTUxODA5_33dcdbcc-9e28-41ca-be27-60fa8beed75a"><ix:nonnumeric contextref="idabffd4f066349768e68ed96ec926cc1_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6ODJmZjFkYTdmOGU5NGJiN2I5ODI3OGUzZmNjNzM3OTQvdGFibGVyYW5nZTo4MmZmMWRhN2Y4ZTk0YmI3Yjk4Mjc4ZTNmY2M3Mzc5NF8yLTAtMS0xLTUxODA5_88c84b20-1fde-4747-a7da-20d5c581f97c">Common Shares, Without Par Value</ix:nonnumeric></ix:nonnumeric></span></td><td colspan="3" style="border-bottom:3pt double #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="i148947114aa14878885e1618d2a6a2b2_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6ODJmZjFkYTdmOGU5NGJiN2I5ODI3OGUzZmNjNzM3OTQvdGFibGVyYW5nZTo4MmZmMWRhN2Y4ZTk0YmI3Yjk4Mjc4ZTNmY2M3Mzc5NF8yLTEtMS0xLTUxODA5_31336685-d02d-4257-8878-e2305596baae"><ix:nonnumeric contextref="idabffd4f066349768e68ed96ec926cc1_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6ODJmZjFkYTdmOGU5NGJiN2I5ODI3OGUzZmNjNzM3OTQvdGFibGVyYW5nZTo4MmZmMWRhN2Y4ZTk0YmI3Yjk4Mjc4ZTNmY2M3Mzc5NF8yLTEtMS0xLTUxODA5_31a8ac35-5f4a-4cdc-b384-1de8fa06ab23">ABT</ix:nonnumeric></ix:nonnumeric></span></td><td colspan="3" style="border-bottom:3pt double #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="i148947114aa14878885e1618d2a6a2b2_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6ODJmZjFkYTdmOGU5NGJiN2I5ODI3OGUzZmNjNzM3OTQvdGFibGVyYW5nZTo4MmZmMWRhN2Y4ZTk0YmI3Yjk4Mjc4ZTNmY2M3Mzc5NF8yLTItMS0xLTUxODA5L3RleHRyZWdpb246MjE0MzhkMmEwODEyNDYwOTlhYmUxMmUwOGY5ZDVmN2RfNQ_fa3298ae-9fdd-4e8b-b0b8-92e00a7d5252">New York Stock Exchange</ix:nonnumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="idabffd4f066349768e68ed96ec926cc1_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6ODJmZjFkYTdmOGU5NGJiN2I5ODI3OGUzZmNjNzM3OTQvdGFibGVyYW5nZTo4MmZmMWRhN2Y4ZTk0YmI3Yjk4Mjc4ZTNmY2M3Mzc5NF8yLTItMS0xLTUxODA5L3RleHRyZWdpb246MjE0MzhkMmEwODEyNDYwOTlhYmUxMmUwOGY5ZDVmN2RfOA_915706fa-fd20-4e95-a9cc-1b11b2acf4fb">Chicago Stock Exchange, Inc.</ix:nonnumeric></span></div></td></tr></tbody></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (l) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of l934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8xODQ2_a0540e76-6783-4f81-8cbb-da8f7829b250">Yes</ix:nonnumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T ( 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8xODQw_af2352c6-f8c9-46a3-898c-bdd30d1a37e5">Yes</ix:nonnumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.666%"><tbody><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6NWJkNDBhZDdiNDczNDE3MDk4NTJlZjRjOGFjOGIzYjAvdGFibGVyYW5nZTo1YmQ0MGFkN2I0NzM0MTcwOTg1MmVmNGM4YWM4YjNiMF8wLTAtMS0xLTUxODA5L3RleHRyZWdpb246ZmM3Y2UwZDk1NDNmNDczNzliMmFmNGU4NDU1YzBmMmNfNA_0c8f2bfc-5655-4760-9652-f0db7a4fc440">Large Accelerated Filer</ix:nonnumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated Filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Accelerated Filer </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6NWJkNDBhZDdiNDczNDE3MDk4NTJlZjRjOGFjOGIzYjAvdGFibGVyYW5nZTo1YmQ0MGFkN2I0NzM0MTcwOTg1MmVmNGM4YWM4YjNiMF8yLTEtMS0xLTUxODA5_9700aa93-d08f-43eb-8efe-a51357b638c5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></ix:nonnumeric></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGFibGU6NWJkNDBhZDdiNDczNDE3MDk4NTJlZjRjOGFjOGIzYjAvdGFibGVyYW5nZTo1YmQ0MGFkN2I0NzM0MTcwOTg1MmVmNGM4YWM4YjNiMF80LTEtMS0xLTUxODA5_52fdaa56-f80c-48fc-9651-276a08977de4"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></ix:nonnumeric></div></td></tr></tbody></table></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8xODQx_756f96b7-47df-4ceb-85e7-2c5981032c1d">x</ix:nonnumeric></span></div><div style="margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&nbsp;31, 2023, Abbott Laboratories had <ix:nonfraction unitref="shares" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xL2ZyYWc6YTlhMjhlZmRlNzc3NDExMTk5MDgxNTVhOGExMWU2YTkvdGV4dHJlZ2lvbjphOWEyOGVmZGU3Nzc0MTExOTkwODE1NWE4YTExZTZhOV8yMTk5MDIzMjU3NDk3_5a2a018b-126c-42b5-823c-4cc7fa04cafb">1,738,946,799</ix:nonfraction> common shares without par value outstanding.</span></div><div style="margin-top:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></tbody></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:30pt;margin-top:24pt;text-align:center"><span><br></span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_7"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:center"><span><br></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tbody><tr><td style="width:1.0%"></td><td style="width:86.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_10">Part I - Financial Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_13">Item 1. Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_16">Condensed Consolidated Statement of Earnings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_19">Condensed Consolidated Statement of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_22">Condensed Consolidated Balance Sheet</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_25">Condensed Consolidated Statement of Shareholders Investment</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_28">Condensed Consolidated Statement of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_31">Notes to the Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_31">8</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_79">Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_79">20</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_103">Item 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_103">25</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_106">Part II - Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_106">25</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_109">Item 1. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_109">25</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_112">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_112">25</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_115">Item 6. Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_115">26</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_118">Signature</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i901bb95f381d40f69da02b9fef764f5e_118">27</a></span></div></td></tr></tbody></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_10"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:center"><span><br></span></div></div><div><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_13"></div><div><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cond</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ensed Consolidated Statement of Earnings</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in millions except per share data; shares in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:76.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMy0xLTEtMS01MTgwOQ_0d8b01a2-b2b7-4599-9f60-a8e778f84e24">9,747</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMy0zLTEtMS01MTgwOQ_93afedbd-e998-4ac3-9677-49a6692983cd">11,895</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold, excluding amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfNS0xLTEtMS01MTgwOQ_267d528b-f383-4f53-a43c-0a00712938fa">4,331</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfNS0zLTEtMS01MTgwOQ_a617e067-f549-4d79-8a9a-c3fc44123a5d">4,987</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfNi0xLTEtMS01MTgwOQ_c3321d07-5686-493a-814e-2c25d52a1e34">491</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfNi0zLTEtMS01MTgwOQ_d2079a32-0a5f-49d9-86e1-4ca85f95526e">512</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfNy0xLTEtMS01MTgwOQ_b7c0358e-932e-466c-9038-fa90e14017d6">654</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfNy0zLTEtMS01MTgwOQ_a8dec9d1-e1dd-4f59-9b85-6e2f30b95795">697</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfOC0xLTEtMS01MTgwOQ_08d902f3-01e0-481f-a98b-be1e98d67e5a">2,762</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfOC0zLTEtMS01MTgwOQ_09e1d622-c3cf-43a2-8a07-2573521fdd0d">2,787</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating cost and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfOS0xLTEtMS01MTgwOQ_e3c6a326-2427-4da7-8514-d2ea68b76581">8,238</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfOS0zLTEtMS01MTgwOQ_b9dbecdb-5bdb-4dd0-949b-929e65c90274">8,983</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTEtMS0xLTEtNTE4MDk_38d55dc6-ceeb-43f1-b406-16f9cb02283e">1,509</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTEtMy0xLTEtNTE4MDk_3d8cd476-875b-43a5-95d2-995fd77bd93d">2,912</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTMtMS0xLTEtNTE4MDk_60eb8dea-067c-43c9-83a6-e1db135d2394">153</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTMtMy0xLTEtNTE4MDk_0b50fe55-736a-4b50-81d9-ce8123e57bc5">131</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTQtMS0xLTEtNTE4MDk_2f8fc7b8-ad7d-4630-a9e5-13b05fd317ba">101</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTQtMy0xLTEtNTE4MDk_0636d720-4085-48e5-ba5d-f374eb9e82b5">14</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTUtMS0xLTEtNTE4MDk_51ff45cf-f90b-4a2d-9c64-d2d42d113e3d">6</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTUtMy0xLTEtNTE4MDk_3da59311-f851-496c-be7c-64880a955ec2">3</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTYtMS0xLTEtNTE4MDk_4c7b133f-c677-42c5-a524-92eda2eecba2">111</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTYtMy0xLTEtNTE4MDk_117fd912-f136-47f9-8951-f9cefc0a0608">78</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTctMS0xLTEtNTE4MDk_bfc12144-a0bf-4d7a-bf85-ff137a7aca5e">1,562</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTctMy0xLTEtNTE4MDk_e682e1eb-0387-4419-99df-e7dd06f8da44">2,876</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes on earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTgtMS0xLTEtNTE4MDk_ee9099b3-5cdb-4de9-872a-b44bbbcb336e">244</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTgtMy0xLTEtNTE4MDk_67878dd4-cfd6-41be-b7fa-9118d64e3ebb">429</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTktMS0xLTEtNTE4MDk_b607ea5b-adf7-48de-8ef7-6934d44bc996">1,318</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMTktMy0xLTEtNTE4MDk_f75aab14-53ff-4d98-83f1-142cf429dda6">2,447</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic Earnings Per Common Share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usdPerShare" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMjEtMS0xLTEtNTE4MDk_0fb85c34-e696-492f-9f0e-eaff9e9865c1">0.75</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usdPerShare" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMjEtMy0xLTEtNTE4MDk_cc9ab133-6d29-4ced-9760-9e252820d4e6">1.38</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings Per Common Share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usdPerShare" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMjMtMS0xLTEtNTE4MDk_877991e8-4f7f-4437-b0c7-7972c2488bb7">0.75</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usdPerShare" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMjMtMy0xLTEtNTE4MDk_77745ff4-a42c-4b56-bf05-0cd33d9788f9">1.37</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="shares" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMjUtMS0xLTEtNTE4MDk_98561fe8-f9cb-47d5-ad0d-9652cdb021e2">1,741,738</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="shares" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMjUtMy0xLTEtNTE4MDk_942be683-e05a-43e3-9e4d-a2f2800bc135">1,761,911</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive Common Stock Options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="shares" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMjYtMS0xLTEtNTE4MDk_955eee7f-a8ce-4353-9853-e0ab1b8d3c1b">9,977</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="shares" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMjYtMy0xLTEtNTE4MDk_543ac8c1-8fa7-4f50-b7d3-08d72feedb9b">12,631</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="shares" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMjctMS0xLTEtNTE4MDk_808b6670-1941-48ae-9d9e-c46422315cfa">1,751,715</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="shares" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMjctMy0xLTEtNTE4MDk_67639152-e7fb-47ce-8bc0-02a4dd9c075e">1,774,542</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding Common Stock Options Having No Dilutive Effect</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="shares" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMjktMS0xLTEtNTE4MDk_99095452-c416-4b4a-9ac5-02338b0f860a">7,332</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="shares" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xNi9mcmFnOjYyNzgzYmJiODE2NDQyYjE4M2ZlMTAzOGRlMTdmMTRmL3RhYmxlOjViZWU2ZDY2ZWQ1MTRlNjc4ZjBhYzY4MDU3NmEwNzkwL3RhYmxlcmFuZ2U6NWJlZTZkNjZlZDUxNGU2NzhmMGFjNjgwNTc2YTA3OTBfMjktMy0xLTEtNTE4MDk_d89cddfc-01bf-473e-8a0a-5568acdf5580">2,655</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_19"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:center"><span><br></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statement of Comprehensive Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">naudited)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in mill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ions)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tbody><tr><td style="width:1.0%"></td><td style="width:71.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.253%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.256%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfMy0xLTEtMS01MTgwOQ_034572da-f788-4e1e-b8cb-d0230e6d0e93">1,318</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfMy0zLTEtMS01MTgwOQ_4c020375-af1d-4ac2-8505-28c632d25f89">2,447</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation gain (loss) adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfNC0xLTEtMS01MTgwOQ_3604568a-6eaa-49ad-b5f1-7d95761b55fd">139</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfNC0zLTEtMS01MTgwOQ_14516753-fe7c-4c66-a7d2-cb9d3c8c8b5b">106</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net actuarial gains (losses) and amortization of net actuarial losses and prior service costs and credits, net of taxes of $<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfNS0wLTEtMS01MTgwOS90ZXh0cmVnaW9uOmI2Nzk4ZmU0Y2FlMjRmYjY5OTMyNDgxN2I1YTlmM2EyXzU0OTc1NTgxNDA0NQ_f3f0fa9e-77ed-4c17-982e-b1bcbcaa5db1"></ix:nonfraction> in 2023 and $<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfNS0wLTEtMS01MTgwOS90ZXh0cmVnaW9uOmI2Nzk4ZmU0Y2FlMjRmYjY5OTMyNDgxN2I1YTlmM2EyXzU0OTc1NTgxNDA1MQ_b487336a-2552-4dc0-8623-c8781e58a80a">13</ix:nonfraction> in 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfNS0xLTEtMS01MTgwOQ_5be6e3e4-7d13-4319-be6b-d9e2d14469f7">2</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfNS0zLTEtMS01MTgwOQ_94824ec2-e6ec-4f7f-9d5b-79230982cfa7">62</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net gains (losses) for derivative instruments designated as cash flow hedges and other, net of taxes of $(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfNi0wLTEtMS01MTgwOS90ZXh0cmVnaW9uOmQ1MjU4NDc5MmU1MTQwZTA5NGU4MWRlYjEwYjU0YTkzXzU0OTc1NTgxNDAyOA_b22f7b96-0e03-45f7-bad0-7a53b8047c1a">58</ix:nonfraction>) in 2023 and $(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfNi0wLTEtMS01MTgwOS90ZXh0cmVnaW9uOmQ1MjU4NDc5MmU1MTQwZTA5NGU4MWRlYjEwYjU0YTkzXzU0OTc1NTgxNDAzNg_c1f5ad64-deaa-43ed-bd3e-f9aa3391fddb">15</ix:nonfraction>) in 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfNi0xLTEtMS01MTgwOQ_f93ca192-99ca-4d60-ac25-dc89b7b026b7">129</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfNi0zLTEtMS01MTgwOQ_1b41d6f6-e298-4327-82e2-ec045cd90a9a">56</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfNy0xLTEtMS01MTgwOQ_54eb6f32-9b0d-4cbd-86af-d5541fc0ebde">12</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfNy0zLTEtMS01MTgwOQ_a9cf9897-ff27-432e-94d2-4d3d128abcad">100</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfOC0xLTEtMS01MTgwOQ_807faec6-030d-40f7-acbe-a38c06f124c2">1,330</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmNmM2EyYWQwMDQ5ZDQ0YThhMGQ5MTMxNmJmMzMwYWMyL3RhYmxlcmFuZ2U6Y2YzYTJhZDAwNDlkNDRhOGEwZDkxMzE2YmYzMzBhYzJfOC0zLTEtMS01MTgwOQ_05a37f06-023f-4fac-83b5-ace5191ff3cc">2,347</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental Accumulated Other Comprehensive Income (Loss) Information, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative foreign currency translation (loss) adjustments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmM3NTU1MjQ2ZmI5NjRiZTRiMzc0ZTY1MTdhNDU2Yjk3L3RhYmxlcmFuZ2U6Yzc1NTUyNDZmYjk2NGJlNGIzNzRlNjUxN2E0NTZiOTdfMi0xLTEtMS01MTgwOQ_220669aa-a538-46aa-a185-90ba8e36e8cf">6,594</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmM3NTU1MjQ2ZmI5NjRiZTRiMzc0ZTY1MTdhNDU2Yjk3L3RhYmxlcmFuZ2U6Yzc1NTUyNDZmYjk2NGJlNGIzNzRlNjUxN2E0NTZiOTdfMi0zLTEtMS01MTgwOQ_ada6f094-628f-40ff-957e-2e86a1313709">6,733</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial (losses) and prior service (costs) and credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmM3NTU1MjQ2ZmI5NjRiZTRiMzc0ZTY1MTdhNDU2Yjk3L3RhYmxlcmFuZ2U6Yzc1NTUyNDZmYjk2NGJlNGIzNzRlNjUxN2E0NTZiOTdfMy0xLTEtMS01MTgwOQ_673a3ecb-d2d8-4775-8002-d09d2a058182">1,491</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmM3NTU1MjQ2ZmI5NjRiZTRiMzc0ZTY1MTdhNDU2Yjk3L3RhYmxlcmFuZ2U6Yzc1NTUyNDZmYjk2NGJlNGIzNzRlNjUxN2E0NTZiOTdfMy0zLTEtMS01MTgwOQ_2df4cbb6-f9f0-430c-8010-6673f5ef4bda">1,493</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative gains (losses) on derivative instruments designated as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmM3NTU1MjQ2ZmI5NjRiZTRiMzc0ZTY1MTdhNDU2Yjk3L3RhYmxlcmFuZ2U6Yzc1NTUyNDZmYjk2NGJlNGIzNzRlNjUxN2E0NTZiOTdfNC0xLTEtMS01MTgwOQ_d72eaf7a-b09c-46e7-9832-9a9c435759a7">46</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmM3NTU1MjQ2ZmI5NjRiZTRiMzc0ZTY1MTdhNDU2Yjk3L3RhYmxlcmFuZ2U6Yzc1NTUyNDZmYjk2NGJlNGIzNzRlNjUxN2E0NTZiOTdfNC0zLTEtMS01MTgwOQ_6215691b-352d-40cb-b3cb-27762f7534e4">175</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmM3NTU1MjQ2ZmI5NjRiZTRiMzc0ZTY1MTdhNDU2Yjk3L3RhYmxlcmFuZ2U6Yzc1NTUyNDZmYjk2NGJlNGIzNzRlNjUxN2E0NTZiOTdfNS0xLTEtMS01MTgwOQ_a33a7855-f037-45dd-bae5-794299595e39">8,039</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8xOS9mcmFnOmQ1NmYzOTU5MGFkYjQ1MzJhMDhmOWRiNjdhNDMzMzQ0L3RhYmxlOmM3NTU1MjQ2ZmI5NjRiZTRiMzc0ZTY1MTdhNDU2Yjk3L3RhYmxlcmFuZ2U6Yzc1NTUyNDZmYjk2NGJlNGIzNzRlNjUxN2E0NTZiOTdfNS0zLTEtMS01MTgwOQ_b927b876-8423-4454-b9fd-1016a480b528">8,051</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_22"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:center"><span><br></span></div></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Balance Sheet</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> millions)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMy0xLTEtMS01MTgwOQ_508cf82c-ff6c-4321-8a6d-341ee36055d9">9,161</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMy0zLTEtMS01MTgwOQ_8694f067-7580-4bd8-9a3e-b0808dc3d097">9,882</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNC0xLTEtMS01MTgwOQ_bbe21232-ef95-46f5-9f22-f5b9bb5fb6d3">371</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNC0zLTEtMS01MTgwOQ_8ab58fea-0fd7-4417-90dd-b13f1c1dd815">288</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Trade receivables, less allowances of $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNS0wLTEtMS01MTgwOS90ZXh0cmVnaW9uOmE3ZGM0ZjM5ZDhmZjQ0YTI4Mzk2Y2NmMDQ1ZjFjYjdlXzU0OTc1NTgxMzk3MA_45e92758-095a-4e30-847a-709c103391dd">503</ix:nonfraction> in 2023 and $<ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNS0wLTEtMS01MTgwOS90ZXh0cmVnaW9uOmE3ZGM0ZjM5ZDhmZjQ0YTI4Mzk2Y2NmMDQ1ZjFjYjdlXzU0OTc1NTgxMzk2Mw_5bf38c38-6370-40d2-8cce-fad7c19e3a12">500</ix:nonfraction> in 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNS0xLTEtMS01MTgwOQ_a854371b-00b5-4f5c-9976-b468fab9cab9">6,020</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNS0zLTEtMS01MTgwOQ_912c6aa2-00a6-4f13-9bb7-26c3977b82f4">6,218</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNy0xLTEtMS01MTgwOQ_de7cd7c3-9d71-4dea-bbe7-32b5e1aff8e5">3,944</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNy0zLTEtMS01MTgwOQ_970ed070-2df7-47d3-ab4f-178466aaf180">3,805</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfOC0xLTEtMS01MTgwOQ_273323cb-29b5-4ea8-a3ec-a5f6592728a1">805</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfOC0zLTEtMS01MTgwOQ_7df09173-3b04-41f5-a009-0b0223eade91">680</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfOS0xLTEtMS01MTgwOQ_66c0d873-af97-4cb1-9c9c-494bfe9ae94b">1,924</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfOS0zLTEtMS01MTgwOQ_6a3391ec-0343-4682-a58a-647bd39892c7">1,688</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventories</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTAtMS0xLTEtNTE4MDk_c31cf511-4b44-41ba-8b7c-515e4614e064">6,673</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTAtMy0xLTEtNTE4MDk_a50e5014-af14-4fbb-856c-74bbeba27660">6,173</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="abt:PrepaidExpenseAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTEtMS0xLTEtNTE4MDk_92dba239-9bf0-44b2-8205-59769f40bd7f">2,152</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="abt:PrepaidExpenseAndOtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTEtMy0xLTEtNTE4MDk_da136b37-4242-4d75-82f6-d54b2e3f9b55">2,663</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Current Assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTItMS0xLTEtNTE4MDk_0bc52fd9-f1bf-4ae2-9a57-ee2c9c7fd58c">24,377</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTItMy0xLTEtNTE4MDk_a7880ad7-28df-42b8-9606-6d3ce45c8b3c">25,224</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTMtMS0xLTEtNTE4MDk_7733aff7-0ab9-4380-9373-9076d6b7c385">776</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTMtMy0xLTEtNTE4MDk_7d0cc370-44f8-4116-9005-79e9cbc64dc7">766</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTQtMS0xLTEtNTE4MDk_979fd816-6ea2-4130-b8ec-fb4e99a1219a">20,605</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTQtMy0xLTEtNTE4MDk_15329f89-a2b3-44b6-b1be-600739833080">20,212</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTUtMS0xLTEtNTE4MDk_73283cf6-05d8-43c7-94e7-d6630b4fd6ed">11,323</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTUtMy0xLTEtNTE4MDk_fff8c5e0-2c03-4328-b31d-e6355a4fe032">11,050</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTYtMS0xLTEtNTE4MDk_80ce3915-ed03-4de1-8529-ac33713598f0">9,282</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTYtMy0xLTEtNTE4MDk_8c6d0fd8-904d-4bba-87d4-55e929a8992f">9,162</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net of amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTctMS0xLTEtNTE4MDk_a7256bd5-ebc4-40e0-8f7f-4e37f813b477">10,006</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTctMy0xLTEtNTE4MDk_a7fe1e75-4977-4bb1-b4f1-b1a5a89ec277">10,454</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTgtMS0xLTEtNTE4MDk_f4c1717b-6e15-4d80-aa2e-b14deb693299">22,927</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTgtMy0xLTEtNTE4MDk_cd2fb874-0300-423d-8fed-99ed769d0b98">22,799</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTktMS0xLTEtNTE4MDk_710b69d0-a746-4291-8013-018d73b6f7bf">6,426</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMTktMy0xLTEtNTE4MDk_aed19a70-2bf7-47d1-b390-7623e307e158">6,033</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjAtMS0xLTEtNTE4MDk_1829be43-21ba-4d60-ac2c-c3cc8f768538">73,794</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjAtMy0xLTEtNTE4MDk_47dfd174-bea5-442d-8e2b-f78e490c477e">74,438</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Liabilities and Shareholders Investment</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjMtMS0xLTEtNTE4MDk_2565c13b-bd67-4fa4-8584-b03378c8b2a3">4,167</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjMtMy0xLTEtNTE4MDk_472a97dc-e6a1-4510-b016-6b6bf38126a8">4,607</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Salaries, wages and commissions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjQtMS0xLTEtNTE4MDk_537c6d67-502b-43d5-ae65-e76749f2ea91">1,098</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjQtMy0xLTEtNTE4MDk_8670def3-b8e2-41b0-9092-dd537a2468a9">1,556</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjUtMS0xLTEtNTE4MDk_814d0ba6-3e14-432c-917a-8507b57452ee">5,758</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjUtMy0xLTEtNTE4MDk_a4b49c25-6d89-43b0-8650-f901217f194b">5,845</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjYtMS0xLTEtNTE4MDk_56284b23-2a75-4995-afc3-438355ac9ea9">888</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjYtMy0xLTEtNTE4MDk_096949f0-c288-4003-a6d6-fbc233396d99">887</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjctMS0xLTEtNTE4MDk_da6ebd09-60b8-4a90-80b1-25e0a5364068">334</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjctMy0xLTEtNTE4MDk_3359d183-8a33-4972-b8c6-41d7de9fb332">343</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjgtMS0xLTEtNTE4MDk_d8f54996-27a3-4f5d-8dc5-e0435a06344e">2,285</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjgtMy0xLTEtNTE4MDk_4515735c-c831-4893-a416-16a96f53cd46">2,251</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Current Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjktMS0xLTEtNTE4MDk_fa6d4199-d2e5-401e-9199-426790acd9f7">14,530</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMjktMy0xLTEtNTE4MDk_c5cd305d-9f62-445c-983b-ede4b58fc9da">15,489</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzAtMS0xLTEtNTE4MDk_8097cda9-5d6d-4caf-8d88-66af805e3332">14,615</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzAtMy0xLTEtNTE4MDk_016bd2cc-f450-4fdc-b888-c244a75937ce">14,522</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Post-employment obligations, deferred income taxes and other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="abt:PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzEtMS0xLTEtNTE4MDk_83eb68ea-c0e6-46c1-ae7c-663eecab832b">7,417</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="abt:PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzEtMy0xLTEtNTE4MDk_31938cb3-1dbc-4071-9f5f-282a5a472d33">7,522</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and Contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzItMS0xLTEtNTE4MDk_f6f746c0-7e90-4a6f-b3cb-b18657e52823"></ix:nonfraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzItMy0xLTEtNTE4MDk_953382cc-392a-493a-ab30-d848dcacb0cf"></ix:nonfraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders Investment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Preferred shares, <ix:nonfraction unitref="usdPerShare" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzQtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo4MzJlN2FiMjI0YjY0MmM5YTk3NTJiNTMyZTdkYmNhNF8xMDk5NTExNjI3ODY0_1ec402b6-2461-435d-9c0b-9e6500b56b9b"><ix:nonfraction unitref="usdPerShare" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzQtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo4MzJlN2FiMjI0YjY0MmM5YTk3NTJiNTMyZTdkYmNhNF8xMDk5NTExNjI3ODY0_e017c246-bfbc-4ac0-935a-fd6e8c0486ab">one</ix:nonfraction></ix:nonfraction> dollar par value Authorized  <ix:nonfraction unitref="shares" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzQtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo4MzJlN2FiMjI0YjY0MmM5YTk3NTJiNTMyZTdkYmNhNF8xMDk5NTExNjI3ODc3_09f7ce81-2d48-43b1-b57a-4b799735a5ee"><ix:nonfraction unitref="shares" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzQtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo4MzJlN2FiMjI0YjY0MmM5YTk3NTJiNTMyZTdkYmNhNF8xMDk5NTExNjI3ODc3_e9787895-197f-46b7-905a-54b1cf084d39">1,000,000</ix:nonfraction></ix:nonfraction> shares, <ix:nonfraction unitref="shares" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzQtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo4MzJlN2FiMjI0YjY0MmM5YTk3NTJiNTMyZTdkYmNhNF8zODQ4MjkwNjk3MzI0_927a184d-4194-41bb-b45f-98a0f537eaa5"><ix:nonfraction unitref="shares" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzQtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo4MzJlN2FiMjI0YjY0MmM5YTk3NTJiNTMyZTdkYmNhNF8zODQ4MjkwNjk3MzI0_e47d689a-1795-42ad-abfd-849981abcc93">none</ix:nonfraction></ix:nonfraction> issued</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzQtMS0xLTEtNTE4MDk_78cc6fb8-437b-4f4a-8205-9905250186d1"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzQtMy0xLTEtNTE4MDk_eddb1ee9-fa9f-4b6a-9e5a-da13630bda11"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common shares, without par value Authorized  <ix:nonfraction unitref="shares" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzUtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo2M2Y5ODliNjgxMGU0ZmEyYWFiZjUyNTUyNDEwMGY4OF81MA_ad9e740d-f652-429e-8b9d-232b6cea9bd2"><ix:nonfraction unitref="shares" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzUtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo2M2Y5ODliNjgxMGU0ZmEyYWFiZjUyNTUyNDEwMGY4OF81MA_b1540fea-d83a-4af1-a666-d9dd479b52a2">2,400,000,000</ix:nonfraction></ix:nonfraction> shares </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issued at stated capital amount  Shares: 2023: <ix:nonfraction unitref="shares" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzUtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo2M2Y5ODliNjgxMGU0ZmEyYWFiZjUyNTUyNDEwMGY4OF8xMDc_f4c7798f-dbbc-4926-b6a2-7f3906054cfa">1,986,904,170</ix:nonfraction>; 2022: <ix:nonfraction unitref="shares" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzUtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo2M2Y5ODliNjgxMGU0ZmEyYWFiZjUyNTUyNDEwMGY4OF8xMTU_8bb305c0-07b9-4998-98e8-e563d2d813c0">1,986,519,278</ix:nonfraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzUtMS0xLTEtNTE4MDk_02f31c1b-6f1e-43e3-b519-0291f3dc547c">24,488</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzUtMy0xLTEtNTE4MDk_d6b239d0-9817-4dff-a4bf-9c108700b53f">24,709</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common shares held in treasury, at cost  Shares: 2023: <ix:nonfraction unitref="shares" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzYtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo1MjY5NWIzMzdjNjA0OTRlODI1NDBiNThkMGZiMzQ5Yl81OA_48a5d94b-f875-4cfb-b57f-9677adef0e63">247,957,371</ix:nonfraction>; 2022: <ix:nonfraction unitref="shares" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzYtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo1MjY5NWIzMzdjNjA0OTRlODI1NDBiNThkMGZiMzQ5Yl82Ng_b20f6cfa-c287-4f52-a251-2ac189490338">248,724,257</ix:nonfraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzYtMS0xLTEtNTE4MDk_426e31d3-5d70-4236-a7a4-81a4bcb776cd">15,307</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzYtMy0xLTEtNTE4MDk_92a08c78-d474-4d61-940f-be6f0506f276">15,229</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings employed in the business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzctMS0xLTEtNTE4MDk_c6f6f0c1-b163-487e-bdeb-4f1a39063fad">35,868</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzctMy0xLTEtNTE4MDk_fe2b3e16-05ff-4683-a37d-c3f4961712af">35,257</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzgtMS0xLTEtNTE4MDk_b2929fe0-789d-4d3c-8349-3684821f7713">8,039</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzgtMy0xLTEtNTE4MDk_ee08f448-8906-4ea8-b76b-49bc689d2550">8,051</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Abbott Shareholders Investment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzktMS0xLTEtNTE4MDk_a19f1121-51aa-419f-85da-bc105f20418d">37,010</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfMzktMy0xLTEtNTE4MDk_d19f8e5b-4229-4fc9-8226-d35a7d9693a8">36,686</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling Interests in Subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNDAtMS0xLTEtNTE4MDk_f884b2f8-ff6e-4284-831f-4867e0da7b75">222</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNDAtMy0xLTEtNTE4MDk_6df06a8c-f97b-4b7f-8257-a3e3ccb6ebde">219</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Shareholders Investment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNDEtMS0xLTEtNTE4MDk_97d451a5-a6eb-454c-8d35-dadb19f68cee">37,232</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNDEtMy0xLTEtNTE4MDk_b2ac3c36-9de2-48c0-8e97-4fa35cbf5c61">36,905</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNDItMS0xLTEtNTE4MDk_e6879827-14a0-428d-b904-4998c63e051e">73,794</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yMi9mcmFnOjBhMzZhYWRkMDNlNjRlN2NhMDFhNmFlZDMxMzU0MWViL3RhYmxlOmFjNjIzNWM0ODQ0ODRjYTViZTFhMjc3ZDIyZTliMzFjL3RhYmxlcmFuZ2U6YWM2MjM1YzQ4NDQ4NGNhNWJlMWEyNzdkMjJlOWIzMWNfNDItMy0xLTEtNTE4MDk_b47625d2-6302-45f5-9635-f981cfbe199e">74,438</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_25"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:center"><span><br></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statement of Shareholders Investment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(in millions except shares and per share data)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares: 2023: <ix:nonfraction unitref="shares" contextref="i43eddea1184d4003aac2ecaff3210d11_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfNC0wLTEtMS01MTgwOS90ZXh0cmVnaW9uOmM2NzFjYzQ0Y2ZkNjRlZjFhMDNlNWJjNjdmMzdkNDI1XzU0OTc1NTgxMzk2Nw_119871ce-28ad-4f9d-bd15-400966e0f262">1,986,519,278</ix:nonfraction>; 2022: <ix:nonfraction unitref="shares" contextref="i5e92df34460247c3950795525eb078de_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfNC0wLTEtMS01MTgwOS90ZXh0cmVnaW9uOmM2NzFjYzQ0Y2ZkNjRlZjFhMDNlNWJjNjdmMzdkNDI1XzU0OTc1NTgxMzk4Mw_ec1a9b83-9366-48bf-a5a5-e8354cfe42bb">1,985,273,421</ix:nonfraction></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i43eddea1184d4003aac2ecaff3210d11_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfNC0xLTEtMS01MTgwOQ_fb65e392-bef1-4094-9cbf-b7fc86e50288">24,709</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i5e92df34460247c3950795525eb078de_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfNC0zLTEtMS01MTgwOQ_ea232a22-726a-4238-a821-e42a2ee61a3c">24,470</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued under incentive stock programs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares: 2023: <ix:nonfraction unitref="shares" contextref="ie4bec63752274c1696da3054faa991f6_D20230101-20230331" decimals="INF" name="abt:StockIssuedDuringPeriodSharesIncentiveStockPrograms" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfNi0wLTEtMS01MTgwOS90ZXh0cmVnaW9uOjFlYzhjNTc2Yjk2NTQzMjI4YTc2YjIwZTkwOGQzZDQ1XzE2_6ab3470a-2afa-43ec-9f5f-d80e358101f4">384,892</ix:nonfraction>; 2022: <ix:nonfraction unitref="shares" contextref="i8046febe850b4d36b2eb7de786797a11_D20220101-20220331" decimals="INF" name="abt:StockIssuedDuringPeriodSharesIncentiveStockPrograms" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfNi0wLTEtMS01MTgwOS90ZXh0cmVnaW9uOjFlYzhjNTc2Yjk2NTQzMjI4YTc2YjIwZTkwOGQzZDQ1XzI0_c14164de-3b98-4200-b27e-46fcfa7535c4">251,632</ix:nonfraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie4bec63752274c1696da3054faa991f6_D20230101-20230331" decimals="-6" name="abt:StockIssuedDuringPeriodValueIncentiveStockPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfNi0xLTEtMS01MTgwOQ_4770a2bd-ceae-4ce8-a612-20c674d3e8d5">16</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8046febe850b4d36b2eb7de786797a11_D20220101-20220331" decimals="-6" name="abt:StockIssuedDuringPeriodValueIncentiveStockPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfNi0zLTEtMS01MTgwOQ_e09ff3b7-db24-4dd8-aa1c-bf80e5755a8b">14</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie4bec63752274c1696da3054faa991f6_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfNy0xLTEtMS01MTgwOQ_d885b79d-abe1-4631-a526-db66a10d9eb2">296</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8046febe850b4d36b2eb7de786797a11_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfNy0zLTEtMS01MTgwOQ_e17d90e3-8f7b-48b0-84b6-b9691c8f700d">324</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ie4bec63752274c1696da3054faa991f6_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfOC0xLTEtMS01MTgwOQ_ea0d28db-7ddd-4687-9877-7c8dd9dfa817">533</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i8046febe850b4d36b2eb7de786797a11_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfOC0zLTEtMS01MTgwOQ_7a51a0e2-efde-4d17-a06b-dc71bd93f070">504</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares: 2023: <ix:nonfraction unitref="shares" contextref="i74b557ae093047c7a2f8bc65d003b8fd_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTAtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjplNzczNmUyNTZlZjU0MDhjYjBmOGIzNDVjODVkZmMxZV8xNg_d4b2d536-c242-44f2-bc88-f2551ca04c48">1,986,904,170</ix:nonfraction>; 2022: <ix:nonfraction unitref="shares" contextref="i50f0c53ec1ef4f159496a8a90a6f3d67_I20220331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTAtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjplNzczNmUyNTZlZjU0MDhjYjBmOGIzNDVjODVkZmMxZV8yNA_089bf3db-0433-47c4-bdec-4f2da1e6ec40">1,985,525,053</ix:nonfraction></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i74b557ae093047c7a2f8bc65d003b8fd_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTAtMS0xLTEtNTE4MDk_78ec9cdd-3cf3-478a-9e1a-0426f6dcaea9">24,488</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i50f0c53ec1ef4f159496a8a90a6f3d67_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTAtMy0xLTEtNTE4MDk_ccfdc689-0fab-4f52-ac0f-64387115c8c9">24,304</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Shares Held in Treasury:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares: 2023: <ix:nonfraction unitref="shares" contextref="ie504d88db6094c919c42dcbb98ea5944_I20221231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTQtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjplMmRjYWFiOGU1YWU0YzhjODNlZTY3MWMyZTliMzIxZF8xNg_2aa84e7e-091d-46c0-941c-b3488dfc0c24">248,724,257</ix:nonfraction>; 2022: <ix:nonfraction unitref="shares" contextref="if9101b120ca64fcaad1fa5a432872701_I20211231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTQtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjplMmRjYWFiOGU1YWU0YzhjODNlZTY3MWMyZTliMzIxZF8yNA_92f82dec-5fba-414b-b4b2-3d9c494e0838">221,191,228</ix:nonfraction></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ie504d88db6094c919c42dcbb98ea5944_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTQtMS0xLTEtNTE4MDk_ecb97e9c-6d05-414e-9bd9-454c18fb6de9">15,229</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="if9101b120ca64fcaad1fa5a432872701_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTQtMy0xLTEtNTE4MDk_b60fc8e4-9107-471f-bbd6-353732cb96e3">11,822</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued under incentive stock programs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares: 2023: <ix:nonfraction unitref="shares" contextref="i1e1b93b791e347b282f9ad3d01ca3f77_D20230101-20230331" decimals="INF" name="abt:StockIssuedDuringPeriodSharesIncentiveStockPrograms" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTYtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo2ZGVmM2E3NDMyNGM0NjcyYjRlYTRmMjAyODI1Y2Q1YV8xNg_8bd0c1a7-b03f-44b7-8321-8baca2b17fbc">3,933,165</ix:nonfraction>; 2022: <ix:nonfraction unitref="shares" contextref="ibb3e94d343f04f94b616bdda585a929b_D20220101-20220331" decimals="INF" name="abt:StockIssuedDuringPeriodSharesIncentiveStockPrograms" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTYtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo2ZGVmM2E3NDMyNGM0NjcyYjRlYTRmMjAyODI1Y2Q1YV8yNA_3a2c29db-92a3-40b9-894e-24350a27e2ba">4,144,476</ix:nonfraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e1b93b791e347b282f9ad3d01ca3f77_D20230101-20230331" decimals="-6" name="abt:StockIssuedDuringPeriodValueIncentiveStockPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTYtMS0xLTEtNTE4MDk_9f2ff609-2b4a-4309-b03a-6ed54a9417ed">242</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ibb3e94d343f04f94b616bdda585a929b_D20220101-20220331" decimals="-6" name="abt:StockIssuedDuringPeriodValueIncentiveStockPrograms" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTYtMy0xLTEtNTE4MDk_d212fdae-04da-4a92-bcd2-a075af46611e">223</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares: 2023: <ix:nonfraction unitref="shares" contextref="i1e1b93b791e347b282f9ad3d01ca3f77_D20230101-20230331" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTgtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo3YTljOGY0YmNhMzM0MTIwOGMzNjhjODI2ZmEyYTgxM18xNg_1b2dc0b9-aabb-4d90-95c3-5ca5fada1e20">3,166,279</ix:nonfraction>; 2022: <ix:nonfraction unitref="shares" contextref="ibb3e94d343f04f94b616bdda585a929b_D20220101-20220331" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTgtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo3YTljOGY0YmNhMzM0MTIwOGMzNjhjODI2ZmEyYTgxM18yNA_08b0b5a7-ff0e-4051-a509-964e306b2acf">17,536,012</ix:nonfraction></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e1b93b791e347b282f9ad3d01ca3f77_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTgtMS0xLTEtNTE4MDk_a1e84435-bef2-403a-843d-0bfff0e77940">320</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ibb3e94d343f04f94b616bdda585a929b_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMTgtMy0xLTEtNTE4MDk_e2cb7a68-ef37-4c1a-b8a0-3dfe2a0a7855">2,127</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares: 2023: <ix:nonfraction unitref="shares" contextref="i4472410f7f314df1aedd4ce4e47115d9_I20230331" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjAtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjpmMTZkMDk3MmU4OTc0YjNhOThiN2JlMDRkYzZkYTMwN18xNg_93dc7b7e-f847-45cb-b4b0-67a40b70e6a3">247,957,371</ix:nonfraction>; 2022: <ix:nonfraction unitref="shares" contextref="i0569afe73985405fbfca5dcfaa7ae9cf_I20220331" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjAtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjpmMTZkMDk3MmU4OTc0YjNhOThiN2JlMDRkYzZkYTMwN18yNA_85728534-f0a4-4cf8-9c5a-2709e4c04646">234,582,764</ix:nonfraction></span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i4472410f7f314df1aedd4ce4e47115d9_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjAtMS0xLTEtNTE4MDk_0f9a9b2c-290b-46bb-9435-fd52ebc9ebdd">15,307</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i0569afe73985405fbfca5dcfaa7ae9cf_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjAtMy0xLTEtNTE4MDk_2960178e-0243-45cd-9e45-812f9f08004f">13,726</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Employed in the Business:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i0ab1ef85c672448dbefc61a84290a420_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjMtMS0xLTEtNTE4MDk_81f2101e-108c-4b89-887b-207c7129950a">35,257</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic5eeacf7e4c844ed9e9f099d77a2073b_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjMtMy0xLTEtNTE4MDk_212dbd56-0e27-4f9e-a850-e1c1cd09710a">31,528</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic2af66263295490e83a3a9ab4083256c_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjQtMS0xLTEtNTE4MDk_c3dc6996-40eb-4c5f-bce8-908f430af84a">1,318</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i82a7d1bae2e84fcd8e4d18bcca11c40f_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjQtMy0xLTEtNTE4MDk_e085776e-a6c7-470e-861f-f8eb910e4352">2,447</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared on common shares (per share  2023: $<ix:nonfraction unitref="usdPerShare" contextref="ic2af66263295490e83a3a9ab4083256c_D20230101-20230331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjUtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo5MWJiMzI2NmQzZmI0OTdmYjBhN2E2YmZkNjJkYTNkZV82Mg_a1d89c6f-d38d-4356-a883-4ac4f446b8b5">0.51</ix:nonfraction>; 2022: $<ix:nonfraction unitref="usdPerShare" contextref="i82a7d1bae2e84fcd8e4d18bcca11c40f_D20220101-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjUtMC0xLTEtNTE4MDkvdGV4dHJlZ2lvbjo5MWJiMzI2NmQzZmI0OTdmYjBhN2E2YmZkNjJkYTNkZV83MA_d29104f7-cc0e-42e6-8868-b839df5f7c95">0.47</ix:nonfraction>)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ic2af66263295490e83a3a9ab4083256c_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjUtMS0xLTEtNTE4MDk_a27f96d1-25ef-465c-a120-9ba4cf70f47a">890</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i82a7d1bae2e84fcd8e4d18bcca11c40f_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjUtMy0xLTEtNTE4MDk_55e43ce3-39c7-4194-bcd7-b6202c2ac64f">826</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of common and treasury share transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic2af66263295490e83a3a9ab4083256c_D20230101-20230331" decimals="-6" sign="-" name="abt:EffectOfCommonAndTreasuryShareTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjYtMS0xLTEtNTE4MDk_4be612ba-9d70-429f-b55a-083599eaad33">183</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i82a7d1bae2e84fcd8e4d18bcca11c40f_D20220101-20220331" decimals="-6" sign="-" name="abt:EffectOfCommonAndTreasuryShareTransactions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjYtMy0xLTEtNTE4MDk_464612fb-ceda-4497-a1a4-6dc23020416c">146</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i33a00ded9e034d1abe17611ca3b7736c_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjctMS0xLTEtNTE4MDk_fa72f76c-6e0d-4bb0-86f7-93e194a269b0">35,868</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i460413cfb141475ebe1cf8057dcfde5a_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMjctMy0xLTEtNTE4MDk_fd0f8d13-9166-4cbd-a472-067aa4edb3f8">33,295</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Income (Loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i730c05ab0d5741d8b302d3a08fdd113b_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMzAtMS0xLTEtNTE4MDk_48ebf123-fdeb-4f81-ac9b-f0df07b63cca">8,051</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i2f5acff3249c49e0808b54ebd4b534a7_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMzAtMy0xLTEtNTE4MDk_2c376c46-62ac-4aa7-9b7b-140f94943e2b">8,374</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49054d032e5341de91083793555ef1fa_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMzEtMS0xLTEtNTE4MDk_b34e7002-1b10-4164-8b46-79acf0708c82">12</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i94ceff5b3d2848a1a71c2469485a57db_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMzEtMy0xLTEtNTE4MDk_07064106-4fa4-4d7b-bc88-0879dcad880f">100</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1c5466b14a304db8a8dafbe006b39ebe_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMzItMS0xLTEtNTE4MDk_2ad533e1-de61-44c4-8943-e0c22cb3c655">8,039</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e0b4d14502b460482bc611016663f26_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMzItMy0xLTEtNTE4MDk_3abaac84-5341-4824-806b-437f75fe57c9">8,474</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling Interests in Subsidiaries:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i0213423de94c44019ccc40bc4245a721_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMzUtMS0xLTEtNTE4MDk_4e54e194-c5d8-40fe-9ef4-fcca6669e817">219</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i26c0630aef8d43e798c3908df7261016_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMzUtMy0xLTEtNTE4MDk_5d1394fd-3d09-42db-96ba-8bc2e0265299">222</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling Interests share of income, business combinations, net of distributions and share repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iecd567dd0d2341e1b29ddcc54c8b7e37_D20230101-20230331" decimals="-6" name="abt:NoncontrollingInterestsShareOfIncomeNetOfDistributionsAndShareRepurchasesAndBusinessCombinations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMzYtMS0xLTEtNTE4MDk_c4c518df-5f2c-4a4a-9fcd-2eb678143984">3</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i035b6168fc8940d2a0449111f396e365_D20220101-20220331" decimals="-6" name="abt:NoncontrollingInterestsShareOfIncomeNetOfDistributionsAndShareRepurchasesAndBusinessCombinations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMzYtMy0xLTEtNTE4MDk_1dafd19e-1ea6-46a4-90a8-b333a9ae37f7">8</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i6c8dee5dd03d4406bc9a1462f0cd0d7e_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMzctMS0xLTEtNTE4MDk_4d14dd34-24e2-4526-8923-b6c1d55bebba">222</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i35351e662b3946778b8bae2908181909_I20220331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yNS9mcmFnOjcyMTczNjdmMTNlNTRkNjE4MjM1N2U5MTFiNjAzNjZmL3RhYmxlOmYyNDA4MzhlYjUxYTQ3MTc5ODdmYTZlN2I3Yzc2YmEyL3RhYmxlcmFuZ2U6ZjI0MDgzOGViNTFhNDcxNzk4N2ZhNmU3YjdjNzZiYTJfMzctMy0xLTEtNTE4MDk_d440a240-4a10-4afb-b532-028e036b7c3c">230</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes to condensed consolidated financial statements are an integral part of this statement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_28"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="margin-top:6pt;text-align:center"><span><br></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Consolidated Statement of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unaudited)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(dollars in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">millions)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.787%"><tbody><tr><td style="width:1.0%"></td><td style="width:68.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.413%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.626%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow From (Used in) Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMy0xLTEtMS01MTgwOQ_36fa5d95-8bb4-4e7f-b25c-84b122921865">1,318</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMy0zLTEtMS01MTgwOQ_5c559e92-2385-4adc-adc9-eb48764e57cc">2,447</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash from operating activities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfNS0xLTEtMS01MTgwOQ_ae4d347c-5001-4b8b-a853-ee5adae8bc35">315</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfNS0zLTEtMS01MTgwOQ_7ba2dd12-8c8b-4c5d-ab3b-837be8c2aeb4">311</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfNi0xLTEtMS01MTgwOQ_0917c5e1-1933-446b-a68b-945db7ac86f1">491</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfNi0zLTEtMS01MTgwOQ_5796a907-8fbd-43d8-bfdf-0d75f653edd2">512</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfNy0xLTEtMS01MTgwOQ_0eb4df87-cb31-47a5-8095-71cf4adbd9bb">281</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfNy0zLTEtMS01MTgwOQ_67e2e94b-bcba-4d73-8ea9-e23898d91d8d">305</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfOC0xLTEtMS01MTgwOQ_c42f0e43-4b58-4ac5-a942-b1e8715bd65f">233</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfOC0zLTEtMS01MTgwOQ_8fe08c00-a66b-4889-b2e5-03970eccce5f">751</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfOS0xLTEtMS01MTgwOQ_629b7ff9-aacd-4325-86da-3f5f145743a1">419</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfOS0zLTEtMS01MTgwOQ_ceb68d5d-a9e8-4819-88bd-807300ee13e2">554</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMTAtMS0xLTEtNTE4MDk_4ba7b3fe-e810-4556-87c2-13b48beb4299">1,076</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMTAtMy0xLTEtNTE4MDk_cc6ae621-d19b-4a14-9573-ac8499c25136">205</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash From Operating Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMTEtMS0xLTEtNTE4MDk_6c97b29b-9ef6-4f69-b44a-22307d9ddc5f">1,143</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMTEtMy0xLTEtNTE4MDk_016885e5-3e69-415a-a480-5abf1e1d6b0f">2,065</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow From (Used in) Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMTQtMS0xLTEtNTE4MDk_fd259bbd-0dd8-4016-9b27-ee050d2ea39d">380</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMTQtMy0xLTEtNTE4MDk_9c5bf929-6a69-479c-ad2f-dbf163daae4c">321</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales (purchases) of other investment securities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForProceedsFromInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMTctMS0xLTEtNTE4MDk_1bcf38ca-920c-46e5-977d-5755c02a232a">86</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForProceedsFromInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMTctMy0xLTEtNTE4MDk_8e889b5c-bd90-4dfe-86be-ccbb803661bf">41</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMTgtMS0xLTEtNTE4MDk_4e4a5bee-4f94-44d7-b1c5-72ace4538c15">4</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMTgtMy0xLTEtNTE4MDk_149a27a3-9ef0-40d4-bb69-3ab4fee54c64">2</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash From (Used in) Investing Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMTktMS0xLTEtNTE4MDk_f5ebafef-3b93-432e-9014-273cbb9cf02f">462</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMTktMy0xLTEtNTE4MDk_26d22c03-e75f-4b89-81c3-480d6c98d316">360</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow From (Used in) Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net borrowings (repayments) of short-term debt and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMjItMS0xLTEtNTE4MDk_ad4f613e-8b00-44a8-bb47-af3d2bfb7030">42</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMjItMy0xLTEtNTE4MDk_cf202a13-66d6-4824-bb41-f42ff33eafaf">8</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMjQtMS0xLTEtNTE4MDk_4e905b91-82b7-48e6-8157-c7853b51d167"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMjQtMy0xLTEtNTE4MDk_6a9e2015-4f22-4b2d-bbed-b35d343f229b">751</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMjUtMS0xLTEtNTE4MDk_cb9338f6-8ac3-42bf-aaa7-8c75cc2b4b78">540</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMjUtMy0xLTEtNTE4MDk_4f25770e-3616-4dea-84ee-d5a8955a1b5c">2,307</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from stock options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMjYtMS0xLTEtNTE4MDk_cb9e0d2e-6d63-4fdc-a0b8-f93101711cc1">62</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMjYtMy0xLTEtNTE4MDk_b7c56415-a7f1-4513-a816-8ce6e8050fa5">59</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMjctMS0xLTEtNTE4MDk_35b6aa1c-56f7-45d3-94ad-e80ef07648d9">890</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMjctMy0xLTEtNTE4MDk_737347bd-b1af-44b1-9050-4e68d5fed114">832</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash From (Used in) Financing Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMjgtMS0xLTEtNTE4MDk_a67580b6-8374-4c63-9485-ff69a16273f3">1,410</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMjgtMy0xLTEtNTE4MDk_cd949421-4006-4b63-a1b4-4500ba084e7a">3,823</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMzAtMS0xLTEtNTE4MDk_0f216d49-2d34-4cd7-8344-db6fc475a1e4">8</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMzAtMy0xLTEtNTE4MDk_6b450bb6-43dd-4df8-9278-6e826ea0d17e">6</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Increase (Decrease) in Cash and Cash Equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMzItMS0xLTEtNTE4MDk_7253ea27-b028-430e-af18-9b1e45026c79">721</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMzItMy0xLTEtNTE4MDk_2e651dd6-64ce-44d7-a8f6-688ca9917599">2,124</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents, Beginning of Year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMzMtMS0xLTEtNTE4MDk_c997f4ff-07bc-479c-a8c9-f0c5f91131d3">9,882</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i0924ac0b390a4722af2911303350de7d_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMzMtMy0xLTEtNTE4MDk_071b8e1f-903f-427f-8231-75c220c83fa8">9,799</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents, End of Period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMzQtMS0xLTEtNTE4MDk_9c0b7a01-f333-40ba-b859-6f39c6d8d9ab">9,161</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i9a77a23aa91644df95f9c0ffd757fc02_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8yOC9mcmFnOmNiMzkyNjJlYzY3OTQ3ODdhMDAwOGU4MzYwZDk4MDQ4L3RhYmxlOjM1YTM3NTdhOWQwNzQ4YWNhYWJhOGIyZTFiZTZiNmY2L3RhYmxlcmFuZ2U6MzVhMzc1N2E5ZDA3NDhhY2FhYmE4YjJlMWJlNmI2ZjZfMzQtMy0xLTEtNTE4MDk_81378957-8124-4d8a-87e6-f849d38de5c8">7,675</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes to the condensed consolidated financial statements are an integral part of this statement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_31"></div><hr style="page-break-after:always"><div style="min-height:126pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&nbsp;31, 2023</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div></div><div><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_34"></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNC9mcmFnOjZmNGYyYmVlYjA1ZDQ5ZWRiMjQ1MDFkOWZlNTA4OTM2L3RleHRyZWdpb246NmY0ZjJiZWViMDVkNDllZGIyNDUwMWQ5ZmU1MDg5MzZfODE3_c6e8e262-e81d-41a1-8199-11ad9582c1ae" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 1  Basis of Presentation</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited, condensed consolidated financial statements have been prepared pursuant to rules and regulations of the Securities and Exchange Commission and, therefore, do not include all information and footnote disclosures normally included in audited financial statements. However, in the opinion of management, all adjustments (which include only normal adjustments) necessary to present fairly the results of operations, financial position and cash flows have been made. It is suggested that these statements be read in conjunction with the financial statements included in Abbotts Annual Report on Form 10-K for the year ended December&nbsp;31, 2022. The condensed consolidated financial statements include the accounts of the parent company and subsidiaries, after elimination of intercompany transactions.</span></div></ix:nonnumeric><div id="i901bb95f381d40f69da02b9fef764f5e_501"></div><div><span><br></span></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81MDEvZnJhZzpkZGMzNjAzNzlhMDk0Y2Q3OTMyNDg5ZDI4NjdmNWQ5NS90ZXh0cmVnaW9uOmRkYzM2MDM3OWEwOTRjZDc5MzI0ODlkMjg2N2Y1ZDk1XzM4NDgyOTA2OTkxOTE_fd2a8dee-2ae2-42b2-8ef1-bd3a1ed1a909" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Note 2  New Accounting Standards</span></div><div><span><br></span></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81MDEvZnJhZzpkZGMzNjAzNzlhMDk0Y2Q3OTMyNDg5ZDI4NjdmNWQ5NS90ZXh0cmVnaW9uOmRkYzM2MDM3OWEwOTRjZDc5MzI0ODlkMjg2N2Y1ZDk1XzM4NDgyOTA2OTkxOTI_6ebda81a-18a2-498c-b681-d04d2be19439" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Recent Adopted Accounting Standards</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update 2022-04, Disclosure of Supplier Finance Program Obligations, which requires an entity to report information about its supplier finance program. Abbott adopted the standard on January 1, 2023. The new standard did not have an impact on Abbott's condensed consolidated financial statements.</span></div></ix:nonnumeric></ix:nonnumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_37"></div><hr style="page-break-after:always"><div style="min-height:126pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&nbsp;31, 2023</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RleHRyZWdpb246M2NjYjNiMDdhZDk5NDcxNzg4ZjExZDE5Y2U3NTA2ODBfMzM4_ec156bd7-4931-422e-a759-1e0b089e3a8a" continuedat="i45cdef9200b64e98a6f6f22e3a6ba1c1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 3  Revenue</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbotts revenues are derived primarily from the sale of a broad line of health care products under short-term receivable arrangements. Abbott has <ix:nonfraction unitref="segment" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RleHRyZWdpb246M2NjYjNiMDdhZDk5NDcxNzg4ZjExZDE5Y2U3NTA2ODBfMTU2_16b0dd4c-3949-4be4-871f-a873bcbffd3f"><ix:nonfraction unitref="segment" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RleHRyZWdpb246M2NjYjNiMDdhZDk5NDcxNzg4ZjExZDE5Y2U3NTA2ODBfMTU2_56f4e9b8-8ee3-4a97-b9ad-f619ce105ff6">four</ix:nonfraction></ix:nonfraction> reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.</span></div><div style="text-align:justify"><span><br></span></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RleHRyZWdpb246M2NjYjNiMDdhZDk5NDcxNzg4ZjExZDE5Y2U3NTA2ODBfMzM5_c70c5cbb-9996-46ed-9655-ac71315025f9" continuedat="i98c857282d9c450c862610c746a0bb56" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide detail by sales category: </span></div><div><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:29.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intl</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intl</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Established Pharmaceutical Products  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Key Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i59aba7288ea94e71a5550948cf3e31eb_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMy0yLTEtMS01MTgwOQ_3967fe00-b3b8-4f79-b6e4-51b79515f98d"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i9ebdacacb92d4e94b4cfa166efd1d8d8_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMy00LTEtMS01MTgwOQ_a9d909fe-21e8-4694-9811-6f096ec02832">912</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ib26333f4c7384ba6a6263ea856ba7765_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMy02LTEtMS01MTgwOQ_3b2c6dc9-69bd-4f95-bc7f-08f2e86ca8f1">912</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i5a5715bd39984cc38dbbf68c7154d5b1_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMy04LTEtMS01MTgwOQ_bda12301-6bcb-45a3-b224-c634e158d461"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ifb6f3a80bcfa41d3b2cd6dd9a97f792e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMy0xMC0xLTEtNTE4MDk_3a331717-e529-47b8-87a5-a1604fc486aa">906</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i30f22b73125a44ab88d22c12d20522ae_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMy0xMi0xLTEtNTE4MDk_1bfe6d9a-f4cf-43db-bcc5-cd090fe932ce">906</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3b6fcc89d8194f59a089ccc16fefab41_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNC0yLTEtMS01MTgwOQ_88f3ec86-5dc7-40c1-9465-ba15bca2dbf7"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i7360b44cf13f40e0a18509a59252c1c3_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNC00LTEtMS01MTgwOQ_15291b30-7466-4ff7-a45e-5d9a9d305f14">277</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i7a82a5ed689848d58d60cfdcd48dd69e_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNC02LTEtMS01MTgwOQ_20171a94-6254-45aa-9b1c-20afdddfe892">277</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonfraction unitref="usd" contextref="i5e1af9d41a3b4ab3a342a1fea73b47e2_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNC04LTEtMS01MTgwOQ_2e19feca-3a4d-401f-8188-6e73832d1da9"></ix:nonfraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i97fccd3d75e147b282b47e4840f28fb3_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNC0xMC0xLTEtNTE4MDk_74a27a9e-42ae-4ba1-ae12-523390c382aa">241</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i134eab6540ec4f4dbf357b01a219b399_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNC0xMi0xLTEtNTE4MDk_4040b904-178f-45b0-b13e-cc8750f0a961">241</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i9e992b933fea4842b103bf588bd86bea_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNS0yLTEtMS01MTgwOQ_e7a4eba2-264b-4235-83ea-7283c482630e"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="icdfc4731de9044a893c37ae5d01c48ad_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNS00LTEtMS01MTgwOQ_7d861fe1-264b-42b8-a6ef-36f4435fb72e">1,189</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i80bdac464a5b478e812274849ec5223a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNS02LTEtMS01MTgwOQ_dd115365-2d7e-46fd-9413-4d187c558789">1,189</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="idf18a527939248739098008e4b29a407_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNS04LTEtMS01MTgwOQ_50fb12ac-3c93-46c7-9ac6-4299ba2d6347"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8fffe02d8f274fd18cf1771ff7523607_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNS0xMC0xLTEtNTE4MDk_45d2895b-14c2-4303-97bf-2ac6a87cb1e0">1,147</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i87c128ad7cdf41f2a4540feb49690207_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNS0xMi0xLTEtNTE4MDk_c951f996-523d-452e-a02a-514c3adad30b">1,147</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nutritionals </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pediatric Nutritionals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i0094b23597384c8cbdaf0944852119ce_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNy0yLTEtMS01MTgwOQ_4bee1b8e-6e13-4889-8b50-149a21b357ef">459</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic4e5e153b4814125a3065aee911a458d_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNy00LTEtMS01MTgwOQ_cb349a50-c0a1-480d-ac3f-4fa03bf2f99d">465</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if34e8c727bb144df8c609d76bd5a03cf_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNy02LTEtMS01MTgwOQ_0d409272-c15b-4826-9684-e824c5ac3cfd">924</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i6806781b344a49b0a0c5d16d2a0b6a64_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNy04LTEtMS01MTgwOQ_b53240eb-b5ca-4588-8527-39d538b0559b">338</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i65005762efa1479cb3214e5da1ff85f9_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNy0xMC0xLTEtNTE4MDk_b2c36ca4-be3a-4190-a9bb-b09af308715d">509</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ibe4683432ae543a0b29600f79845855e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfNy0xMi0xLTEtNTE4MDk_bbf4c2e1-768b-45ba-9b26-691a9f53d929">847</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adult Nutritionals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia74f7b68d81c49f595a77babb4b32b59_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfOC0yLTEtMS01MTgwOQ_d4876d0c-87c9-478a-8972-2f900be1e703">353</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8aebe0cb600744b9b428d851205dfe9a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfOC00LTEtMS01MTgwOQ_837e1558-1a2f-4c6d-9f49-49835e63a6ec">690</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3cc39e67e0a941cbb6ea0cd7c05a973a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfOC02LTEtMS01MTgwOQ_90f5451c-7d5f-431f-99a6-b0b568c05438">1,043</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ib19245edea6545c69a5a060ee055e6cf_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfOC04LTEtMS01MTgwOQ_2ad7b355-ef5b-4e5a-a2b8-faece6982df7">339</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i0933f550888544758127f3bbb77e8514_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfOC0xMC0xLTEtNTE4MDk_f0d4a539-8273-4b75-b9f9-9ee6887c2898">708</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i304ed4ed6b784fea9c983fea52ceab58_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfOC0xMi0xLTEtNTE4MDk_3bd711c9-fbb2-4a1a-8fc6-85b9bffadcb5">1,047</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1a3ee799596543719e38577d55a2b71f_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfOS0yLTEtMS01MTgwOQ_b285d868-ec9a-4eaf-b476-2239b67f2e6a">812</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia0047b1773f449f99652fd15a3986991_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfOS00LTEtMS01MTgwOQ_d4898fe4-13b8-4e41-85b9-9d3cf2adda95">1,155</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if64f8bcdd1344462b07f0f7628dc9c4a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfOS02LTEtMS01MTgwOQ_dd2868ed-fc23-4853-b7ff-b24eec3a02d9">1,967</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i06e8771634214f839f213274ebcbe975_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfOS04LTEtMS01MTgwOQ_74fe953d-b64e-4dc0-8c28-5c0cd6008b68">677</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iadeda33da14441c3be8a37bc0f849cb8_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfOS0xMC0xLTEtNTE4MDk_19735acc-b6b7-4bd9-92f5-c19cc8ae8200">1,217</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iad19be6b48f74f50897a26a787246f32_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfOS0xMi0xLTEtNTE4MDk_b8d2ae93-5e5b-4ecf-a9bb-e91b6e5e2752">1,894</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diagnostics  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Core Laboratory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i6167e462fff04de986cb20fd88562feb_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTEtMi0xLTEtNTE4MDk_687a292a-3647-4606-8322-238c966b2f88">289</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i281689992ca54db180c68fa0228e88f2_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTEtNC0xLTEtNTE4MDk_8949aa52-4ee9-4c4b-b2ad-c25434d178b3">893</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i7b258789836648d7a2f5e3be11622347_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTEtNi0xLTEtNTE4MDk_1880d8f1-163e-4063-82bf-ec59c91af6ec">1,182</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if0332618caa140a8958a26f8c46d6e98_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTEtOC0xLTEtNTE4MDk_f284efad-c712-4eb7-ad0e-ab38b3a5804b">268</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i14150977ccca4670bd894d440b922297_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTEtMTAtMS0xLTUxODA5_281d8e72-3997-4d7f-9f0a-eda5fe81b330">916</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i592812b741174076b7c80a521a491695_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTEtMTItMS0xLTUxODA5_81a5821f-c007-4b32-b51a-68fe7212e492">1,184</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Molecular</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ib0120d48d28243cfb5d5a31669316bf0_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTItMi0xLTEtNTE4MDk_23f291e9-87a9-4e3a-aaf8-f25bc3b1a097">47</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="idcae26082e684fdcb5cfe8675fd7d48e_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTItNC0xLTEtNTE4MDk_2ba3b129-38da-4769-9be8-343bee553121">100</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ib90060698b8740759ab704f1b607027b_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTItNi0xLTEtNTE4MDk_08cf9d3c-4f95-432d-b134-fc8100885072">147</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i52fd3e63b10f4ad8a02bf89b5f5ece92_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTItOC0xLTEtNTE4MDk_912b6f9a-64e3-406e-8118-ad13f6e6f315">172</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i5550e3bd258f4bd9bc46dd449ca1f750_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTItMTAtMS0xLTUxODA5_6932aa7b-d4fe-4819-abcb-d2d52f8fc773">248</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1c030b14d2ed4dafa4e017d1c3ad73ae_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTItMTItMS0xLTUxODA5_40c8c94a-5a57-435c-aca3-5636436f5aa5">420</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Point of Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie56024caffd9449b9ca89a72fd10841e_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTMtMi0xLTEtNTE4MDk_4a9002f9-6c64-4456-a7b8-65bfc146f134">93</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i387286629b6a434190f677743d3ab5af_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTMtNC0xLTEtNTE4MDk_b9e3fbf0-b7ca-402c-a34c-a4080453856d">41</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i143a3624c7c24e5781b2305a929c1a8c_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTMtNi0xLTEtNTE4MDk_b38e94b8-d66d-43b6-8cee-ab6fcf401ff8">134</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i9d6c41d34faf4b89956fc0655e23f9f7_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTMtOC0xLTEtNTE4MDk_72e936c9-ca7b-4145-bae3-f73917d56aac">91</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4de327650d0a49f6a32a9a2fcb9f1d73_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTMtMTAtMS0xLTUxODA5_69eaf08e-e66d-452b-a3a7-c15c6e91d490">37</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i0b802995d3a74eceb6ff50800caf206d_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTMtMTItMS0xLTUxODA5_5ec1a18a-c198-4985-8825-6b957fe4b137">128</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rapid Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ib58fc5fa176e47f58a635219f5d00bd6_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTQtMi0xLTEtNTE4MDk_3e36d3b6-621d-4c5d-8eae-a42e7f4ff1c8">906</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4387a4d73657496899800472d96ffcca_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTQtNC0xLTEtNTE4MDk_943bd146-48b7-4c88-9a10-c3479ee86130">319</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ifc37260ce3e44c7588f25a0ffddc87ce_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTQtNi0xLTEtNTE4MDk_d3dc531f-7a26-4d57-be73-64c9411af8d7">1,225</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ib0446f2175664fd8847cc0c6ddbf5ec1_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTQtOC0xLTEtNTE4MDk_d6bac8d9-e2a2-4ca9-93a3-65bc57dd0ae3">2,181</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i6bb810c4f1e14b8fba5fd14365fecb74_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTQtMTAtMS0xLTUxODA5_a1a4fcdb-e4af-4c56-bc42-ef4054dbea6f">1,344</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i9e667177b5274ac2b66f3f4984d8aaee_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTQtMTItMS0xLTUxODA5_137d5782-1fec-42bc-b019-0cdf273ba9d3">3,525</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4e2cd9411b4547259f234f3d37d3bca1_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTUtMi0xLTEtNTE4MDk_ec6582ee-5459-4cca-b278-83715c3e32d4">1,335</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i44bd8c3ccdae427ab72707bf761d1ff2_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTUtNC0xLTEtNTE4MDk_fbd0c62c-3cd4-4f5e-822e-f587d1710e5e">1,353</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i6ccaf9e4adbc467aa509133f505b80f3_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTUtNi0xLTEtNTE4MDk_d9e4f99c-30fb-4f8f-85fa-b36593d2a475">2,688</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i7d206d9d2dea4f5090681ce6bd95fc8a_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTUtOC0xLTEtNTE4MDk_f8edd430-b2e6-4f6f-9ea4-8a9e7d7193dd">2,712</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49785b34f77f4d9a8a9c75323d922c59_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTUtMTAtMS0xLTUxODA5_48b27482-16e5-4633-a9e1-e901b9db950d">2,545</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iccded785322744b594d6e95a5da23cce_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTUtMTItMS0xLTUxODA5_f3738876-9baa-49d6-ab68-36c030bed8f9">5,257</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medical Devices </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rhythm Management</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iffe98fb9bd35435daf251e4efdc4b53b_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTctMi0xLTEtNTE4MDk_4807890f-28f9-484f-9ff9-261e0f901484">260</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i629ad9f792aa4fa49fb18992fd403311_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTctNC0xLTEtNTE4MDk_5f25b2b8-3f73-4024-895b-8140d67fd273">267</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if438dbd694e14134b8ee4662274142dd_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTctNi0xLTEtNTE4MDk_87a8392f-8303-4ece-abdb-8f0083577d04">527</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic7f8ccb50f8f41248e43ce7e269bda9f_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTctOC0xLTEtNTE4MDk_cc878a83-5239-4aaa-a26a-5225183b75fd">248</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i01ca6ce2ed294098accc68795b89cb80_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTctMTAtMS0xLTUxODA5_64fd7d49-63a6-4017-b546-317dc4dae862">276</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i9dee10034a194d35b58557d7a4a45803_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTctMTItMS0xLTUxODA5_67d76a60-9b7b-4485-9b45-63c3612d4330">524</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i278cae30cfa04edf96da4117c92b3bf7_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTgtMi0xLTEtNTE4MDk_1efa609f-6a2c-4d83-bd8e-41828beb43a8">238</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i95ae93b460414c0890cd72e01cf0a8af_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTgtNC0xLTEtNTE4MDk_8fd50ce7-4d11-47fc-a3bb-0e13b74f3fd4">267</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie7bb5920d33e4f59919844e3fa1c033a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTgtNi0xLTEtNTE4MDk_dade05e1-1f34-4857-8a42-f71da0b2bc13">505</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie8dd2b4a668844859f5f04f521e68a5e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTgtOC0xLTEtNTE4MDk_b12aa80f-36d3-49e4-a796-9a933de6aa8a">216</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie25798391d5c4abfac5364d540963f6c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTgtMTAtMS0xLTUxODA5_24accd1e-a4d7-4bab-8063-c29a243cc135">269</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i35f82eb217ad4a66955ae6d68452ffec_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTgtMTItMS0xLTUxODA5_f51cd316-1bcc-4e12-b061-da67c30214a6">485</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Heart Failure</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ifca3c9c92061430a9e5012925b5ffa8f_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTktMi0xLTEtNTE4MDk_0106ba33-6828-4810-baab-221ce5291d49">218</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i70f9f63253ad4ea6b0092f253634ea53_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTktNC0xLTEtNTE4MDk_23574189-78ef-4c8b-8f21-1248541f5bc9">63</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3ea28159eedd440c80b47bf69c2e6ece_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTktNi0xLTEtNTE4MDk_560e90f4-8dc0-4c75-8c86-77e26439350d">281</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iacd37a9e90d146ebbf3fa932199cd1f8_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTktOC0xLTEtNTE4MDk_0d89e47b-8938-452c-84b9-b57f5610d8c9">196</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia4d7158afe7247c5a67c8dfcf660c8b6_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTktMTAtMS0xLTUxODA5_89de90ad-df21-48aa-8c19-2fa8984fa8ab">54</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1bc2d7b2295746b89599c5881eb06d9e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMTktMTItMS0xLTUxODA5_c3bb16a5-5bb2-45be-a7f1-197c7710eaf4">250</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vascular</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i0d10995fad4f4e68b0b42535f6985da1_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjAtMi0xLTEtNTE4MDk_c7f0f7b9-8aa9-49d0-9175-c78d8fb8e8e8">218</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i0ef6699ffe4b4409bc2c802b16490f1b_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjAtNC0xLTEtNTE4MDk_505a575b-40ef-4e9b-a8ea-c08f28af8732">399</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3eab75ad790346a5b04b97aca04de241_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjAtNi0xLTEtNTE4MDk_c1af8691-9ffa-4526-aa24-5a9b034d8be4">617</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ida046084cd8b4327aaf410e813cfbc87_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjAtOC0xLTEtNTE4MDk_d534331e-8cb7-43cf-8ed2-536d5776cc9d">209</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic8ff6c26944e436080707d429c1fe83c_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjAtMTAtMS0xLTUxODA5_a4ec4d09-4aee-4b48-9415-c4b82c5d0c45">410</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i47b8849655454b3b9ae6be820fcbc882_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjAtMTItMS0xLTUxODA5_abb507fb-231e-43a4-a074-888148f18764">619</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Structural Heart</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iff5f1c784e284962b8b7c4bc421208e4_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjEtMi0xLTEtNTE4MDk_5878919e-8856-439c-8857-bf94148c425e">210</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i9d3904b1d45b48b59ee68e66916ceac9_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjEtNC0xLTEtNTE4MDk_e182eda8-3861-4766-8d51-d2e08ea5f314">251</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i786ab705e493445eb34f55b1eb5ddf20_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjEtNi0xLTEtNTE4MDk_b15cf77c-5d1e-41a4-a335-1760c9313173">461</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="idfc85f81336044ec99488fdba150b49b_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjEtOC0xLTEtNTE4MDk_90eac414-6014-4a8c-bd22-1842bc411ba9">190</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3856ac1965a146daba9616ee78f324df_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjEtMTAtMS0xLTUxODA5_e02d84d5-d01a-461a-8197-6dcb1cf5e925">221</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie7c15499bb9540cda46fff7ca5ab7e3e_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjEtMTItMS0xLTUxODA5_fc56f490-5ac1-4648-ba42-2984f0e40677">411</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie51e511274f54fbe8c911836606e333b_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjItMi0xLTEtNTE4MDk_acb28d50-c389-48b9-a9e1-c45fb3b30b53">155</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i82236fd5a1ca46f199e8dbec45d2de3a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjItNC0xLTEtNTE4MDk_fa95f937-7477-4445-be83-ea4822fc8240">41</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4cca5abdefe246a0a05fbf5b7393e643_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjItNi0xLTEtNTE4MDk_6abd2682-2656-49a9-bf4b-fed36badca69">196</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8a4179f516f945238226482679562f8f_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjItOC0xLTEtNTE4MDk_19083193-7cd2-4a9d-8198-b2be5dfbb865">143</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie5ce64384838468ca71cfaf072d74f52_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjItMTAtMS0xLTUxODA5_3b9b2344-a447-48bf-9633-92fecc662c6b">36</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic1b04c8cab9841dd8f219e8458446458_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjItMTItMS0xLTUxODA5_968eb581-e9d2-44b4-b28b-e14b1ee1472c">179</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diabetes Care </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ib2e0bdc856f44f69bd2e263e7e36dc90_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjMtMi0xLTEtNTE4MDk_4c210c5c-f876-4c27-9698-b1ef763e9d04">479</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ied48007fb48a477aaa267e8012542fbe_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjMtNC0xLTEtNTE4MDk_23787aef-0940-4783-9bbc-f9c5bc0fa058">834</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ifbe87acf79904f4a9af1462d1f5613d9_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjMtNi0xLTEtNTE4MDk_444bf718-9ae3-4d47-81f0-52ef377a29b3">1,313</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i003487c6713f4c318b0f09493f097953_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjMtOC0xLTEtNTE4MDk_76ccdcf0-8355-40ac-be19-68de6dbcbc21">343</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ibec0c9c5cbc646d782779493d1b40abc_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjMtMTAtMS0xLTUxODA5_2b2571fa-1255-4254-9e93-e84db2100ad1">783</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i79e2fa9ad01a4159961b496f38cd1d88_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjMtMTItMS0xLTUxODA5_56a30102-fed3-4125-8648-355681e12387">1,126</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ifb84f4ca990746d8a452b63917e79c09_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjQtMi0xLTEtNTE4MDk_1c08f9a8-7a61-4e25-a71a-ef4273870c9a">1,778</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="id96a38e2bc044570a817a5c0ba42831d_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjQtNC0xLTEtNTE4MDk_fd110783-dcc8-476b-a370-762b1542ac82">2,122</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i177a8252ee4d4b638b47a978d0522747_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjQtNi0xLTEtNTE4MDk_d5065529-afca-4bbe-a9f1-9978b5820863">3,900</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3825497610b3467f8635e666639656e0_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjQtOC0xLTEtNTE4MDk_53b79be3-00ff-4cae-9f71-d8d0d2e9f08b">1,545</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if1f45cd596b047c0ab26ae3215e0e193_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjQtMTAtMS0xLTUxODA5_ee60bfe7-b230-43fc-877f-6e9c76c99451">2,049</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i2fbad5ec961c47268cd7ee759ec58b03_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjQtMTItMS0xLTUxODA5_89c46e29-ac8a-46b5-9e0d-4e3bd0dc0827">3,594</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="id2d122de90e54253b56ca49a6b721e76_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjYtMi0xLTEtNTE4MDk_6d11e67e-0503-4a12-93da-70e1e5729420">3</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i509f762913654fcbb109fbfc9799b62a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjYtNC0xLTEtNTE4MDk_8ea171c6-8713-4801-b87e-6a85b24f9cfd"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i7029047dc9064ff098b29e87076ce957_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjYtNi0xLTEtNTE4MDk_219418d1-d58b-4a19-9e6d-09fea8da090e">3</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i519bf96b09ae4f1793962f40cf441cbd_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjYtOC0xLTEtNTE4MDk_7e372022-b5d7-4e3c-9460-340600783724">3</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i734facbe414049a18242f4d7ba6c2291_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjYtMTAtMS0xLTUxODA5_331401c9-abe5-4375-b3e8-1a3342ec4095"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i5cf2d116860c4936bd9ccc36e0b34824_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjYtMTItMS0xLTUxODA5_4b1c5435-ccc0-40c4-84c6-c008789f58d8">3</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i71d01cbdf0754e8d8ab741a8776b49fa_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjgtMi0xLTEtNTE4MDk_2884dc09-7984-4c7d-813d-d89dc7b1fcfb">3,928</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i2961f711f2fb4d39865c08a50497fd94_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjgtNC0xLTEtNTE4MDk_12cf33fb-e4b4-4391-8c78-1fd18216e16e">5,819</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjgtNi0xLTEtNTE4MDk_6569f058-10df-4d70-95fa-005736201d0d">9,747</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iad3854f04a58422ca5267adc30e0b611_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjgtOC0xLTEtNTE4MDk_d93c1d33-b5bd-43b2-b843-c8c54a8df382">4,937</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic44e3664ddaa40d2b3ec8e93fc77a6d2_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjgtMTAtMS0xLTUxODA5_1d5ac9b2-1189-4512-85dd-fac4ff313b60">6,958</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RhYmxlOmI1NjJiZTliYWU4YjQ0YTA5NDVkYWYwMmEzYjdjODY1L3RhYmxlcmFuZ2U6YjU2MmJlOWJhZThiNDRhMDk0NWRhZjAyYTNiN2M4NjVfMjgtMTItMS0xLTUxODA5_f852e360-98f4-4886-a6bc-1f05286e6b0c">11,895</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div></ix:nonnumeric></ix:nonnumeric><div><span><br></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i45cdef9200b64e98a6f6f22e3a6ba1c1" continuedat="id1a1d9ae78dd445298f919251dfc7136"><ix:continuation id="i98c857282d9c450c862610c746a0bb56">Note: The Acelis Connected Health business was internally transferred from Rapid Diagnostics to Heart Failure on January 1, 2023. As a result, $<ix:nonfraction unitref="usd" contextref="idb1e2171349541a5b81da95cde32766f_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RleHRyZWdpb246M2NjYjNiMDdhZDk5NDcxNzg4ZjExZDE5Y2U3NTA2ODBfMTA5OTUxMTYzMjE3NQ_02f91211-2ee1-442f-85ed-da8ffac55884"><ix:nonfraction unitref="usd" contextref="i8c5ce2d75f054eb9a1042f3f638183c9_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV8zNy9mcmFnOjNjY2IzYjA3YWQ5OTQ3MTc4OGYxMWQxOWNlNzUwNjgwL3RleHRyZWdpb246M2NjYjNiMDdhZDk5NDcxNzg4ZjExZDE5Y2U3NTA2ODBfMTA5OTUxMTYzMjE3NQ_7374b615-2c79-4228-a8f4-e3370fea3aaf">29</ix:nonfraction></ix:nonfraction>&nbsp;million of sales for the first quarter of 2022 were moved from Rapid Diagnostics to Heart Failure.</ix:continuation> </ix:continuation></span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div id="i901bb95f381d40f69da02b9fef764f5e_40"></div><div><span><br></span></div><ix:continuation id="id1a1d9ae78dd445298f919251dfc7136" continuedat="ie7e54e0e433c4c53aa050b3fda6c4991"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&nbsp;31, 2023, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) was approximately $<ix:nonfraction unitref="usd" contextref="i8b699eeae0254fd0b47201e9f19cd838_I20230331" decimals="-8" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80MC9mcmFnOmM3MTNmODc0MGE4MTQ3NzFhNGM3YTU0YzRjMTJhMWZiL3RleHRyZWdpb246YzcxM2Y4NzQwYTgxNDc3MWE0YzdhNTRjNGMxMmExZmJfMjE2_c8a48e78-1d17-412f-8277-9b692b414f32">4.1</ix:nonfraction> billion in the Diagnostics segment and approximately $<ix:nonfraction unitref="usd" contextref="ibc7d17d7f58c4472b5827157f00898fb_I20230331" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80MC9mcmFnOmM3MTNmODc0MGE4MTQ3NzFhNGM3YTU0YzRjMTJhMWZiL3RleHRyZWdpb246YzcxM2Y4NzQwYTgxNDc3MWE0YzdhNTRjNGMxMmExZmJfMjY0_74177461-0e7d-42a7-ad7c-2c28cbb0e603">450</ix:nonfraction> million in the Medical Devices segment. Abbott expects to recognize revenue on approximately <ix:nonfraction unitref="number" contextref="i0d3805a00f3445b28539df123a4cfdf6_D20230101-20230331" decimals="2" name="abt:RevenueRemainingPerformanceObligationExpectedTimingPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80MC9mcmFnOmM3MTNmODc0MGE4MTQ3NzFhNGM3YTU0YzRjMTJhMWZiL3RleHRyZWdpb246YzcxM2Y4NzQwYTgxNDc3MWE0YzdhNTRjNGMxMmExZmJfMzUy_5e23617b-1ee8-4c03-9423-a48c72404966">60</ix:nonfraction> percent of these remaining performance obligations over the next <ix:nonnumeric contextref="icd6e8cc6801e4ffc8ed77cb2afedfe4c_I20230331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80MC9mcmFnOmM3MTNmODc0MGE4MTQ3NzFhNGM3YTU0YzRjMTJhMWZiL3RleHRyZWdpb246YzcxM2Y4NzQwYTgxNDc3MWE0YzdhNTRjNGMxMmExZmJfNDEy_ffbc832c-b6ef-4f92-ac83-fe0ea17a2135">24</ix:nonnumeric> months, approximately <ix:nonfraction unitref="number" contextref="ic4950353c947435f8a28167dbb179b77_D20230101-20230331" decimals="2" name="abt:RevenueRemainingPerformanceObligationExpectedTimingPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80MC9mcmFnOmM3MTNmODc0MGE4MTQ3NzFhNGM3YTU0YzRjMTJhMWZiL3RleHRyZWdpb246YzcxM2Y4NzQwYTgxNDc3MWE0YzdhNTRjNGMxMmExZmJfNDMw_ad861a3b-f180-4c15-b362-fcc820f1dd48">17</ix:nonfraction> percent over the subsequent <ix:nonnumeric contextref="i5108fc6f881a4422b13f734c804e80cc_I20230331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80MC9mcmFnOmM3MTNmODc0MGE4MTQ3NzFhNGM3YTU0YzRjMTJhMWZiL3RleHRyZWdpb246YzcxM2Y4NzQwYTgxNDc3MWE0YzdhNTRjNGMxMmExZmJfNDUz_d2951c8f-cd18-41a5-8608-a2f5e4fe432c">12</ix:nonnumeric> months and the remainder thereafter.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><hr style="page-break-after:always"><div style="min-height:126pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&nbsp;31, 2023</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 3  Revenue (Continued)</span></div></div><ix:continuation id="ie7e54e0e433c4c53aa050b3fda6c4991"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These performance obligations primarily reflect the future sale of reagents/consumables in contracts with minimum purchase obligations, extended warranty or service obligations related to previously sold equipment, and remote monitoring services related to previously implanted devices. Abbott has applied the practical expedient described in FASB Accounting Standards Codification (ASC) 606-10-50-14 and has not included remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</span></div><div style="text-align:justify"><span><br></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Contract Assets and Liabilities</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott discloses Trade receivables separately in the Condensed Consolidated Balance Sheet at the net amount expected to be collected. Contract assets primarily relate to Abbotts conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were not significant.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. Abbotts contract liabilities arise primarily in the Medical Devices reportable segment when payment is received upfront for various multi-period extended service arrangements.</span></div><div style="text-align:justify"><span><br></span></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80MC9mcmFnOmM3MTNmODc0MGE4MTQ3NzFhNGM3YTU0YzRjMTJhMWZiL3RleHRyZWdpb246YzcxM2Y4NzQwYTgxNDc3MWE0YzdhNTRjNGMxMmExZmJfMTg3OQ_3df6d252-4325-41f2-9859-c60f28f665c4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the contract liabilities during the period are as follows:</span></div><div style="text-align:justify"><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:85.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80MC9mcmFnOmM3MTNmODc0MGE4MTQ3NzFhNGM3YTU0YzRjMTJhMWZiL3RhYmxlOjM2NzI2ZTIzYjU3YjRiMDRhNjQ4NTM1MDNiNGE3NmE4L3RhYmxlcmFuZ2U6MzY3MjZlMjNiNTdiNGIwNGE2NDg1MzUwM2I0YTc2YThfMi0yLTEtMS01MTgwOQ_46d82cde-0cea-44d0-96ce-f085f7a30399">500</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenue from cash received during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="abt:ContractWithCustomerLiabilityChangeInUnearnedRevenueFromCashReceivedRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80MC9mcmFnOmM3MTNmODc0MGE4MTQ3NzFhNGM3YTU0YzRjMTJhMWZiL3RhYmxlOjM2NzI2ZTIzYjU3YjRiMDRhNjQ4NTM1MDNiNGE3NmE4L3RhYmxlcmFuZ2U6MzY3MjZlMjNiNTdiNGIwNGE2NDg1MzUwM2I0YTc2YThfMy0yLTEtMS01MTgwOQ_47cd3f65-6a6b-4c98-8fe1-1adb020ae297">122</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized related to contract liability balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80MC9mcmFnOmM3MTNmODc0MGE4MTQ3NzFhNGM3YTU0YzRjMTJhMWZiL3RhYmxlOjM2NzI2ZTIzYjU3YjRiMDRhNjQ4NTM1MDNiNGE3NmE4L3RhYmxlcmFuZ2U6MzY3MjZlMjNiNTdiNGIwNGE2NDg1MzUwM2I0YTc2YThfNC0yLTEtMS01MTgwOQ_a3a08519-305c-4c82-9f72-e3648c43e3b8">93</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80MC9mcmFnOmM3MTNmODc0MGE4MTQ3NzFhNGM3YTU0YzRjMTJhMWZiL3RhYmxlOjM2NzI2ZTIzYjU3YjRiMDRhNjQ4NTM1MDNiNGE3NmE4L3RhYmxlcmFuZ2U6MzY3MjZlMjNiNTdiNGIwNGE2NDg1MzUwM2I0YTc2YThfNS0yLTEtMS01MTgwOQ_7a8e6793-7c01-4df7-8d14-886b5afdcde3">529</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div></ix:nonnumeric></ix:continuation><div><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_43"></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RleHRyZWdpb246YWRlY2E2ODE5NGQxNDcwYThmMzYzMGEyMjlhZjJlZDVfMjYxOQ_e3515c04-0021-4702-b8ca-43997ab0b61b" continuedat="ie43e44857e604fbb8b5f407e565802d4" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 4  Supplemental Financial Information</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of unvested restricted stock that contain non-forfeitable rights to dividends are treated as participating securities and are included in the computation of earnings per share under the two-class method. Under the two-class method, net earnings are allocated between common shares and participating securities. Net earnings allocated to common shares for the three months ended March&nbsp;31, 2023 and 2022 were $<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RleHRyZWdpb246YWRlY2E2ODE5NGQxNDcwYThmMzYzMGEyMjlhZjJlZDVfNTQ5NzU1ODE2NTky_a9a53a9c-1de0-4c45-9cf0-9f90c0df64b8">1.313</ix:nonfraction> billion and $<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RleHRyZWdpb246YWRlY2E2ODE5NGQxNDcwYThmMzYzMGEyMjlhZjJlZDVfNTQ5NzU1ODE2NTg3_5d83007d-4720-452e-b9a4-0a1098549a2d">2.438</ix:nonfraction> billion, respectively.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other, net in Net cash from operating activities in the Condensed Consolidated Statement of Cash Flows for the first three months of 2023 includes $<ix:nonfraction unitref="usd" contextref="i26b45a5d06bf4e98bc964d213c98fcfd_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RleHRyZWdpb246YWRlY2E2ODE5NGQxNDcwYThmMzYzMGEyMjlhZjJlZDVfNjQ1_270313e3-12e9-4508-a122-8dd359b5554f">282</ix:nonfraction> million of pension contributions and the payment of cash taxes of approximately $<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForOtherTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RleHRyZWdpb246YWRlY2E2ODE5NGQxNDcwYThmMzYzMGEyMjlhZjJlZDVfNzIw_2d703e9d-4b64-4cad-a67c-1edff3695f3a">122</ix:nonfraction> million. The first three months of 2022 includes $<ix:nonfraction unitref="usd" contextref="ie355518a75604e0da15ec6e9051ddfb4_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RleHRyZWdpb246YWRlY2E2ODE5NGQxNDcwYThmMzYzMGEyMjlhZjJlZDVfNzU5_9a0cc1f3-2b81-46f9-becd-75bf07ba8b83">334</ix:nonfraction> million of pension contributions and the payment of cash taxes of approximately $<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForOtherTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RleHRyZWdpb246YWRlY2E2ODE5NGQxNDcwYThmMzYzMGEyMjlhZjJlZDVfODM0_1fe0ccdd-984d-4f4a-a68d-463befe33a56">195</ix:nonfraction> million.</span></div><div style="text-align:justify"><span><br></span></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RleHRyZWdpb246YWRlY2E2ODE5NGQxNDcwYThmMzYzMGEyMjlhZjJlZDVfMjYyMA_0ba8b156-4af8-46c9-ac69-d18783b131fa" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity for the first three months of 2023 related to the allowance for doubtful accounts as of March&nbsp;31, 2023:</span></div><div style="text-align:justify"><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:85.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for Doubtful Accounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RhYmxlOjY5NDUzYjQwMzI0YjQzYTNiZWU2YTc0ODBlZTExZWM0L3RhYmxlcmFuZ2U6Njk0NTNiNDAzMjRiNDNhM2JlZTZhNzQ4MGVlMTFlYzRfMi0yLTEtMS01MTgwOQ_f6171ad8-5869-4f63-b959-ef731ab71cb8">262</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provisions/charges to income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RhYmxlOjY5NDUzYjQwMzI0YjQzYTNiZWU2YTc0ODBlZTExZWM0L3RhYmxlcmFuZ2U6Njk0NTNiNDAzMjRiNDNhM2JlZTZhNzQ4MGVlMTFlYzRfMy0yLTEtMS01MTgwOQ_13ebcc25-5363-4dd8-9208-f241e8780394">8</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts charged off and other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RhYmxlOjY5NDUzYjQwMzI0YjQzYTNiZWU2YTc0ODBlZTExZWM0L3RhYmxlcmFuZ2U6Njk0NTNiNDAzMjRiNDNhM2JlZTZhNzQ4MGVlMTFlYzRfNC0yLTEtMS01MTgwOQ_522d5de2-9b5d-45a2-b5f3-65c4fe0cb8f0">2</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RhYmxlOjY5NDUzYjQwMzI0YjQzYTNiZWU2YTc0ODBlZTExZWM0L3RhYmxlcmFuZ2U6Njk0NTNiNDAzMjRiNDNhM2JlZTZhNzQ4MGVlMTFlYzRfNS0yLTEtMS01MTgwOQ_69abf39c-dc14-4da7-9d92-bb0f53da64b6">272</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div></ix:nonnumeric></ix:nonnumeric><div><span><br></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><hr style="page-break-after:always"><div style="min-height:126pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&nbsp;31, 2023</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 4  Supplemental Financial Information (Continued)</span></div></div><ix:continuation id="ie43e44857e604fbb8b5f407e565802d4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for doubtful accounts reflects the current estimate of credit losses expected to be incurred over the life of the accounts receivable. Abbott considers various factors in establishing, monitoring, and adjusting its allowance for doubtful accounts, including the aging of the accounts and aging trends, the historical level of charge-offs, and specific exposures related to particular customers. Abbott also monitors other risk factors and forward-looking information, such as country risk, when determining credit limits for customers and establishing adequate allowances.</span></div><div style="text-align:justify"><span><br></span></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="abt:ScheduleOfLongTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RleHRyZWdpb246YWRlY2E2ODE5NGQxNDcwYThmMzYzMGEyMjlhZjJlZDVfMjYyMQ_9b9b545b-5350-46d2-ac38-3bcf1c6f7f9b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of long-term investments as of March&nbsp;31, 2023 and December&nbsp;31, 2022 are as follows:</span></div><div style="text-align:justify"><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i0b1d2d67615d43239119edc548f2cd67_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RhYmxlOjhmYjU4NTAxZTk0NTRhMDVhYTEzOWE1N2ZhYzJlYTQwL3RhYmxlcmFuZ2U6OGZiNTg1MDFlOTQ1NGEwNWFhMTM5YTU3ZmFjMmVhNDBfMi0yLTEtMS01MTgwOQ_145da537-01a4-4043-8f60-6de8cf7d0ca0">565</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ib6f35fc95a184f259b82549da3bff5c9_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RhYmxlOjhmYjU4NTAxZTk0NTRhMDVhYTEzOWE1N2ZhYzJlYTQwL3RhYmxlcmFuZ2U6OGZiNTg1MDFlOTQ1NGEwNWFhMTM5YTU3ZmFjMmVhNDBfMi00LTEtMS01MTgwOQ_e7fdae1a-bb44-4853-9e3d-651af55fac51">558</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie65d4c8bae924c4a81a63f23de909521_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RhYmxlOjhmYjU4NTAxZTk0NTRhMDVhYTEzOWE1N2ZhYzJlYTQwL3RhYmxlcmFuZ2U6OGZiNTg1MDFlOTQ1NGEwNWFhMTM5YTU3ZmFjMmVhNDBfMy0yLTEtMS01MTgwOQ_d62992ea-b4fb-4716-a832-8fbf26398a07">211</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic16ab6c51e434fd08693e117279bd2d7_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RhYmxlOjhmYjU4NTAxZTk0NTRhMDVhYTEzOWE1N2ZhYzJlYTQwL3RhYmxlcmFuZ2U6OGZiNTg1MDFlOTQ1NGEwNWFhMTM5YTU3ZmFjMmVhNDBfMy00LTEtMS01MTgwOQ_736dd7e2-3514-4916-b4ee-477cd5dc094b">208</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RhYmxlOjhmYjU4NTAxZTk0NTRhMDVhYTEzOWE1N2ZhYzJlYTQwL3RhYmxlcmFuZ2U6OGZiNTg1MDFlOTQ1NGEwNWFhMTM5YTU3ZmFjMmVhNDBfNC0yLTEtMS01MTgwOQ_bfd59c69-894e-44f2-9a0e-3f4e0ab9bb85">776</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RhYmxlOjhmYjU4NTAxZTk0NTRhMDVhYTEzOWE1N2ZhYzJlYTQwL3RhYmxlcmFuZ2U6OGZiNTg1MDFlOTQ1NGEwNWFhMTM5YTU3ZmFjMmVhNDBfNC00LTEtMS01MTgwOQ_b854823a-dc7f-4842-b726-56f2c6d68ea1">766</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div></ix:nonnumeric><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in Abbotts long-term investments as of March&nbsp;31, 2023 versus the balance as of December&nbsp;31, 2022 primarily relates to an increase in the value of securities held in a rabbi trust and additional investments,</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partially offset by equity method investment losses.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbotts equity securities as of March&nbsp;31, 2023, include $<ix:nonfraction unitref="usd" contextref="if914a80751d14e9f8c339ba932064d93_I20230331" decimals="-6" name="us-gaap:CommonStockSharesHeldInEmployeeTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RleHRyZWdpb246YWRlY2E2ODE5NGQxNDcwYThmMzYzMGEyMjlhZjJlZDVfMTk0OQ_4632394f-6350-4c1a-85a5-b4df02f8810e">305</ix:nonfraction> million of investments in mutual funds that are held in a rabbi trust and were acquired as part of the St. Jude Medical, Inc. (St. Jude Medical) business acquisition. These investments, which are specifically designated as available for the purpose of paying benefits under a deferred compensation plan, are not available for general corporate purposes and are subject to creditor claims in the event of insolvency.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott also holds certain investments as of March&nbsp;31, 2023 with a carrying value of $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RleHRyZWdpb246YWRlY2E2ODE5NGQxNDcwYThmMzYzMGEyMjlhZjJlZDVfMjQzMw_81c19b24-6f27-4126-8a27-6c781a5e9d70">162</ix:nonfraction> million that are accounted for under the equity method of accounting and other equity investments with a carrying value of approximately $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80My9mcmFnOmFkZWNhNjgxOTRkMTQ3MGE4ZjM2MzBhMjI5YWYyZWQ1L3RleHRyZWdpb246YWRlY2E2ODE5NGQxNDcwYThmMzYzMGEyMjlhZjJlZDVfMjU2NQ_2ac65fb3-a736-48b1-b01c-f3783d937fb1">88</ix:nonfraction> million that do not have a readily determinable fair value.</span></div></ix:continuation><div style="text-align:justify"><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_46"></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RleHRyZWdpb246YTNjZjZjMmU0YzkwNDI4MmE4Y2VmZTU3NThmOTNjYzZfMzI4_1bf31129-212d-48d5-9394-4abec15234dc" continuedat="ie9941cc58240456994d2f25821703720" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 5  Changes In Accumulated Other Comprehensive Income (Loss)</span></div><div><span><br></span></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RleHRyZWdpb246YTNjZjZjMmU0YzkwNDI4MmE4Y2VmZTU3NThmOTNjYzZfMzI5_7b83e8ac-613d-4074-942f-877edc77586e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in accumulated other comprehensive income (loss), net of income taxes, are as follows:</span></div><div><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.964%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Foreign<br>Currency Translation<br>(Loss) Adjustments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Actuarial (Losses) and<br>Prior Service (Costs) and<br>Credits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Gains (Losses)<br>on Derivative Instruments<br>Designated as Cash Flow<br>Hedges and Other</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i5def2b3772eb4eb9be46d803e62013b7_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfMy0yLTEtMS01MTgwOQ_43436e1b-6465-4f4f-8c7a-467dfb9bff48">6,733</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i59a0edfa852f4e538dbd150170f6a956_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfMy00LTEtMS01MTgwOQ_b2cce761-9380-4252-9cf5-3de399176256">5,839</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i8d7cdcd3a63a4328ad43f9d17e35fd89_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfMy02LTEtMS01MTgwOQ_fff72cb6-4380-415d-b6f6-ee22706bf970">1,493</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i244422ab50f64c0193508e254b558dd5_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfMy04LTEtMS01MTgwOQ_6308cab5-f09d-45d4-b954-d1b684f27908">2,670</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i487f0bc874554e53a6fa6076e6071318_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfMy0xMC0xLTEtNTE4MDk_c6fae686-7e9b-4a8a-bdd4-43697dd44308">175</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i58b2ca6f87a64974a9447f3e5cfe313b_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfMy0xMi0xLTEtNTE4MDk_e782f367-9351-40ff-83f0-e59e45a2512c">135</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iafbd9a2533724636a830035207efcc90_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNC0yLTEtMS01MTgwOQ_3812343e-a080-4b6b-90ff-790eec4cd821">139</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ied1f76fd93524b358abd3835cd8f3821_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNC00LTEtMS01MTgwOQ_0eeeed6e-3ec2-4377-a77f-d72c76d0a44e">106</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i6f81dc76c38c4cf497beb7f57dde7172_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNC02LTEtMS01MTgwOQ_bb493b75-2d47-4a57-9942-85e4308adb0c">2</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4561966d0b5348b4803b599bf3e9b5bc_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNC04LTEtMS01MTgwOQ_f48dbf88-34e7-41c8-8481-0e8394f5a8a4">17</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i30ef9ac6448c411b90140bf9eb2d98a9_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNC0xMC0xLTEtNTE4MDk_eaf58b6b-5be1-492a-8ddd-acd42f4b06df">42</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="if859f647bbea4641a63a5f0475c60ec7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNC0xMi0xLTEtNTE4MDk_81b6332e-8c4e-416a-8f3e-bf0fe7057967">34</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iafbd9a2533724636a830035207efcc90_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNS0yLTEtMS01MTgwOQ_271c4e0f-6a7c-4aca-82e9-a91ca68a7c88"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ied1f76fd93524b358abd3835cd8f3821_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNS00LTEtMS01MTgwOQ_283f10b7-efe7-4d63-a044-3b46ab008895"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i6f81dc76c38c4cf497beb7f57dde7172_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNS02LTEtMS01MTgwOQ_0b10757b-1263-4746-968f-42ad89e94046"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4561966d0b5348b4803b599bf3e9b5bc_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNS04LTEtMS01MTgwOQ_91c5ff08-6dd1-498f-a8ef-dd4dea0f0da7">45</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i30ef9ac6448c411b90140bf9eb2d98a9_D20230101-20230331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNS0xMC0xLTEtNTE4MDk_728adc80-1d9f-43c8-ac5b-574149a02b39">87</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="if859f647bbea4641a63a5f0475c60ec7_D20220101-20220331" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNS0xMi0xLTEtNTE4MDk_9d6aaf03-9263-4e50-9f1b-f871662effc5">22</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current period comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iafbd9a2533724636a830035207efcc90_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNi0yLTEtMS01MTgwOQ_5d8a2f8d-c25c-41f1-920c-84f3b57967c5">139</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ied1f76fd93524b358abd3835cd8f3821_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNi00LTEtMS01MTgwOQ_a21f3ba3-4de3-4c47-a6ac-b554c61676f2">106</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i6f81dc76c38c4cf497beb7f57dde7172_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNi02LTEtMS01MTgwOQ_d4c09cb8-6b63-41cf-98c0-dc3d62d64229">2</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4561966d0b5348b4803b599bf3e9b5bc_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNi04LTEtMS01MTgwOQ_053238cc-08d3-4d6c-967e-5f0d8eafad5c">62</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i30ef9ac6448c411b90140bf9eb2d98a9_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNi0xMC0xLTEtNTE4MDk_bc82e07c-37f3-4277-bf01-e3e3e4ed3b4e">129</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="if859f647bbea4641a63a5f0475c60ec7_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNi0xMi0xLTEtNTE4MDk_2d4f8a76-7cb5-481e-a6a7-15fb42a81525">56</ix:nonfraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i6abf118e0f92461c91fc8118dd251e12_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNy0yLTEtMS01MTgwOQ_061d2a89-9906-4c30-aa20-4917777db55b">6,594</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ic903e7c4e980491ebab4dc0ae42affd5_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNy00LTEtMS01MTgwOQ_164dbe02-9036-4877-8c65-da27047ef67d">5,945</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i4676364e8eeb483db9ddc8e376318361_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNy02LTEtMS01MTgwOQ_8287d54d-c143-47d4-b7f9-bd3f36a0cef4">1,491</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i141ab5fb55224d0b9e671a5085b06dff_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNy04LTEtMS01MTgwOQ_b10775e8-5c4a-4120-bde8-04fb4cd7379f">2,608</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iefdc7d9f562a42d5b58bd39a15c39301_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNy0xMC0xLTEtNTE4MDk_d0a8a288-223c-4089-b147-db87b1b742cf">46</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1a7ee0bfa68b4f6096f89461b0168802_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80Ni9mcmFnOmEzY2Y2YzJlNGM5MDQyODJhOGNlZmU1NzU4ZjkzY2M2L3RhYmxlOjgyZTZlODQ3MDBhNjRhZjg5YWM5ZDJiNThlN2UzMGU4L3RhYmxlcmFuZ2U6ODJlNmU4NDcwMGE2NGFmODlhYzlkMmI1OGU3ZTMwZThfNy0xMi0xLTEtNTE4MDk_1d94eae2-8556-4b22-aa73-a75693bb3e0e">79</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div></ix:nonnumeric></ix:nonnumeric><div><span><br></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><hr style="page-break-after:always"><div style="min-height:126pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&nbsp;31, 2023</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 5  Changes In Accumulated Other Comprehensive Income (Loss) (Continued)</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie9941cc58240456994d2f25821703720">Reclassified amounts for cash flow hedges are recorded as Cost of products sold. Net actuarial losses and prior service cost are included as a component of net periodic benefit costs; see Note 12 for additional details.</ix:continuation></span></div><div style="text-align:justify"><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_49"></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfMTEwMw_d71c92b5-d014-4875-bb23-4d529455d54c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 6  Goodwill and Intangible Assets</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total amount of goodwill reported was $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-8" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfNTE_bffe66ff-6a90-4f5d-bba9-39059b14d4cd">22.9</ix:nonfraction> billion at March&nbsp;31, 2023 and $<ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-8" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfNjQ_9793b16a-7661-4ddb-bb14-33eeb5cf34d8">22.8</ix:nonfraction> billion at December&nbsp;31, 2022. Foreign currency translation adjustments increased goodwill by approximately $<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfMTQ0_646f9815-e2fa-4b07-a2aa-a7b0fe292173">128</ix:nonfraction> million in the first three months of 2023. The amount of goodwill related to reportable segments at March&nbsp;31, 2023 was $<ix:nonfraction unitref="usd" contextref="i43a264a6f390491bad652977df76d77c_I20230331" decimals="-8" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfMjQx_7fa0a7d4-7f89-4544-bb8e-e6b33cdd58ad">2.7</ix:nonfraction> billion for the Established Pharmaceutical Products segment, $<ix:nonfraction unitref="usd" contextref="i9aa4f9893a214cd0aed34ed012e62e6f_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfMjk3_b8026555-5f41-4a79-b90e-7c7b154eb1b5">286</ix:nonfraction> million for the Nutritional Products segment, $<ix:nonfraction unitref="usd" contextref="i8b699eeae0254fd0b47201e9f19cd838_I20230331" decimals="-8" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfMzM4_b970c5ac-b706-46a6-9085-b8721ceed1b2">3.5</ix:nonfraction> billion for the Diagnostic Products segment, and $<ix:nonfraction unitref="usd" contextref="ibc7d17d7f58c4472b5827157f00898fb_I20230331" decimals="-8" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfMzgy_72ac265f-90ce-44cd-a423-0026472c3a4d">16.4</ix:nonfraction> billion for the Medical Devices segment. There was <ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-8" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfNDI4_5fba6f2b-bee2-484a-8a0f-ccc2466ae83c">no</ix:nonfraction> reduction of goodwill relating to impairments in the first three months of 2023.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross amount of amortizable intangible assets, primarily product rights and technology, was $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-8" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfNjA0_4aa33adf-cbac-4a7b-a0d8-1a7f4b937e8c">27.4</ix:nonfraction> billion and $<ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-8" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfNjEx_2963a8e7-066f-46b0-b11e-58ebaf55671b">27.2</ix:nonfraction> billion as of March&nbsp;31, 2023 and December&nbsp;31, 2022, respectively. Accumulated amortization was $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-8" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfNjc0_8b3927b9-dc64-4d58-b957-a9c9fdeea0dc">18.2</ix:nonfraction> billion and $<ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-8" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfNjgx_68c9e9b1-c62b-4d80-8531-3425ae8a1d0f">17.6</ix:nonfraction> billion as of March&nbsp;31, 2023 and December&nbsp;31, 2022, respectively. Foreign currency translation adjustments increased intangible assets by $<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfNzgx_55a51460-3c4c-4055-ae71-0af5a0e64776">43</ix:nonfraction> million in the first three months of 2023. Abbotts estimated annual amortization expense for intangible assets is approximately $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-8" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfOTAw_f7c22290-9ca6-40c8-96fa-56e12e12c698">2.0</ix:nonfraction> billion in 2023, $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-8" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfOTEw_44a25e2e-43a9-4044-b211-4acb68f31cdf">1.9</ix:nonfraction> billion in 2024, $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-8" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfOTIw_42141cb2-8580-40cf-a66d-caadc19c1e2d">1.7</ix:nonfraction> billion in 2025, $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-8" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfOTMw_89339a58-490a-4649-a246-7a7eea82364b">1.5</ix:nonfraction> billion in 2026 and $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-8" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfOTQz_2d26ed87-f16f-4e97-ba0c-ab6fbfb8327c">1.2</ix:nonfraction> billion in 2027.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets, which relate to in-process R&amp;D (IPR&amp;D) acquired in a business combination, were approximately $<ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfMTA4NA_5aa5a60a-ea91-4257-a7ad-77fec6a8a4b5"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV80OS9mcmFnOjA1ZTA4MDFjNDM1NzRjODk4NjQ2OWQyMzU0NDc0YjkyL3RleHRyZWdpb246MDVlMDgwMWM0MzU3NGM4OTg2NDY5ZDIzNTQ0NzRiOTJfMTA4NA_5f4946c2-eb0e-44e4-aae4-abbf0cb01836">807</ix:nonfraction></ix:nonfraction> million as of March&nbsp;31, 2023 and December&nbsp;31, 2022.</span></div></ix:nonnumeric><div><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_52"></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81Mi9mcmFnOmNiNTU0YmFkY2Q3YjQxNTVhNjJhY2I5ZDQyZTUwYjRmL3RleHRyZWdpb246Y2I1NTRiYWRjZDdiNDE1NWE2MmFjYjlkNDJlNTBiNGZfMjIwNQ_60dcfb62-6dc4-4ce6-836b-e3fd1a672ea3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 7  Restructuring Plans </span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022 and 2023, Abbott management approved various plans to streamline operations in order to reduce costs and improve efficiencies in its medical devices, nutritional, diagnostic, and established pharmaceutical businesses. In the first three months of 2023, Abbott recorded employee related severance and other charges of approximately $<ix:nonfraction unitref="usd" contextref="ida280bcec74742538f374257f20ca0ca_D20230101-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81Mi9mcmFnOmNiNTU0YmFkY2Q3YjQxNTVhNjJhY2I5ZDQyZTUwYjRmL3RleHRyZWdpb246Y2I1NTRiYWRjZDdiNDE1NWE2MmFjYjlkNDJlNTBiNGZfNTQ5NzU1ODE2ODY5_ce5ebab4-4ae9-4633-9eb2-951a6b7e389c">17</ix:nonfraction> million, of which approximately $<ix:nonfraction unitref="usd" contextref="i1203f7dfdbbc4e048c4adffc592e6578_D20230101-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81Mi9mcmFnOmNiNTU0YmFkY2Q3YjQxNTVhNjJhY2I5ZDQyZTUwYjRmL3RleHRyZWdpb246Y2I1NTRiYWRjZDdiNDE1NWE2MmFjYjlkNDJlNTBiNGZfNTQ5NzU1ODE2ODg1_4017e571-8bfe-458a-a3e1-19aa8eea2a3b">6</ix:nonfraction> million was recorded in Cost of products sold, and approximately $<ix:nonfraction unitref="usd" contextref="i1ad25241e1bd480890c1f6c850441f0b_D20230101-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81Mi9mcmFnOmNiNTU0YmFkY2Q3YjQxNTVhNjJhY2I5ZDQyZTUwYjRmL3RleHRyZWdpb246Y2I1NTRiYWRjZDdiNDE1NWE2MmFjYjlkNDJlNTBiNGZfNTQ5NzU1ODE2OTIy_28ab0e9a-9cce-4bf5-9ae0-736f4e886346">11</ix:nonfraction> million was recorded in Selling, general and administrative expenses. </span></div><div style="text-align:justify"><span><br></span></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81Mi9mcmFnOmNiNTU0YmFkY2Q3YjQxNTVhNjJhY2I5ZDQyZTUwYjRmL3RleHRyZWdpb246Y2I1NTRiYWRjZDdiNDE1NWE2MmFjYjlkNDJlNTBiNGZfMzg0ODI5MDcwMDQ3NA_84cd9003-698e-4711-a4ee-995a0627910e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to these restructuring actions and the status of the related accruals as of March 31, 2023:</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:85.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i7f618d7af5084ff39a1bde7d1d6eee37_I20221231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81Mi9mcmFnOmNiNTU0YmFkY2Q3YjQxNTVhNjJhY2I5ZDQyZTUwYjRmL3RhYmxlOjhjMzgzYzgzM2JmMjRhYWZhZGFiZTNkZjhkZWQ3YTlmL3RhYmxlcmFuZ2U6OGMzODNjODMzYmYyNGFhZmFkYWJlM2RmOGRlZDdhOWZfMS0yLTEtMS02NDA4MA_823433d5-c0d9-4140-bcc5-c7226f2f1d23">228</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges in 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ida280bcec74742538f374257f20ca0ca_D20230101-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81Mi9mcmFnOmNiNTU0YmFkY2Q3YjQxNTVhNjJhY2I5ZDQyZTUwYjRmL3RhYmxlOjhjMzgzYzgzM2JmMjRhYWZhZGFiZTNkZjhkZWQ3YTlmL3RhYmxlcmFuZ2U6OGMzODNjODMzYmYyNGFhZmFkYWJlM2RmOGRlZDdhOWZfMS0yLTEtMS01MzA4Mw_66e04dd0-af54-441c-a1f7-1d7bf39f9219">17</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments and other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ida280bcec74742538f374257f20ca0ca_D20230101-20230331" decimals="-6" name="abt:RestructuringReservePeriodCashSettledAndOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81Mi9mcmFnOmNiNTU0YmFkY2Q3YjQxNTVhNjJhY2I5ZDQyZTUwYjRmL3RhYmxlOjhjMzgzYzgzM2JmMjRhYWZhZGFiZTNkZjhkZWQ3YTlmL3RhYmxlcmFuZ2U6OGMzODNjODMzYmYyNGFhZmFkYWJlM2RmOGRlZDdhOWZfMi0yLTEtMS01MzA4Mw_73ebf44e-f438-4746-a715-122f45f6f9ca">61</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued balance at March 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ib5a5f7a9afee4615af611ef4ff744b64_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81Mi9mcmFnOmNiNTU0YmFkY2Q3YjQxNTVhNjJhY2I5ZDQyZTUwYjRmL3RhYmxlOjhjMzgzYzgzM2JmMjRhYWZhZGFiZTNkZjhkZWQ3YTlmL3RhYmxlcmFuZ2U6OGMzODNjODMzYmYyNGFhZmFkYWJlM2RmOGRlZDdhOWZfMy0yLTEtMS01MzA4Mw_e595a26d-1d9d-42a9-b08b-3054027f4856">184</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div></ix:nonnumeric></ix:nonnumeric><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span><br></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_55"></div><hr style="page-break-after:always"><div style="min-height:126pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&nbsp;31, 2023</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RleHRyZWdpb246NDJkY2E5MzAxNzNmNGY2Nzk3YTcyY2IyNjhhZGRiZGJfNDY1_2f14999e-bf4c-4f80-bf8a-2466de3145dc" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 8  Incentive Stock Programs</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of 2023, Abbott granted <ix:nonfraction unitref="shares" contextref="i339e5af605d5441f9250ae0685656b7d_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RleHRyZWdpb246NDJkY2E5MzAxNzNmNGY2Nzk3YTcyY2IyNjhhZGRiZGJfNTQ_d12c2404-fe36-416e-9882-4663ebfb5e72">1,887,093</ix:nonfraction> stock options, <ix:nonfraction unitref="shares" contextref="i6ae83cffb65b4863863e8fa97bbb2a59_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RleHRyZWdpb246NDJkY2E5MzAxNzNmNGY2Nzk3YTcyY2IyNjhhZGRiZGJfNzI_9d816f86-260b-472a-b8b3-64c69ece28fd">445,278</ix:nonfraction> restricted stock awards and <ix:nonfraction unitref="shares" contextref="idcc10e688b78487a8083dfc915a0e318_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RleHRyZWdpb246NDJkY2E5MzAxNzNmNGY2Nzk3YTcyY2IyNjhhZGRiZGJfMTAz_ccd6e660-fd9a-4afd-8780-988aee2c5e63">4,761,433</ix:nonfraction> restricted stock units under its incentive stock program. At March&nbsp;31, 2023, approximately <ix:nonfraction unitref="shares" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RleHRyZWdpb246NDJkY2E5MzAxNzNmNGY2Nzk3YTcyY2IyNjhhZGRiZGJfMTg1_35b7a637-d7a5-4372-9c2b-1047586be9f4">74</ix:nonfraction> million shares were reserved for future grants. <ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RleHRyZWdpb246NDJkY2E5MzAxNzNmNGY2Nzk3YTcyY2IyNjhhZGRiZGJfNDY3_bea1f1ad-c845-4f44-bbc5-7283395b7a60" continuedat="i461b187c0cf84fa183f127979c98f5ad" escape="true">Information regarding the number of options outstanding and exercisable at March&nbsp;31, 2023 is as follows:</ix:nonnumeric></span></div><div style="text-align:justify"><span><br></span></div><div><ix:continuation id="i461b187c0cf84fa183f127979c98f5ad"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercisable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of shares </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="shares" contextref="iff57da08c935407fb6ed698c0c11d7c7_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RhYmxlOmQwMzA1MmI0NjBiODQ5NDU4ZGI4YzUxMzQwOTU0YjJhL3RhYmxlcmFuZ2U6ZDAzMDUyYjQ2MGI4NDk0NThkYjhjNTEzNDA5NTRiMmFfMS0yLTEtMS01MTgwOQ_d9420b3b-2826-4240-b93a-485da0b8704c">29,760,644</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="shares" contextref="iff57da08c935407fb6ed698c0c11d7c7_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RhYmxlOmQwMzA1MmI0NjBiODQ5NDU4ZGI4YzUxMzQwOTU0YjJhL3RhYmxlcmFuZ2U6ZDAzMDUyYjQ2MGI4NDk0NThkYjhjNTEzNDA5NTRiMmFfMS00LTEtMS01MTgwOQ_dfa13045-8ddf-465d-91d4-4ded81b6098d">25,107,006</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining life </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i339e5af605d5441f9250ae0685656b7d_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RhYmxlOmQwMzA1MmI0NjBiODQ5NDU4ZGI4YzUxMzQwOTU0YjJhL3RhYmxlcmFuZ2U6ZDAzMDUyYjQ2MGI4NDk0NThkYjhjNTEzNDA5NTRiMmFfMi0yLTEtMS01MTgwOQ_b1378829-fc0a-4df3-92ac-4930a286a4d6">5.4</ix:nonnumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonnumeric contextref="i339e5af605d5441f9250ae0685656b7d_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RhYmxlOmQwMzA1MmI0NjBiODQ5NDU4ZGI4YzUxMzQwOTU0YjJhL3RhYmxlcmFuZ2U6ZDAzMDUyYjQ2MGI4NDk0NThkYjhjNTEzNDA5NTRiMmFfMi00LTEtMS01MTgwOQ_991223bf-665a-41c7-9f72-58fc852beefa">4.7</ix:nonnumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average exercise price </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usdPerShare" contextref="iff57da08c935407fb6ed698c0c11d7c7_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RhYmxlOmQwMzA1MmI0NjBiODQ5NDU4ZGI4YzUxMzQwOTU0YjJhL3RhYmxlcmFuZ2U6ZDAzMDUyYjQ2MGI4NDk0NThkYjhjNTEzNDA5NTRiMmFfMy0yLTEtMS01MTgwOQ_2b7c3815-8737-40d9-8834-f33ef270eb77">73.33</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usdPerShare" contextref="iff57da08c935407fb6ed698c0c11d7c7_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RhYmxlOmQwMzA1MmI0NjBiODQ5NDU4ZGI4YzUxMzQwOTU0YjJhL3RhYmxlcmFuZ2U6ZDAzMDUyYjQ2MGI4NDk0NThkYjhjNTEzNDA5NTRiMmFfMy00LTEtMS01MTgwOQ_6e1d5942-683d-4aae-b544-d0b995bbd6ef">65.76</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate intrinsic value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iff57da08c935407fb6ed698c0c11d7c7_I20230331" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RhYmxlOmQwMzA1MmI0NjBiODQ5NDU4ZGI4YzUxMzQwOTU0YjJhL3RhYmxlcmFuZ2U6ZDAzMDUyYjQ2MGI4NDk0NThkYjhjNTEzNDA5NTRiMmFfNC0yLTEtMS01MTgwOQ_1449e403-a281-44a7-9447-1e418b50c17b">947</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iff57da08c935407fb6ed698c0c11d7c7_I20230331" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RhYmxlOmQwMzA1MmI0NjBiODQ5NDU4ZGI4YzUxMzQwOTU0YjJhL3RhYmxlcmFuZ2U6ZDAzMDUyYjQ2MGI4NDk0NThkYjhjNTEzNDA5NTRiMmFfNC00LTEtMS01MTgwOQ_6c73444a-1c27-4750-b0fe-93c7c0524a3a">946</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></ix:continuation></div><div style="text-align:justify"><span><br></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total unrecognized share-based compensation cost at March&nbsp;31, 2023 amounted to approximately $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RleHRyZWdpb246NDJkY2E5MzAxNzNmNGY2Nzk3YTcyY2IyNjhhZGRiZGJfNDEw_b92f9c7a-5757-47cf-9679-216d4999984d">760</ix:nonfraction> million, which is expected to be recognized over the next <ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81NS9mcmFnOjQyZGNhOTMwMTczZjRmNjc5N2E3MmNiMjY4YWRkYmRiL3RleHRyZWdpb246NDJkY2E5MzAxNzNmNGY2Nzk3YTcyY2IyNjhhZGRiZGJfNDYy_228f3b2d-e7a4-4d65-9bb4-fcc627c098da">three years</ix:nonnumeric>.</span></div></ix:nonnumeric><div><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_58"></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81OC9mcmFnOjgzMjNmZjc2YTIwNDRmNDNiNTAwM2FiNDNmNDk5ZWJkL3RleHRyZWdpb246ODMyM2ZmNzZhMjA0NGY0M2I1MDAzYWI0M2Y0OTllYmRfOTY_bd7a9441-ef82-455e-bf9e-16c5716e1c7f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 9  Debt and Lines of Credit</span></div><div><span><br></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&nbsp;15, 2022, Abbott repaid the $<ix:nonfraction unitref="usd" contextref="ide5227ecbb644c8aa728cc6feb96660b_D20220315-20220315" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81OC9mcmFnOjgzMjNmZjc2YTIwNDRmNDNiNTAwM2FiNDNmNDk5ZWJkL3RleHRyZWdpb246ODMyM2ZmNzZhMjA0NGY0M2I1MDAzYWI0M2Y0OTllYmRfMzQ_f1831bdf-e14c-4a9a-be78-296651d72fd1">750</ix:nonfraction> million outstanding principal amount of its <ix:nonfraction unitref="number" contextref="i96075db6479749c9b6bcab55f2bcbbc5_I20220315" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81OC9mcmFnOjgzMjNmZjc2YTIwNDRmNDNiNTAwM2FiNDNmNDk5ZWJkL3RleHRyZWdpb246ODMyM2ZmNzZhMjA0NGY0M2I1MDAzYWI0M2Y0OTllYmRfNzM_7c8303f9-bfed-46cb-af6c-d0e3f18d2962">2.55</ix:nonfraction>% Notes upon maturity.</span></div></ix:nonnumeric><div><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_61"></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfNDUwNA_0d2fa4bc-b01a-4293-924e-197e2acc10f4" continuedat="i6d344afdff874f26ab4b967414a477f0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 10  Financial Instruments, Derivatives and Fair Value Measures</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain Abbott foreign subsidiaries enter into foreign currency forward exchange contracts to manage exposures to changes in foreign exchange rates, primarily for anticipated intercompany purchases by those subsidiaries whose functional currencies are not the U.S. dollar. These contracts, with gross notional amounts totaling $<ix:nonfraction unitref="usd" contextref="ie8481f7ce10e4885ba9d374c46559537_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfMzM1_fb82ec9c-7ab3-4d00-b154-69e28ff05ba1">7.1</ix:nonfraction> billion at March&nbsp;31, 2023 and $<ix:nonfraction unitref="usd" contextref="i1589346f503d4eed8f4857355bd853da_I20221231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfMzQ4_6bff9c2d-c959-481b-b164-e08c162c4cc3">7.7</ix:nonfraction> billion at December&nbsp;31, 2022, are designated as cash flow hedges of the variability of the cash flows due to changes in foreign exchange rates and are recorded at fair value. Accumulated gains and losses as of March&nbsp;31, 2023 will be included in Cost of products sold at the time the products are sold, generally through the next <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfNjQ1_32bee6dc-b03d-416a-a3d9-73785c6a1ebe">twelve</span> to <ix:nonnumeric contextref="iaf806062f75b4ffea296eff43c880913_D20230101-20230331" name="us-gaap:MaximumLengthOfTimeHedgedInCashFlowHedge1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfNjUx_d6c53686-c49c-4c56-8852-f2bb4d5c598e">eighteen months</ix:nonnumeric>.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott enters into foreign currency forward exchange contracts to manage currency exposures for foreign currency denominated third-party trade payables and receivables, and for intercompany loans and trade accounts payable where the receivable or payable is denominated in a currency other than the functional currency of the entity. For intercompany loans, the contracts require Abbott to sell or buy foreign currencies, primarily European currencies, in exchange for primarily U.S. dollars and other European currencies. For intercompany and trade payables and receivables, the currency exposures are primarily the U.S. dollar and European currencies. At March&nbsp;31, 2023 and December&nbsp;31, 2022, Abbott held the gross notional amounts of $<ix:nonfraction unitref="usd" contextref="ib678f550d770441f847639b178cf7162_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfMTM2Ng_d50d4d15-55f9-4d08-b74c-7560c924e1d0">11.4</ix:nonfraction> billion and $<ix:nonfraction unitref="usd" contextref="i7a8fbfa046dd44fdbd60eb9de204aa57_I20221231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfMTM3Mw_de322add-983d-4414-81cf-44a8f91402d4">12.0</ix:nonfraction> billion, respectively, of such foreign currency forward exchange contracts.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott has designated a yen-denominated, <ix:nonnumeric contextref="i3e21b3a86372457bbb29bacd53de21a4_D20230101-20230331" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfMTQ4Ng_9dc7883d-fdfc-49d1-9378-43ff09acb4ed"><ix:nonnumeric contextref="i5842560320884b4ca09d1ee717234960_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfMTQ4Ng_d4c7f483-ae66-4ba1-a903-1466e35aad38">5</ix:nonnumeric></ix:nonnumeric>-year term loan of approximately $<ix:nonfraction unitref="usd" contextref="ie652ddad8da44ab7b3257e35e97deacc_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfMTUyMQ_7d1fff27-5011-4893-8a22-b8175dd0aa1e">451</ix:nonfraction> million and $<ix:nonfraction unitref="usd" contextref="i29316e017ecb4fd9ac8c025fd280f73f_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfMTUyOA_0a934228-df2c-46a5-8fdd-1e4e89cafdb6">446</ix:nonfraction> million as of March&nbsp;31, 2023 and December&nbsp;31, 2022, respectively, as a hedge of the net investment in certain foreign subsidiaries. The change in the value of the debt, which is due to changes in foreign exchange rates, is recorded in Accumulated other comprehensive income (loss), net of tax.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott is a party to interest rate hedge contracts with a notional amount totaling approximately $<ix:nonfraction unitref="usd" contextref="i83bfce258f914f0282a0ceacbba11109_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfMTg2NQ_299afe41-ea74-4d14-ad70-913f9d389741"><ix:nonfraction unitref="usd" contextref="ic737d070671843d4b4e94d2dc20e5ae2_I20221231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfMTg2NQ_55f2d1ce-1e34-47af-b143-0d363a178cb7">2.9</ix:nonfraction></ix:nonfraction> billion at March&nbsp;31, 2023 and December&nbsp;31, 2022 to manage its exposure to changes in the fair value of fixed-rate debt. These contracts are designated as fair value hedges of the variability of the fair value of fixed-rate debt due to changes in the long-term benchmark interest rates. The effect of the hedge is to change a fixed-rate interest obligation to a variable rate for that portion of the debt. Abbott records the contracts at fair value and adjusts the carrying amount of the fixed-rate debt by an offsetting amount.</span></div></ix:nonnumeric><div style="text-align:justify"><span><br></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><hr style="page-break-after:always"><div style="min-height:126pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&nbsp;31, 2023</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 10  Financial Instruments, Derivatives and Fair Value Measures (Continued)</span></div></div><ix:continuation id="i6d344afdff874f26ab4b967414a477f0" continuedat="i2a133a9198e844238e8f81b8d3bd126e"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfNDUwMA_3fe37608-acd4-492d-8078-383514a43d16" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amounts and location of certain derivative financial instruments as of March&nbsp;31, 2023 and December&nbsp;31, 2022:</span></div><div style="text-align:justify"><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:24.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value - Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value - Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br>2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Caption</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br>2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br>2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Caption</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest rate swaps designated as fair value hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i682fcf1581804c00bd53145e30ef97d5_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfMy0yLTEtMS01MzI3Mg_00a54d7c-2687-4114-b991-d99c36670d0d"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i857b08dd304843728a2b4edc9e2adac1_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfMy00LTEtMS01MzI3Mg_92926787-11f8-403c-b9dc-233c1e36fbf1"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes and other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if94f09c2f32f40d195fce39b541ed4e4_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfMy04LTEtMS01MzI5MQ_7f296701-4edb-426a-b42c-3f24926e5d26">126</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i80a38e9e75bc4ab99c5bc45ed48fd0dc_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfMy0xMC0xLTEtNTMyOTE_5c4c791b-5ee8-465d-b4ae-c8659f1cd279">136</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Post-employment obligations, deferred income taxes and other long-term liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i9c59a71f371048d6b8149957110b0729_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNC0yLTEtMS01MzI3Mg_1d3f512b-b7ea-4b3f-8a0b-6ec2174849a7"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if9060369b6314002bd98da0301ffe2ec_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNC00LTEtMS01MzI3Mg_bb6018c6-3c56-4f94-a3a3-55c8610c3fb5"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ib6d9607924084c2e9ee592b6e86ebe84_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNC04LTEtMS01MzI5MQ_8424ccb2-1d1a-4732-9a06-b7bcb8ac3dc3">21</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i08d2fd67dc0247838e1d296020aad581_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNC0xMC0xLTEtNTMyOTE_eec2bc16-4eb9-44b3-9ab1-4e8550e89db5">20</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3f6b87f1a44c43999b0843c43f268585_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNC0yLTEtMS01MTgwOQ_6d8a1fce-8b38-494a-9e62-e1b6fb3c7e26">76</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia70cc62a14fc48a4af6f4a094df5c760_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNC00LTEtMS01MTgwOQ_24367ab9-84fc-43bf-9d00-61ef3ef21eff">304</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other receivables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ibace88747ab645ceb30928a36e8827a3_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNC04LTEtMS01MTgwOQ_d9af1494-3075-4db5-8bf9-1c70ab4af83e">139</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i80a3f534c2ca41fba4e80966dcb0c985_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNC0xMC0xLTEtNTE4MDk_5d2366d9-0318-4308-b14e-9d77ac2feafd">96</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Others not designated as hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i13e6528878e0408083556c84d7eabf48_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNS0yLTEtMS01MTgwOQ_9aea5ef1-ab88-4ad0-a912-ec03e4e27759">78</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ifce8644e0ff04779a198e6d96140ed67_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNS00LTEtMS01MTgwOQ_83f0e85b-a47c-4b41-bd12-56eba659612e">108</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other receivables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i25a5e508ceaa4ebea2e0f9821d7e70bb_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNS04LTEtMS01MTgwOQ_820af47e-8461-4932-9b5f-61609af524d8">96</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ifd757bdbdf4141aaa446c3b809816bb7_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNS0xMC0xLTEtNTE4MDk_380f3181-214c-44ea-8c81-bd7593d6d6fa">130</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt designated as a hedge of net investment in a foreign subsidiary</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1549e8f60a4d446fb9bba234c7aec8d2_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNi04LTEtMS01MTgwOQ_abe6e455-3a81-4a05-a11e-59dd094d4886">451</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i2efe3615243f4d548169acebbd2ada5f_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNi0xMC0xLTEtNTE4MDk_16d26407-0c75-43aa-ad67-3a79fdfb7977">446</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNy0yLTEtMS01MTgwOQ_14bbc0c5-783b-46d1-81c3-c5564828343a">154</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNy00LTEtMS01MTgwOQ_76b9d395-4c83-4970-904c-e054f6eec9df">412</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNy04LTEtMS01MTgwOQ_8ff91caf-eac5-4109-ae80-6ac90fe6ce66">833</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if307ce6e7ff74c5fad71a793c76ddaf7_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjk0YmZmMTM1YzU5MDQwZTVhM2ZkZDg5NmFmMmY3ODU3L3RhYmxlcmFuZ2U6OTRiZmYxMzVjNTkwNDBlNWEzZmRkODk2YWYyZjc4NTdfNy0xMC0xLTEtNTE4MDk_4458322b-6fa4-4bad-8703-f3bcc38c0fcd">828</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></tbody></table></div></ix:nonnumeric><div><span><br></span></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfNDUwMQ_14afa6de-cbac-4cfb-a157-7ba41c1f090a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for foreign currency forward exchange contracts designated as cash flow hedges and certain other derivative financial instruments, as well as the amounts and location of income (expense) and gain (loss) reclassified into income for the three months ended March&nbsp;31, 2023 and 2022.</span></div><div style="text-align:justify"><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:42.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.388%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gain (loss) Recognized in Other Comprehensive Income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (expense) and<br>&nbsp;Gain (loss) Reclassified into Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months<br>Ended March 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months<br>Ended March 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income Statement Caption</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i00fd463fc60e4769986c725c3e2546a7_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOmMxM2ZmYTRjZTliYTRiNDU5NzAwNmNmNDM3Zjk1OWMxL3RhYmxlcmFuZ2U6YzEzZmZhNGNlOWJhNGI0NTk3MDA2Y2Y0MzdmOTU5YzFfMy0yLTEtMS01MTgwOQ_baa4bcf8-9d31-4d65-b897-caadb8cde6cd">63</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="id5c76d4bbb8d474c9c9cf72dd3a988a4_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOmMxM2ZmYTRjZTliYTRiNDU5NzAwNmNmNDM3Zjk1OWMxL3RhYmxlcmFuZ2U6YzEzZmZhNGNlOWJhNGI0NTk3MDA2Y2Y0MzdmOTU5YzFfMy00LTEtMS01MTgwOQ_a4bc4274-baf4-4d24-a1c4-43539b0fd6a2">49</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i00fd463fc60e4769986c725c3e2546a7_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOmMxM2ZmYTRjZTliYTRiNDU5NzAwNmNmNDM3Zjk1OWMxL3RhYmxlcmFuZ2U6YzEzZmZhNGNlOWJhNGI0NTk3MDA2Y2Y0MzdmOTU5YzFfMy0xMC0xLTEtNTE4MDk_c25a49fb-565e-4683-ae17-3759673d8f68">126</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="id5c76d4bbb8d474c9c9cf72dd3a988a4_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOmMxM2ZmYTRjZTliYTRiNDU5NzAwNmNmNDM3Zjk1OWMxL3RhYmxlcmFuZ2U6YzEzZmZhNGNlOWJhNGI0NTk3MDA2Y2Y0MzdmOTU5YzFfMy0xMi0xLTEtNTE4MDk_f6eb67e7-e7f4-4c13-8be4-e0ffe0d78a45">27</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt designated as a hedge of net investment in a foreign subsidiary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i9673a64edeb74f94a2da30d9a9d98d48_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOmMxM2ZmYTRjZTliYTRiNDU5NzAwNmNmNDM3Zjk1OWMxL3RhYmxlcmFuZ2U6YzEzZmZhNGNlOWJhNGI0NTk3MDA2Y2Y0MzdmOTU5YzFfNC0yLTEtMS01MTgwOQ_4ff183bd-55cb-4f86-a3a9-25eaeec95721">5</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie9b7b52be44b4296a0e398df027b85ce_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOmMxM2ZmYTRjZTliYTRiNDU5NzAwNmNmNDM3Zjk1OWMxL3RhYmxlcmFuZ2U6YzEzZmZhNGNlOWJhNGI0NTk3MDA2Y2Y0MzdmOTU5YzFfNC00LTEtMS01MTgwOQ_ede0aa9c-18d9-46b2-9ef4-4168096be7c8">30</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swaps designated as fair value hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i38bd7945f5274d06bb441615ea32b940_D20230101-20230331" decimals="-6" name="abt:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOmMxM2ZmYTRjZTliYTRiNDU5NzAwNmNmNDM3Zjk1OWMxL3RhYmxlcmFuZ2U6YzEzZmZhNGNlOWJhNGI0NTk3MDA2Y2Y0MzdmOTU5YzFfNS0xMC0xLTEtNTE4MDk_99b193b3-64d1-429f-bebc-4bdc90317855">9</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1e6fc926e07d46cd9a154e136cae40fb_D20220101-20220331" decimals="-6" sign="-" name="abt:OtherComprehensiveIncomeLossFairValueHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOmMxM2ZmYTRjZTliYTRiNDU5NzAwNmNmNDM3Zjk1OWMxL3RhYmxlcmFuZ2U6YzEzZmZhNGNlOWJhNGI0NTk3MDA2Y2Y0MzdmOTU5YzFfNS0xMi0xLTEtNTE4MDk_f5705f90-ae30-4efa-b488-60680a6a5206">121</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td></tr></tbody></table></div></ix:nonnumeric></ix:continuation><div><span><br></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><hr style="page-break-after:always"><div style="min-height:126pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&nbsp;31, 2023</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 10  Financial Instruments, Derivatives and Fair Value Measures (Continued)</span></div></div><ix:continuation id="i2a133a9198e844238e8f81b8d3bd126e" continuedat="iec8fa0aac5794c21809f64a2389130f4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Losses of $<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfMjc5OQ_9436b43b-765f-4b8e-a919-af9359f809e3">103</ix:nonfraction> million and $<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfMjgwNw_6cc2d0a5-b951-4c3b-8425-53bb34d9e854">51</ix:nonfraction> million were recognized in the three months ended March&nbsp;31, 2023 and 2022, respectively, related to foreign currency forward exchange contracts not designated as a hedge. These amounts are reported in the Condensed Consolidated Statement of Earnings on the Net foreign exchange (gain) loss line.</span></div><div style="text-align:justify"><span><br></span></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfNDUwMg_71ff6ab3-7b3e-4b0f-b5b1-d7dc8b9811fc" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values and fair values of certain financial instruments as of March&nbsp;31, 2023 and December&nbsp;31, 2022 are shown in the following table. The carrying values of all other financial instruments approximate their estimated fair values. The counterparties to financial instruments consist of select major international financial institutions. Abbott does not expect any losses from non-performance by these counterparties.</span></div><div style="text-align:justify"><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying<br>Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Investment Securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i461bc13197304e459e934cf29a484ca3_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfMy0yLTEtMS01MTgwOQ_f8b9617b-937a-4d36-aa38-9b8b1d10cdfe">565</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ied3160c612f04b29956478fa57e5fec7_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfMy00LTEtMS01MTgwOQ_1ee0a8e7-8138-493e-b9a2-14273b24cdff">565</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i2f37ddf98f7e49a28c4aab1cb538e2e9_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfMy02LTEtMS01MTgwOQ_8dc521b0-dfff-4275-97b9-0ed94e389998">558</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i186ce20e309041229664a85b3c0493cf_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfMy04LTEtMS01MTgwOQ_c3985e3d-882b-43ab-b621-1e2b5a82ab35">558</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie9e36025d6e949d8bc2a1555cd4ef618_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfNC0yLTEtMS01MTgwOQ_8b84809f-6f76-4286-9229-949674cf2bb1">211</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i76fb6d5d675443e8bef64a59f1ee902d_I20230331" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfNC00LTEtMS01MTgwOQ_fcb64c14-2538-42ad-86f6-08ade917dbf2">211</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic2ebcbddcbdc402b96f02d02939c7313_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfNC02LTEtMS01MTgwOQ_46bca87b-0c02-48ff-b1b3-3cdd13ca216d">208</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia3d5d3487ee54862a2d17bc9c8c33841_I20221231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfNC04LTEtMS01MTgwOQ_07cccb1f-3955-47eb-908a-11054260a4a1">208</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Long-term Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i1648f1c4a921402d87b8daf2f56a458a_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfNS0yLTEtMS01MTgwOQ_63b0bc43-7e0c-4d88-ab52-616fa5821d4a">16,900</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i898dd9c510204dc5b25118b6e332d35a_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfNS00LTEtMS01MTgwOQ_ce083c13-1ba9-41af-99ef-f45d1ba97aca">16,927</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ie630ad9b25fd40dab00199e1b0add32a_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfNS02LTEtMS01MTgwOQ_657f91e0-bd83-40c7-b986-ef7b034db68f">16,773</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="icf5a3ff902f44ab68d0abff8a44f764e_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfNS04LTEtMS01MTgwOQ_cd9aff84-0e9a-42f0-b11e-d66ee81d504f">16,313</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign Currency Forward Exchange Contracts:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable position</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i768adc7924e942e1a5ced688fbdf28ad_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfNy0yLTEtMS01MTgwOQ_21584c1b-64d7-4958-ad23-4c37aa03252e">154</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i40731783197147729ebc7d999fea9ca6_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfNy00LTEtMS01MTgwOQ_8d287ee8-9d51-40e8-8fe7-166dbc26551a">154</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="icdcbf0e5e0544a539946ac553e1ad902_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfNy02LTEtMS01MTgwOQ_98e975ca-0e92-46f9-a5ec-27a2c0edaa67">412</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i2ac2b9a95b9b4e838b3e3e9b6198b7ff_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfNy04LTEtMS01MTgwOQ_3f9d70bf-0ad3-46c9-8c29-6dcec8103006">412</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Payable) position</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i768adc7924e942e1a5ced688fbdf28ad_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfOC0yLTEtMS01MTgwOQ_7afe4939-a9b8-4753-a36e-6cbdfcd0faac">235</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i40731783197147729ebc7d999fea9ca6_I20230331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfOC00LTEtMS01MTgwOQ_e0d4453a-8ce9-41cc-a990-631c8d5f3d56">235</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="icdcbf0e5e0544a539946ac553e1ad902_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfOC02LTEtMS01MTgwOQ_50b81f79-2e0b-4c56-99e0-4b546c210903">226</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i2ac2b9a95b9b4e838b3e3e9b6198b7ff_I20221231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfOC04LTEtMS01MTgwOQ_9d25a82f-b9fd-4aa5-873a-9c136c8c37e0">226</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate Hedge Contracts:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Payable) position</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ie3860c46361b4e899d38a0feb173be1a_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfMTEtMi0xLTEtNTE4MDk_c5918e8d-678e-436d-9306-43162da9dce8">147</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ibb49b60ef38446dab1a692e805ebc375_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfMTEtNC0xLTEtNTE4MDk_7a7e7050-6e75-4b30-83a1-e5cd55f53ab5">147</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ia517410d985b484bae03d66b28895365_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfMTEtNi0xLTEtNTE4MDk_9485d658-8a2d-47ab-874a-3231ec8a5019">156</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i90903797dbd045c4876732e6152e2a31_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjRhOTk1Y2ZhNjI3ODRmOGM4YTJjM2Y0NTViYmY4YzI0L3RhYmxlcmFuZ2U6NGE5OTVjZmE2Mjc4NGY4YzhhMmMzZjQ1NWJiZjhjMjRfMTEtOC0xLTEtNTE4MDk_662f7097-8ab6-48ae-8992-ae74cf45e07f">156</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div></ix:nonnumeric><div><span><br></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the debt was determined based on significant other observable inputs, including current interest rates.</span></div></ix:continuation><div><span><br></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><hr style="page-break-after:always"><div style="min-height:126pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&nbsp;31, 2023</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 10  Financial Instruments, Derivatives and Fair Value Measures (Continued)</span></div></div><ix:continuation id="iec8fa0aac5794c21809f64a2389130f4"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RleHRyZWdpb246MzZjZDYzYTJjODQ1NDg4Zjk3NDcxMDAwMDlkOTJiZDZfNDUwMw_e0ce834a-0453-4e9a-b84b-bea19be48480" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis in the balance sheet:</span></div><div style="text-align:justify"><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding<br>Balances</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted<br>Prices in<br>Active<br>Markets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br>Other<br>Observable<br>Inputs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant<br>Unobservable<br>Inputs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 31, 2023:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4fb068383bf046a1a3b9160d60a024c3_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMy0yLTEtMS01MTgwOQ_e2a96c96-3976-44f2-adc2-5b4c5dfb8c6c">315</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia2168e799b254629935c893ee4e1613c_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMy00LTEtMS01MTgwOQ_65873d9b-635b-403f-b244-6de8d62f17b9">315</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="icd05d1a66a1d49e6859dfb6ef7567333_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMy02LTEtMS01MTgwOQ_2e776f8f-0898-4398-a7d2-92f2fdb75be2"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8157806eaebb4a74a10d8a79b40b7ab6_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMy04LTEtMS01MTgwOQ_397ce9bc-f5b4-473b-981b-8734ccfe46ce"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4fb068383bf046a1a3b9160d60a024c3_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfNC0yLTEtMS01MTgwOQ_728be677-6e02-4b99-bca7-cff4436a488d">154</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia2168e799b254629935c893ee4e1613c_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfNC00LTEtMS01MTgwOQ_fe20e6f7-6a68-45dd-84d3-def4c2adff33"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="icd05d1a66a1d49e6859dfb6ef7567333_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfNC02LTEtMS01MTgwOQ_c371375e-e4c6-4f14-b6b4-b00a73428483">154</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8157806eaebb4a74a10d8a79b40b7ab6_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfNC04LTEtMS01MTgwOQ_e965bca0-d1e6-4a66-9fe1-e19168dadb30"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4fb068383bf046a1a3b9160d60a024c3_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfNS0yLTEtMS01MTgwOQ_1b200ee3-ab06-45a3-9c25-e12f3a63bfdb">469</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia2168e799b254629935c893ee4e1613c_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfNS00LTEtMS01MTgwOQ_b479779a-b5fc-4788-baa1-de4a62b79356">315</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="icd05d1a66a1d49e6859dfb6ef7567333_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfNS02LTEtMS01MTgwOQ_b7d5a355-3681-45e6-b473-7fc3d0dfc347">154</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8157806eaebb4a74a10d8a79b40b7ab6_I20230331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfNS04LTEtMS01MTgwOQ_3f6c03ae-8b49-46e7-a11d-a4ad1ad802c2"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of hedged long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4fb068383bf046a1a3b9160d60a024c3_I20230331" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfNy0yLTEtMS01MTgwOQ_504b5709-fc72-46cc-b3f1-e2830586a0f5">2,720</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia2168e799b254629935c893ee4e1613c_I20230331" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfNy00LTEtMS01MTgwOQ_34db74da-cd0e-43d2-9f26-38cc9d57f90f"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="icd05d1a66a1d49e6859dfb6ef7567333_I20230331" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfNy02LTEtMS01MTgwOQ_0b81cab5-8df5-4223-9b88-d561eadea60e">2,720</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8157806eaebb4a74a10d8a79b40b7ab6_I20230331" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfNy04LTEtMS01MTgwOQ_5d367ce8-608b-4845-852d-ed533d9a951b"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative financial instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4fb068383bf046a1a3b9160d60a024c3_I20230331" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfOC0yLTEtMS01MTgwOQ_98c41be3-8139-45a0-b2b2-76314f927537">147</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia2168e799b254629935c893ee4e1613c_I20230331" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfOC00LTEtMS01MTgwOQ_ebebc246-d02c-492b-813f-a5a01da19bd0"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="icd05d1a66a1d49e6859dfb6ef7567333_I20230331" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfOC02LTEtMS01MTgwOQ_00dfc237-a8af-46f2-89b1-b7559bd97bc7">147</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8157806eaebb4a74a10d8a79b40b7ab6_I20230331" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfOC04LTEtMS01MTgwOQ_04fec823-3813-4615-931c-4b86c7881de6"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4fb068383bf046a1a3b9160d60a024c3_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfOS0yLTEtMS01MTgwOQ_b17795fd-43ec-4e6d-b63e-938a61fdeef1">235</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia2168e799b254629935c893ee4e1613c_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfOS00LTEtMS01MTgwOQ_3d01baa0-1501-44b0-90fe-eb40d0108b02"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="icd05d1a66a1d49e6859dfb6ef7567333_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfOS02LTEtMS01MTgwOQ_83cb0372-b46c-40af-81f2-cb155f175b21">235</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8157806eaebb4a74a10d8a79b40b7ab6_I20230331" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfOS04LTEtMS01MTgwOQ_ababa5c8-1678-48ac-9543-09c76b5caba3"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration related to business combinations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4fb068383bf046a1a3b9160d60a024c3_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTAtMi0xLTEtNTE4MDk_ec5612ef-930a-4ca6-a280-92c8ff2744c4">133</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia2168e799b254629935c893ee4e1613c_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTAtNC0xLTEtNTE4MDk_b9b6d074-ba32-40f5-bc42-53dcb5193877"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="icd05d1a66a1d49e6859dfb6ef7567333_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTAtNi0xLTEtNTE4MDk_1adc5b69-6714-4938-a0ae-4a5523f765c9"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8157806eaebb4a74a10d8a79b40b7ab6_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTAtOC0xLTEtNTE4MDk_e552a035-e230-4a34-8a58-f4a4fdf78618">133</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i4fb068383bf046a1a3b9160d60a024c3_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTEtMi0xLTEtNTE4MDk_e8a9dfb0-c747-4a58-9b82-d1d849a8a66f">3,235</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ia2168e799b254629935c893ee4e1613c_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTEtNC0xLTEtNTE4MDk_b4868be2-3139-4f32-a3e0-5d92ce98fcbe"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="icd05d1a66a1d49e6859dfb6ef7567333_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTEtNi0xLTEtNTE4MDk_0fb24aea-8ecc-4155-9a4a-9b4adb75e68e">3,102</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8157806eaebb4a74a10d8a79b40b7ab6_I20230331" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTEtOC0xLTEtNTE4MDk_0cca127c-138a-4108-a370-3c1faa34108e">133</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="idd236f73d0ec46c3a2283cf439977a5f_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTQtMi0xLTEtNTE4MDk_fb8b0d46-39f7-4fc7-a091-01a9959cdbf1">307</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie651f1bcada8451a9f822de9a86f0970_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTQtNC0xLTEtNTE4MDk_c0d857cd-23c8-4fa9-bfbd-242aae39c860">307</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="id7c1d3530e0c475d84f88d994a38b641_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTQtNi0xLTEtNTE4MDk_9c9892c0-aa7a-4b58-adc3-753de2a1ab31"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i851a46afc50e4f75995a54d5be04ec0e_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTQtOC0xLTEtNTE4MDk_47260b04-0755-47af-90fb-bb3383954cb5"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="idd236f73d0ec46c3a2283cf439977a5f_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTYtMi0xLTEtNTE4MDk_01141bfb-c1db-4e86-aaa1-495d577423e8">412</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie651f1bcada8451a9f822de9a86f0970_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTYtNC0xLTEtNTE4MDk_75196358-6ab6-4a11-a2a7-a493aadd89af"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="id7c1d3530e0c475d84f88d994a38b641_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTYtNi0xLTEtNTE4MDk_25fefd2e-9545-4315-a11f-ae788627467a">412</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i851a46afc50e4f75995a54d5be04ec0e_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeAssetAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTYtOC0xLTEtNTE4MDk_2ea003ae-fa07-46f5-a767-5b55e1499b73"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="idd236f73d0ec46c3a2283cf439977a5f_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTctMi0xLTEtNTE4MDk_bc248668-e87d-47dd-99e4-334a717d6c8a">719</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie651f1bcada8451a9f822de9a86f0970_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTctNC0xLTEtNTE4MDk_333817e7-cdcd-4dd7-8565-312e80a50d14">307</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="id7c1d3530e0c475d84f88d994a38b641_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTctNi0xLTEtNTE4MDk_efbc4159-38cf-4cf2-b257-c8a69619577a">412</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i851a46afc50e4f75995a54d5be04ec0e_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTctOC0xLTEtNTE4MDk_a2010397-6a58-4d05-88ca-78f23a5c8d58"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of hedged long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="idd236f73d0ec46c3a2283cf439977a5f_I20221231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTktMi0xLTEtNTE4MDk_7f95a7dc-7d81-4f1f-9879-5d84fa4e2908">2,691</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie651f1bcada8451a9f822de9a86f0970_I20221231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTktNC0xLTEtNTE4MDk_5d250334-e3a1-4c2b-bd78-6efef8898403"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="id7c1d3530e0c475d84f88d994a38b641_I20221231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTktNi0xLTEtNTE4MDk_84f3c79a-4978-47c9-895d-c05b3a465a22">2,691</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i851a46afc50e4f75995a54d5be04ec0e_I20221231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedge" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMTktOC0xLTEtNTE4MDk_c4aec0c8-4aeb-42fd-b0f6-c0603973ae9a"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap derivative financial instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="idd236f73d0ec46c3a2283cf439977a5f_I20221231" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjAtMi0xLTEtNTM3MTk_3bf57b7d-79a5-4a61-a0ad-0284584d88bf">156</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie651f1bcada8451a9f822de9a86f0970_I20221231" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjAtNC0xLTEtNTM3MTk_ab93e629-2514-43ac-979d-4c69239d54ab"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="id7c1d3530e0c475d84f88d994a38b641_I20221231" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjAtNi0xLTEtNTM3MTk_b701de96-535a-4d7f-9d46-44d0aae40648">156</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i851a46afc50e4f75995a54d5be04ec0e_I20221231" decimals="-6" name="us-gaap:InterestRateDerivativeLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjAtOC0xLTEtNTM3MTk_7e79bf95-e954-4a98-88af-e084f75b9ff1"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward exchange contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="idd236f73d0ec46c3a2283cf439977a5f_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjAtMi0xLTEtNTE4MDk_2ea77765-f14d-4703-81a2-5fd30f8edf6f">226</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie651f1bcada8451a9f822de9a86f0970_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjAtNC0xLTEtNTE4MDk_7f35b18d-a742-4ad4-9888-a24ce3f4768f"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="id7c1d3530e0c475d84f88d994a38b641_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjAtNi0xLTEtNTE4MDk_b65bd024-286b-4f18-86ec-f19a96ea2cc5">226</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i851a46afc50e4f75995a54d5be04ec0e_I20221231" decimals="-6" name="us-gaap:ForeignCurrencyCashFlowHedgeLiabilityAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjAtOC0xLTEtNTE4MDk_7b4773d9-ddf6-4ff7-b3c1-d24c16b557ee"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration related to business combinations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="idd236f73d0ec46c3a2283cf439977a5f_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjEtMi0xLTEtNTE4MDk_1d2bb940-004d-4ec9-9a3d-a7766dcbd808">130</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie651f1bcada8451a9f822de9a86f0970_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjEtNC0xLTEtNTE4MDk_53437dd0-9484-4329-8f71-223ddcf2e133"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="id7c1d3530e0c475d84f88d994a38b641_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjEtNi0xLTEtNTE4MDk_2acbeb08-112c-4cb9-b80a-ef6de9f48c0d"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i851a46afc50e4f75995a54d5be04ec0e_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjEtOC0xLTEtNTE4MDk_928e1941-3764-4168-96bb-ebfffb817bc8">130</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="idd236f73d0ec46c3a2283cf439977a5f_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjItMi0xLTEtNTE4MDk_de086888-58f0-46e3-aeac-18bf15638764">3,203</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie651f1bcada8451a9f822de9a86f0970_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjItNC0xLTEtNTE4MDk_19faf565-3b92-4e19-8e60-4ac3cf2155e2"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="id7c1d3530e0c475d84f88d994a38b641_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjItNi0xLTEtNTE4MDk_ec124345-5755-429d-95ca-fdf0079d5735">3,073</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i851a46afc50e4f75995a54d5be04ec0e_I20221231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82MS9mcmFnOjM2Y2Q2M2EyYzg0NTQ4OGY5NzQ3MTAwMDA5ZDkyYmQ2L3RhYmxlOjViMjc1OTM0NGRhZjQ2NTlhZjlmMGMwMWZiZTJiMzQ5L3RhYmxlcmFuZ2U6NWIyNzU5MzQ0ZGFmNDY1OWFmOWYwYzAxZmJlMmIzNDlfMjItOC0xLTEtNTE4MDk_bba41272-e5e8-41bf-b0fe-49258706ad82">130</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div></ix:nonnumeric><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of foreign currency forward exchange contracts is determined using a market approach, which utilizes values for comparable derivative instruments. The fair value of debt was determined based on the face value of the debt adjusted for the fair value of the interest rate swaps, which is based on a discounted cash flow analysis using significant other observable inputs. The fair value of the contingent consideration was determined based on independent appraisals at the time of acquisition, adjusted for the time value of money and other changes in fair value.</span></div></ix:continuation><div style="text-align:justify"><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_64"></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82NC9mcmFnOjUwYTk0Yzg4OGJmOTQ4NWE5NzMwOTIwNzdmYzdlOWJiL3RleHRyZWdpb246NTBhOTRjODg4YmY5NDg1YTk3MzA5MjA3N2ZjN2U5YmJfMTM0Mg_c8932b76-72c9-411c-9993-7eb7a08bedf7" continuedat="i55b9056498ab4e4480ed9da95581dd12" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11  Litigation and Environmental Matters</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott has been identified as a potentially responsible party for investigation and cleanup costs at a number of locations in the United States and Puerto Rico under federal and state remediation laws and is investigating potential contamination at a number of company-owned locations. Abbott has recorded an estimated cleanup cost for each site for which management believes Abbott has a probable loss exposure. No individual site cleanup exposure is expected to exceed $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="abt:LossContingencyRangeOfPossibleLossMaximumIndividualSite" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82NC9mcmFnOjUwYTk0Yzg4OGJmOTQ4NWE5NzMwOTIwNzdmYzdlOWJiL3RleHRyZWdpb246NTBhOTRjODg4YmY5NDg1YTk3MzA5MjA3N2ZjN2U5YmJfNDgw_88bfeb89-8e37-4523-95b9-8e505d99316f">4</ix:nonfraction> million, and the aggregate cleanup exposure is not expected to exceed $<ix:nonfraction unitref="usd" contextref="i3958ddc5550840698e906a82b841f72e_I20230331" decimals="-6" name="abt:LossContingencyRangeOfPossibleLossMaximumAggregateSites" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82NC9mcmFnOjUwYTk0Yzg4OGJmOTQ4NWE5NzMwOTIwNzdmYzdlOWJiL3RleHRyZWdpb246NTBhOTRjODg4YmY5NDg1YTk3MzA5MjA3N2ZjN2U5YmJfNTQ1_7859a7db-7f48-4c16-a78e-76dbafa7e551">10</ix:nonfraction> million.</span></div></ix:nonnumeric><div style="text-align:justify"><span><br></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><hr style="page-break-after:always"><div style="min-height:126pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&nbsp;31, 2023</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11  Litigation and Environmental Matters (Continued)</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i55b9056498ab4e4480ed9da95581dd12">Abbott is involved in various claims and legal proceedings, and Abbott estimates the range of possible loss for its legal proceedings and environmental exposures to be from approximately $<ix:nonfraction unitref="usd" contextref="ia23654808aa54e79b4b5dbb6c3309213_I20230331" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82NC9mcmFnOjUwYTk0Yzg4OGJmOTQ4NWE5NzMwOTIwNzdmYzdlOWJiL3RleHRyZWdpb246NTBhOTRjODg4YmY5NDg1YTk3MzA5MjA3N2ZjN2U5YmJfNzM3_9ca94d98-e253-44cc-9a1e-70f442dc52b4">25</ix:nonfraction> million to $<ix:nonfraction unitref="usd" contextref="i698883eb766c454c8f2e05dea484a168_I20230331" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82NC9mcmFnOjUwYTk0Yzg4OGJmOTQ4NWE5NzMwOTIwNzdmYzdlOWJiL3RleHRyZWdpb246NTBhOTRjODg4YmY5NDg1YTk3MzA5MjA3N2ZjN2U5YmJfNzQz_432c31ee-f39b-4c09-bd86-9c93dcc2b114">35</ix:nonfraction> million. The recorded accrual balance at March&nbsp;31, 2023 for these proceedings and exposures was approximately $<ix:nonfraction unitref="usd" contextref="i4640127e23034d04832e15db19017ae6_I20230331" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82NC9mcmFnOjUwYTk0Yzg4OGJmOTQ4NWE5NzMwOTIwNzdmYzdlOWJiL3RleHRyZWdpb246NTBhOTRjODg4YmY5NDg1YTk3MzA5MjA3N2ZjN2U5YmJfODM2_a1125926-3066-41bf-ab33-ebc28c586329">30</ix:nonfraction> million. This accrual represents managements best estimate of probable loss, as defined by FASB ASC No. 450, Contingencies. Within the next year, legal proceedings may occur that may result in a change in the estimated loss accrued by Abbott. While it is not feasible to predict the outcome of all such proceedings and exposures with certainty, management believes that their ultimate disposition should not have a material adverse effect on Abbotts financial position, cash flows, or results of operations.</ix:continuation></span></div><div style="text-align:justify"><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_67"></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:PostemploymentBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RleHRyZWdpb246ZDMzYTc5N2VjMmI2NGI5OGI4MGVkZjcyNTc1Nzc4NzVfOTE1_20d32d60-9be9-42aa-8d2c-8d5efd87d9dc" continuedat="i86b6febc7e7c49c288c2ec63a592cf1e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12  Post-Employment Benefits</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retirement plans consist of defined benefit, defined contribution, and medical and dental plans. Net periodic benefit costs, other than service costs, are recognized in the Other (income) expense, net line of the Condensed Consolidated Statement of Earnings. <ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RleHRyZWdpb246ZDMzYTc5N2VjMmI2NGI5OGI4MGVkZjcyNTc1Nzc4NzVfOTE2_bb3cc3e6-c51e-48c6-b785-0873282a195e" continuedat="i71bd2c2d90d54e5fbf8f7455e986a4c1" escape="true">Net cost recognized for the three months ended March&nbsp;31 for Abbotts major defined benefit plans and post-employment medical and dental benefit plans is as follows:</ix:nonnumeric></span></div><div style="text-align:justify"><span><br></span></div><div><ix:continuation id="i71bd2c2d90d54e5fbf8f7455e986a4c1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:50.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Defined Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Medical and Dental Plans</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months<br>Ended March 31</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months<br>Ended March 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service cost - benefits earned during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i26b45a5d06bf4e98bc964d213c98fcfd_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfMy0yLTEtMS01MTgwOQ_122ff75d-444b-434d-8391-a6498fa63240">60</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie355518a75604e0da15ec6e9051ddfb4_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfMy00LTEtMS01MTgwOQ_38b92e91-02a0-4136-8ad3-170c0e6ef0ee">96</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i5cb6450851b64b5b87131e6771e96169_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfMy0xMC0xLTEtNTE4MDk_cdf8995e-9f8e-4e91-8fff-12226bb999ba">9</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic06ce61e37914a0aba177ee8c8d0aa99_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfMy0xMi0xLTEtNTE4MDk_de308673-2860-432b-aa49-d385f1ba681a">13</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest cost on projected benefit obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i26b45a5d06bf4e98bc964d213c98fcfd_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfNC0yLTEtMS01MTgwOQ_bb9612a3-7a93-4c8d-a0b6-10faf2417380">114</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie355518a75604e0da15ec6e9051ddfb4_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfNC00LTEtMS01MTgwOQ_fd51ed18-f525-482d-a75e-fcf034a85819">76</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i5cb6450851b64b5b87131e6771e96169_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfNC0xMC0xLTEtNTE4MDk_eb6d40ee-a4fa-4912-936e-f172ead35ec8">14</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic06ce61e37914a0aba177ee8c8d0aa99_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfNC0xMi0xLTEtNTE4MDk_8aa8a615-5cf3-43b4-8ff9-dfa24c96f4ca">10</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i26b45a5d06bf4e98bc964d213c98fcfd_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfNS0yLTEtMS01MTgwOQ_4e32fee1-e1a1-4d3c-a2a1-3bcffea8f796">242</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ie355518a75604e0da15ec6e9051ddfb4_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfNS00LTEtMS01MTgwOQ_a51e3b7b-adf9-4746-b666-693febb83c40">236</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i5cb6450851b64b5b87131e6771e96169_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfNS0xMC0xLTEtNTE4MDk_943f4a0e-8788-4831-aa7b-e453af0d978b">6</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ic06ce61e37914a0aba177ee8c8d0aa99_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfNS0xMi0xLTEtNTE4MDk_183479e4-708e-4942-8246-95cea0af71a6">7</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net amortization of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Actuarial loss, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i26b45a5d06bf4e98bc964d213c98fcfd_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfNy0yLTEtMS01MTgwOQ_3012f706-143c-409f-8b33-ba9a91d69933">3</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie355518a75604e0da15ec6e9051ddfb4_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfNy00LTEtMS01MTgwOQ_f096cf16-9906-465b-83b5-a8b50d91c2f8">59</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i5cb6450851b64b5b87131e6771e96169_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfNy0xMC0xLTEtNTE4MDk_3f7a2df3-0384-4c13-b198-cc31c7f2b340"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic06ce61e37914a0aba177ee8c8d0aa99_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfNy0xMi0xLTEtNTE4MDk_c5948417-0e84-4da7-a483-da0d2c77a9b8">5</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i26b45a5d06bf4e98bc964d213c98fcfd_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfOC0yLTEtMS01MTgwOQ_2442ece5-1d55-44fe-8526-cac5f642879f"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ie355518a75604e0da15ec6e9051ddfb4_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfOC00LTEtMS01MTgwOQ_abc602e1-93dd-4640-8afd-d3d3699d8f0c"></ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i5cb6450851b64b5b87131e6771e96169_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfOC0xMC0xLTEtNTE4MDk_92bcdd66-2d85-4ad2-a9f0-41a52d0c7721">3</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ic06ce61e37914a0aba177ee8c8d0aa99_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfOC0xMi0xLTEtNTE4MDk_293db710-78b5-49fe-947f-7cae2a2a175b">6</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cost (credit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i26b45a5d06bf4e98bc964d213c98fcfd_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfOS0yLTEtMS01MTgwOQ_f8f65d4b-196f-4811-9b8a-85ffeb8538ba">65</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="ie355518a75604e0da15ec6e9051ddfb4_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfOS00LTEtMS01MTgwOQ_8d3b5c45-ac6f-4a14-a02e-5407643b6d66">5</ix:nonfraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i5cb6450851b64b5b87131e6771e96169_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfOS0xMC0xLTEtNTE4MDk_4adbf579-6150-450d-ba91-0828149683f7">14</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="ic06ce61e37914a0aba177ee8c8d0aa99_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RhYmxlOjUzZDdkOTg3ODJhOTQ4MTBhOGU1YTRlYzk3ZjRhN2I2L3RhYmxlcmFuZ2U6NTNkN2Q5ODc4MmE5NDgxMGE4ZTVhNGVjOTdmNGE3YjZfOS0xMi0xLTEtNTE4MDk_2fe7d7db-4ea3-4d2d-996f-0e0879b5f134">15</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></ix:continuation></div></ix:nonnumeric><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i86b6febc7e7c49c288c2ec63a592cf1e">Abbott funds its domestic defined benefit plans according to Internal Revenue Service funding limitations. International pension plans are funded according to similar regulations. In the first three months of 2023 and 2022, $<ix:nonfraction unitref="usd" contextref="i26b45a5d06bf4e98bc964d213c98fcfd_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RleHRyZWdpb246ZDMzYTc5N2VjMmI2NGI5OGI4MGVkZjcyNTc1Nzc4NzVfNjQ1_198bacea-f638-4832-ad5e-733bf9a76641">282</ix:nonfraction> million and $<ix:nonfraction unitref="usd" contextref="ie355518a75604e0da15ec6e9051ddfb4_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RleHRyZWdpb246ZDMzYTc5N2VjMmI2NGI5OGI4MGVkZjcyNTc1Nzc4NzVfNjUy_ab522022-34f8-44f8-8b8e-014ceaadf850">334</ix:nonfraction> million, respectively, were contributed to defined benefit plans. In the first three months of 2023 and 2022, $<ix:nonfraction unitref="usd" contextref="ic06ce61e37914a0aba177ee8c8d0aa99_D20220101-20220331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RleHRyZWdpb246ZDMzYTc5N2VjMmI2NGI5OGI4MGVkZjcyNTc1Nzc4NzVfNzQz_2451feac-aa19-442e-8a9e-25b5166b15e9"><ix:nonfraction unitref="usd" contextref="i5cb6450851b64b5b87131e6771e96169_D20230101-20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV82Ny9mcmFnOmQzM2E3OTdlYzJiNjRiOThiODBlZGY3MjU3NTc3ODc1L3RleHRyZWdpb246ZDMzYTc5N2VjMmI2NGI5OGI4MGVkZjcyNTc1Nzc4NzVfNzQz_b4235881-6ec9-4919-b63b-4a2c31497ab8">28</ix:nonfraction></ix:nonfraction> million was contributed in each year to the post-employment medical and dental plans.</ix:continuation> </span></div><div style="text-align:justify"><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_70"></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83MC9mcmFnOmU4ODBhMmYwY2VhZDQzMjE4OTdjNjg3ZGJiOWU3YTdkL3RleHRyZWdpb246ZTg4MGEyZjBjZWFkNDMyMTg5N2M2ODdkYmI5ZTdhN2RfODIz_2757f348-1b14-48a3-877c-efe6fb9d541f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 13  Taxes on Earnings</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taxes on earnings reflect the estimated annual effective rates and include charges for interest and penalties. In the first three months of 2023 and 2022, taxes on earnings include approximately $<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="abt:ExcessTaxBenefitFromShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83MC9mcmFnOmU4ODBhMmYwY2VhZDQzMjE4OTdjNjg3ZGJiOWU3YTdkL3RleHRyZWdpb246ZTg4MGEyZjBjZWFkNDMyMTg5N2M2ODdkYmI5ZTdhN2RfMTk3_cbdf1148-cc89-44e3-a205-03a22524cdde">3</ix:nonfraction> million and $<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="abt:ExcessTaxBenefitFromShareBasedCompensation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83MC9mcmFnOmU4ODBhMmYwY2VhZDQzMjE4OTdjNjg3ZGJiOWU3YTdkL3RleHRyZWdpb246ZTg4MGEyZjBjZWFkNDMyMTg5N2M2ODdkYmI5ZTdhN2RfMjA0_011b9a15-2022-4c84-9e45-83374cf1993f">30</ix:nonfraction> million, respectively, in excess tax benefits associated with share-based compensation. In the first three months of 2023 and 2022, taxes on earnings also include approximately $<ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83MC9mcmFnOmU4ODBhMmYwY2VhZDQzMjE4OTdjNjg3ZGJiOWU3YTdkL3RleHRyZWdpb246ZTg4MGEyZjBjZWFkNDMyMTg5N2M2ODdkYmI5ZTdhN2RfMzYy_db145ea3-b2f6-4e78-9290-f175d06fa3d5">22</ix:nonfraction> million and $<ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83MC9mcmFnOmU4ODBhMmYwY2VhZDQzMjE4OTdjNjg3ZGJiOWU3YTdkL3RleHRyZWdpb246ZTg4MGEyZjBjZWFkNDMyMTg5N2M2ODdkYmI5ZTdhN2RfNTQ5NzU1ODE0Nzgw_fe69d4dd-18ac-407c-b764-4a1402ca82eb">30</ix:nonfraction>&nbsp;million, respectively, of tax expense as the result of the resolution of various tax positions related to prior years.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax authorities in various jurisdictions regularly review Abbotts income tax filings. Abbott believes that it is reasonably possible that the recorded amount of gross unrecognized tax benefits may decrease approximately $<ix:nonfraction unitref="usd" contextref="i5219a82760434126b153001fe7d898bc_I20230331" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83MC9mcmFnOmU4ODBhMmYwY2VhZDQzMjE4OTdjNjg3ZGJiOWU3YTdkL3RleHRyZWdpb246ZTg4MGEyZjBjZWFkNDMyMTg5N2M2ODdkYmI5ZTdhN2RfNjgz_a0ad5db8-48a8-4f7a-bcbc-675c7cb8bf1f">75</ix:nonfraction> million to $<ix:nonfraction unitref="usd" contextref="i65daf295837843f99c4ef575a76fb9ad_I20230331" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83MC9mcmFnOmU4ODBhMmYwY2VhZDQzMjE4OTdjNjg3ZGJiOWU3YTdkL3RleHRyZWdpb246ZTg4MGEyZjBjZWFkNDMyMTg5N2M2ODdkYmI5ZTdhN2RfNjg5_0fc0cb17-1847-4419-ad66-b662fb3d1151">80</ix:nonfraction> million, including cash adjustments, within the next twelve months as a result of concluding various domestic and international tax matters.</span></div></ix:nonnumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_73"></div><hr style="page-break-after:always"><div style="min-height:103.46pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&nbsp;31, 2023</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83My9mcmFnOmE5OWE2MDk4MWFkNTQ1OGE4ZDNmMGE0MmIyM2RkOTFmL3RleHRyZWdpb246YTk5YTYwOTgxYWQ1NDU4YThkM2YwYTQyYjIzZGQ5MWZfMjA4NA_6fd72734-2e17-4ba4-9b90-7c70bcedfe08" continuedat="i3dabbd1fc94c454b87329cfb6e7ab1b9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 14  Segment Information</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbotts principal business is the discovery, development, manufacture and sale of a broad line of health care products. Abbotts products are generally sold directly to retailers, wholesalers, hospitals, health care facilities, laboratories, physicians offices and government agencies throughout the world.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbotts reportable segments are as follows:</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Established Pharmaceutical Products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> International sales of a broad line of branded generic pharmaceutical products.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nutritional Products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Worldwide sales of a broad line of adult and pediatric nutritional products.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diagnostic Products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. For segment reporting purposes, the Core Laboratories Diagnostics, Rapid Diagnostics, Molecular Diagnostics and Point of Care Diagnostics divisions are aggregated and reported as the Diagnostic Products segment.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Devices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. For segment reporting purposes, the Cardiac Rhythm Management, Electrophysiology, Heart Failure, Vascular, Structural Heart, Neuromodulation and Diabetes Care divisions are aggregated and reported as the Medical Devices segment.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbotts underlying accounting records are maintained on a legal entity basis for government and public reporting requirements. Segment disclosures are on a performance basis consistent with internal management reporting. Intersegment transfers of inventory are recorded at standard cost and are not a measure of segment operating earnings. The cost of some corporate functions and the cost of certain employee benefits are charged to segments at predetermined rates that approximate cost. Remaining costs, if any, are not allocated to segments. In addition, intangible asset amortization is not allocated to operating segments, and intangible assets and goodwill are not included in the measure of each segments assets.</span></div></ix:nonnumeric><div style="text-align:justify"><span><br></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_76"></div><hr style="page-break-after:always"><div style="min-height:126pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott Laboratories and Subsidiaries</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Condensed Consolidated Financial Statements</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&nbsp;31, 2023</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 14  Segment Information (Continued)</span></div></div><ix:continuation id="i3dabbd1fc94c454b87329cfb6e7ab1b9"><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RleHRyZWdpb246YjE3MzU1NzMxNzUwNGU5Njg4MmU1MjJiNzFkOGVhMTZfMzg0ODI5MDY5NzgwOQ_669dd599-0c16-4965-81a4-f39071e25967" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following segment information has been prepared in accordance with the internal accounting policies of Abbott, as described above, and is not presented in accordance with generally accepted accounting principles applied to the consolidated financial statements.</span></div><div style="text-align:justify"><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:54.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&nbsp;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Sales to External Customers</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Earnings</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months <br>Ended March 31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months <br>Ended March 31</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&nbsp;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Established Pharmaceutical Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i80bdac464a5b478e812274849ec5223a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMy0yLTEtMS01MTgwOQ_3dcf229f-b3f7-4e4e-9d34-8312f102b478">1,189</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i87c128ad7cdf41f2a4540feb49690207_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMy00LTEtMS01MTgwOQ_1a611d89-8041-4b5f-bfc3-2a0f239ace2d">1,147</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i80bdac464a5b478e812274849ec5223a_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMy0xMC0xLTEtNTE4MDk_ebd27c62-d45d-4055-bfe0-a96575eac94e">300</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i87c128ad7cdf41f2a4540feb49690207_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMy0xMi0xLTEtNTE4MDk_f8f951f0-74ff-4ff5-957b-80ee125c3b54">242</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutritional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if64f8bcdd1344462b07f0f7628dc9c4a_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNC0yLTEtMS01MTgwOQ_d908afb2-af23-4e70-81af-eef2b0d4cb10">1,967</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iad19be6b48f74f50897a26a787246f32_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNC00LTEtMS01MTgwOQ_cfcc6794-91ba-4c84-90c6-308db8bceb45">1,894</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if64f8bcdd1344462b07f0f7628dc9c4a_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNC0xMC0xLTEtNTE4MDk_12a5094a-18d4-4529-a505-bdcc5287b564">380</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iad19be6b48f74f50897a26a787246f32_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNC0xMi0xLTEtNTE4MDk_df8061f1-c52d-4151-9239-e0669ff2d3fc">251</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i6ccaf9e4adbc467aa509133f505b80f3_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNS0yLTEtMS01MTgwOQ_341dd7ac-b759-462d-8b8e-a1959ed647c7">2,688</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iccded785322744b594d6e95a5da23cce_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNS00LTEtMS01MTgwOQ_966a0db4-dc65-4c06-9046-df5de446c9fa">5,257</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i6ccaf9e4adbc467aa509133f505b80f3_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNS0xMC0xLTEtNTE4MDk_e7c5da44-11be-40e4-b72a-d4728c4bc5e3">651</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="iccded785322744b594d6e95a5da23cce_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNS0xMi0xLTEtNTE4MDk_b5301a6b-0a65-46e2-a509-a639fd48ed11">2,564</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Devices</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i177a8252ee4d4b638b47a978d0522747_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNi0yLTEtMS01MTgwOQ_1308e859-fcf1-4a0f-af19-e4f4dda5b834">3,900</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i2fbad5ec961c47268cd7ee759ec58b03_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNi00LTEtMS01MTgwOQ_cce98240-816c-40e4-8a54-35668d16c455">3,594</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i177a8252ee4d4b638b47a978d0522747_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNi0xMC0xLTEtNTE4MDk_316f8879-4b4c-4f4b-833a-c36c4df28dff">1,078</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i2fbad5ec961c47268cd7ee759ec58b03_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNi0xMi0xLTEtNTE4MDk_557d357f-1607-44a2-93be-6edc17377e26">1,083</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Reportable Segments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if6f76f234e6c4cfaa609a306888b7c66_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNy0yLTEtMS01MTgwOQ_8286c656-1e7f-4367-bbf4-319dfbdc79f6">9,744</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i71dce819097046398fee1e1eb1fd6224_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNy00LTEtMS01MTgwOQ_654c898c-4c9c-4d26-806a-8bd25765e63e">11,892</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="if6f76f234e6c4cfaa609a306888b7c66_D20230101-20230331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNy0xMC0xLTEtNTE4MDk_b774555c-2983-471c-bd03-cbc2554c0106">2,409</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i71dce819097046398fee1e1eb1fd6224_D20220101-20220331" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfNy0xMi0xLTEtNTE4MDk_901dfa2f-3b3d-4cac-8b91-de00b6ef5030">4,140</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i7029047dc9064ff098b29e87076ce957_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfOC0yLTEtMS01MTgwOQ_65ba163d-e37c-443b-b351-bb0850c4829b">3</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i5cf2d116860c4936bd9ccc36e0b34824_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfOC00LTEtMS01MTgwOQ_87e0097a-75d9-40e2-b4e9-8266f236ae45">3</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfOS0yLTEtMS01MTgwOQ_f8f27f34-ba3f-45e4-91b9-e652d7e85f4a">9,747</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfOS00LTEtMS01MTgwOQ_e3caa288-967b-4722-ad34-cdc313f47aee">11,895</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate functions and benefit plan costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i8f1ac95fbcc84f30b270c838706a1f88_D20230101-20230331" decimals="-6" name="abt:CorporateAndBenefitPlanCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMTAtMTAtMS0xLTUxODA5_348962eb-9252-4829-8059-7649fac51cb3">77</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i776935560ed1406990537cfbfafb2032_D20220101-20220331" decimals="-6" name="abt:CorporateAndBenefitPlanCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMTAtMTItMS0xLTUxODA5_1436f58d-6433-46b6-9045-63438abb5a21">114</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i8f1ac95fbcc84f30b270c838706a1f88_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMTEtMTAtMS0xLTUxODA5_dc5190be-e0cb-4094-a43f-5ea775bcd0ef">52</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i776935560ed1406990537cfbfafb2032_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMTEtMTItMS0xLTUxODA5_f7412ccb-bc73-4681-b1be-db5f576c8607">117</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation (a) </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i8f1ac95fbcc84f30b270c838706a1f88_D20230101-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMTItMTAtMS0xLTUxODA5_61bb3a09-6022-412e-a1af-6657e4776b3a">281</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i776935560ed1406990537cfbfafb2032_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMTItMTItMS0xLTUxODA5_4ca0de51-b112-4d53-a729-5f293ba6521c">305</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i8f1ac95fbcc84f30b270c838706a1f88_D20230101-20230331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMTMtMTAtMS0xLTUxODA5_41bed76a-4aa6-4f19-b0cf-34eb1574be2e">491</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i776935560ed1406990537cfbfafb2032_D20220101-20220331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMTMtMTItMS0xLTUxODA5_dcdb030e-2bb9-4b84-8c3a-10466c47f2c1">512</ix:nonfraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i8f1ac95fbcc84f30b270c838706a1f88_D20230101-20230331" decimals="-6" sign="-" name="abt:OtherCostAndExpenseOperatingAndNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMTQtMTAtMS0xLTUxODA5_98739bc4-db7b-4492-9208-bdd5ce7a9033">54</ix:nonfraction>&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonfraction unitref="usd" contextref="i776935560ed1406990537cfbfafb2032_D20220101-20220331" decimals="-6" name="abt:OtherCostAndExpenseOperatingAndNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMTQtMTItMS0xLTUxODA5_2abca34b-801d-4884-a105-dd0be5d47f25">216</ix:nonfraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMTUtMTAtMS0xLTUxODA5_ec284e1c-c4e9-40f0-b1dc-6047aa1a3caa">1,562</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonfraction unitref="usd" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOmNjNjFkMzQ2YjFlMDRjMjM4MjdiZjlmNzRmOTVmNDAzL3RhYmxlcmFuZ2U6Y2M2MWQzNDZiMWUwNGMyMzgyN2JmOWY3NGY5NWY0MDNfMTUtMTItMS0xLTUxODA5_19fd78a6-0a0e-4bb2-a821-7fea5bb9e3c9">2,876</ix:nonfraction>&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:5.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2022 Sales and Operating Earnings for the Diagnostic Products and Medical Devices reportable segments have been updated to reflect the internal transfer of the Acelis Connected Health business from Diagnostic Products to Medical Devices on January 1, 2023.  </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Approximately <ix:nonfraction unitref="number" contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" decimals="2" name="abt:AnnualShareBasedAwardsRecognizedInFirstQuarterPercent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOjE3YzhiNmJjOWZjOTQ3YTZhZGI3Yzg1Yjk2NmE3Y2I4L3RhYmxlcmFuZ2U6MTdjOGI2YmM5ZmM5NDdhNmFkYjdjODViOTY2YTdjYjhfMS0xLTEtMS02Mzk0My90ZXh0cmVnaW9uOjVmYjdkODI4ODJjMzQzOWJhYWUwMzVkZjI0NDc4Y2IyXzU0OTc1NTgxNDUyMg_94c2a746-081e-44b7-91ec-66db2ca81f33"><ix:nonfraction unitref="number" contextref="i1e8d671828e34662996906aee71f388b_D20220101-20220331" decimals="2" name="abt:AnnualShareBasedAwardsRecognizedInFirstQuarterPercent" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOjE3YzhiNmJjOWZjOTQ3YTZhZGI3Yzg1Yjk2NmE3Y2I4L3RhYmxlcmFuZ2U6MTdjOGI2YmM5ZmM5NDdhNmFkYjdjODViOTY2YTdjYjhfMS0xLTEtMS02Mzk0My90ZXh0cmVnaW9uOjVmYjdkODI4ODJjMzQzOWJhYWUwMzVkZjI0NDc4Y2IyXzU0OTc1NTgxNDUyMg_bf832c15-5187-49ca-86e8-f96ddf111750">45</ix:nonfraction></ix:nonfraction> percent of the annual net cost of share-based awards will typically be recognized in the first quarter due to the timing of the granting of share-based awards. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other, net for the three months ended March 31, 2022 includes $<ix:nonfraction unitref="usd" contextref="ia6d8428c497b486fbccee9b4027ea3c4_D20220101-20220331" decimals="-6" name="us-gaap:InventoryRecallExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV83Ni9mcmFnOmIxNzM1NTczMTc1MDRlOTY4ODJlNTIyYjcxZDhlYTE2L3RhYmxlOjE3YzhiNmJjOWZjOTQ3YTZhZGI3Yzg1Yjk2NmE3Y2I4L3RhYmxlcmFuZ2U6MTdjOGI2YmM5ZmM5NDdhNmFkYjdjODViOTY2YTdjYjhfMi0xLTEtMS02Mzk0Ni90ZXh0cmVnaW9uOjcxN2Y3M2VhNjFiYTQ0NWU4MzEzMDViYWQ0ZWViYWNkXzU0OTc1NTgxNDAyOA_923bc840-ed29-4d64-9dd0-129619cc44ef">120</ix:nonfraction> million of charges related to a voluntary recall within the Nutritional Products segment.  </span></div></td></tr></tbody></table></div></ix:nonnumeric></ix:continuation><div id="i901bb95f381d40f69da02b9fef764f5e_527"></div><div style="text-align:justify"><span><br></span></div><ix:nonnumeric contextref="i49322c6503cc4057b5c79cd8bb23b5c1_D20230101-20230331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81MjcvZnJhZzo0MmFiOGE1NWJjZGY0ZDJiYjdjY2JiNDQ1MjY4ZDI3Yy90ZXh0cmVnaW9uOjQyYWI4YTU1YmNkZjRkMmJiN2NjYmI0NDUyNjhkMjdjXzEwOTk1MTE2MzAwNzY_14d8fa4e-bb70-4028-9504-6e1da449253f" escape="true"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 15  Subsequent Event</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 27, 2023, Abbott completed the acquisition of Cardiovascular Systems, Inc. (CSI) for $<ix:nonfraction unitref="usdPerShare" contextref="i9dc04df89731484890459c9dcce08c88_I20230427" decimals="INF" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81MjcvZnJhZzo0MmFiOGE1NWJjZGY0ZDJiYjdjY2JiNDQ1MjY4ZDI3Yy90ZXh0cmVnaW9uOjQyYWI4YTU1YmNkZjRkMmJiN2NjYmI0NDUyNjhkMjdjXzEwOTk1MTE2MzAwOTI_9bfab358-4447-4d6e-8fa2-e465d8bd9990">20</ix:nonfraction> per common share, which equated to a purchase price of approximately $<ix:nonfraction unitref="usd" contextref="i325b9a6ea8f94445a28e2f79fb22141c_D20230427-20230427" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkwMWJiOTVmMzgxZDQwZjY5ZGEwMmI5ZmVmNzY0ZjVlL3NlYzo5MDFiYjk1ZjM4MWQ0MGY2OWRhMDJiOWZlZjc2NGY1ZV81MjcvZnJhZzo0MmFiOGE1NWJjZGY0ZDJiYjdjY2JiNDQ1MjY4ZDI3Yy90ZXh0cmVnaW9uOjQyYWI4YTU1YmNkZjRkMmJiN2NjYmI0NDUyNjhkMjdjXzEwOTk1MTE2MzAwNzg_bc944b5b-4228-4b56-9356-b12d689fb268">850</ix:nonfraction>&nbsp;million. The acquisition was funded with cash on hand. CSI sells an atherectomy system used in treating peripheral and coronary artery disease. The acquisition adds complementary technologies to Abbotts portfolio of vascular device offerings. The transaction will be accounted for as a business combination. Abbott has begun the process of measuring, as of the acquisition date, the acquired assets and assumed liabilities. Preliminary purchase price allocation estimates will be disclosed in Abbotts Form 10-Q for the period ending June 30, 2023.</span></div></ix:nonnumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_79"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 2.&nbsp;&nbsp;&nbsp;&nbsp;Managements Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i901bb95f381d40f69da02b9fef764f5e_82"></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial Review  Results of Operations</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbotts revenues are derived primarily from the sale of a broad line of health care products under short-term receivable arrangements. Patent protection and licenses, technological and performance features, and inclusion of Abbotts products under a contract most impact which products are sold; price controls, competition and rebates most impact the net selling prices of products; and foreign currency translation impacts the measurement of net sales and costs. Abbotts primary products are medical devices, diagnostic testing products, nutritional products and branded generic pharmaceuticals.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables detail sales by reportable segment for the three months ended March 31. Percent changes are versus the prior year and are based on unrounded numbers.</span></div><div style="text-align:justify"><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Sales to External Customers</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br>March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br>March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total<br>Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Impact of<br>Foreign<br>Exchange</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total Change <br>Excl. Foreign <br>Exchange</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Established Pharmaceutical Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,189&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutritional Products</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Products</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,257&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Devices</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,900&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,594&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Reportable Segments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,744&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,892&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/m</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/m</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,747&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,895&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,928&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,937&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total International</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,819&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,958&nbsp;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"></td></tr></tbody></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:5.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.385%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Acelis Connected Health business was internally transferred from Diagnostic Products to Medical Devices on January 1, 2023. As a result, $29 million of sales for the first quarter of 2022 were moved from Diagnostic Products to Medical Devices.  <br></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In order to compute results excluding the impact of exchange rates, current year U.S. dollar sales are multiplied or divided, as appropriate, by the current year average foreign exchange rates and then those amounts are multiplied or divided, as appropriate, by the prior year average foreign exchange rates.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">n/m = Percent change is not meaningful</span></td></tr></tbody></table></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 14.8 percent decrease in total net sales during the first three months of 2023, excluding the impact of foreign exchange, reflected the decrease in demand for Abbotts rapid diagnostic tests to detect COVID-19, partially offset by higher growth across other businesses. Abbotts COVID-19 testing-related sales totaled approximately $730 million during the first quarter of 2023 and approximately $3.3 billion during the first quarter of 2022. Excluding the impact of COVID-19 testing-related sales, Abbotts total net sales increased 4.9 percent. Excluding the impacts of COVID-19 testing-related sales and foreign exchange, Abbotts total net sales increased 9.4 percent. Abbotts net sales were unfavorably impacted by changes in foreign exchange rates in the first quarter as the relatively stronger U.S. dollar decreased total international sales by 5.7 percent and total sales by 3.3 percent.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the unpredictability of demand for COVID-19 tests, the future extent to which COVID-19 will have a material effect on Abbotts business, financial condition or results of operations is uncertain.</span></div><div style="text-align:justify"><span><br></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides detail by sales category for the three months ended March 31. Percent changes are versus the prior year and are based on unrounded numbers. </span></div><div><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.023%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total<br>Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Impact of <br>Foreign<br>Exchange</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total Change <br>Excl. Foreign <br>Exchange</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Established Pharmaceutical Products </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Key Emerging Markets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Emerging Markets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nutritionals </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Pediatric Nutritionals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pediatric Nutritionals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Adult Nutritionals</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Adult Nutritionals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Laboratory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,182&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Point of Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rapid Diagnostics</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,225&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,525&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Devices </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhythm Management</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Electrophysiology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heart Failure</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vascular</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Structural Heart</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neuromodulation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Care</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></tbody></table></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: The Acelis Connected Health business was internally transferred from Rapid Diagnostics to Heart Failure on January 1, 2023. As a result, $29 million of sales for the first quarter of 2022 were moved from Rapid Diagnostics to Heart Failure. </span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the unfavorable effect of foreign exchange, sales in the Key Emerging Markets for Established Pharmaceutical Products increased 8.3 percent in the first three months of 2023, led by growth in several countries, including Brazil, China and southeast Asia, and across several therapeutic areas, including cardio-metabolic, respiratory, and central nervous system/pain management. Other Emerging Markets, excluding the effect of foreign exchange, increased by 21.8 percent in the first three months of 2023.</span></div><div><span><br></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Excluding the impact of foreign exchange, total Nutritional Products sales in the first three months of 2023 increased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">7.7 percent</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> U.S. Pediatric Nutritionals, the 36.1 percent increase in sales in the first three months of 2023 refle</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">cts the impact of the unfavorable effects of the voluntary recall of certain infant formula products in the first quarter of 2022, partially offset by a decrease in 2023 Pedialyte</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">s. Excluding the effect of foreign exchange, the 3.9 percent decrease in International Pediatric Nutritional sales in the first three months of 2023 primarily reflects the impact of exiting the pediatric nutrition business in China, partially offset by growth in several other markets</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Excluding the effect of foreign exchange, the increases of 3.9 percent in U.S. Adult Nutritionals and 4.4 percent in International Adult Nutritionals in the first three months of 2023 were led by growth of Ensure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 47.1 percent decrease in Diagnostic Products sales in the first three months of 2023, excluding the impact of foreign exchange, was driven by lower demand for COVID-19 tests. In Rapid Diagnostics, sales decreased 64.5 percent in the first three months of 2023, excluding the effect of foreign exchange, due to lower demand for COVID-19 tests. In the first three months of 2023 and 2022, Rapid Diagnostics COVID-19 testing-related sales were $704 million and $3.0 billion, respectively. In the first three months of 2023, Rapid Diagnostics sales increased 5.1 percent, excluding COVID-19 testing-related sales, and increased 8.0 percent, excluding the impact of foreign exchange and COVID-19 testing-related sales.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Core Laboratory Diagnostics, sales increased 5.1 percent in the first three months of 2023, excluding the effect of foreign exchange, due to the higher volume of routine diagnostic testing performed in hospitals and other laboratories, partially offset by lower test sales for the detection of COVID-19 IgG and IgM antibodies. In the first three months of 2023 and 2022, Core Laboratory Diagnostics COVID-19 testing-related sales were $6 million and $28 million, respectively. In the first three months of 2023, Core Laboratory Diagnostics sales increased 1.7 percent, excluding COVID-19 testing-related sales, and increased 7.1 percent, excluding the impact of foreign exchange and COVID-19 testing-related sales.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 64.0 percent decrease in Molecular Diagnostics sales in the first three months of 2023, excluding the effect of foreign exchange, was driven by </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lower demand for laboratory-based molecular tests for COVID-19 as well as lower demand for respiratory testing compared to significantly higher-than-usual demand in the first quarter of 2022. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of 2023 and 2022, Molecular Diagnostics COVID-19 testing-related sales were $20 million and $246 million, respectively. In the first three months of 2023, Molecular Diagnostics sales decreased 27.1 percent, excluding COVID-19 testing-related sales, and decreased 24.8 percent, excluding the impact of foreign exchange and COVID-19 testing-related sales.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding the effect of foreign exchange, total Medical Devices sales grew 12.4 percent in the first three months of 2023, led by double-digit growth in Diabetes Care, Structural Heart, Heart Failure and Neuromodulation. Higher Diabetes Care sales were driven by continued growth of FreeStyle Libre</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Abbotts continuous glucose monitoring system, in the U.S. and internationally. FreeStyle Libre sales totaled $1.2 billion in the first three months of 2023, which reflected a 25.4 percent increase, excluding the effect of foreign exchange, over the first three months of 2022 when FreeStyle Libre sales totaled $1.0 billion. </span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first three months of 2023, procedure volumes increased across the cardiovascular and neuromodulation businesses. In Structural Heart, the 16.4 percent increase in sales, excluding the effect of foreign exchange, reflects an acceleration in the growth of the MitraClip</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product along with contributions from recently launched products, including  Amulet</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Navitor</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and TriClip</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In Vascular, the 3.9 percent increase in sales, excluding the impact of foreign exchange, during the first three months of 2023 primarily reflects double-digit growth in endovascular sales.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</span></div></div></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Electrophysiology, the 8.8 percent increase in sales, excluding the effect of foreign exchange, primarily reflects higher procedure volumes in various European countries and the U.S. In Neuromodulation the 11.2 percent increase in sales, excluding the effect of foreign exchange, was driven by the recent launch of the Eterna</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> rechargeable spinal cord stimulation system for the treatment of chronic pain along with market growth compared to the prior year period.  </span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of 2023, Medical Devices received various product approvals. In January 2023, Abbott announced that the U.S. Food and Drug Administration (FDA) had approved Navitor, Abbott's second-generation transcatheter aortic valve implantation system to treat people with severe aortic stenosis who are at high or extreme risk for open-heart surgery. In March 2023, Abbott's Freestyle Libre continuous glucose monitoring system received U.S. FDA clearance for integration with automated insulin delivery systems. In March 2023, the U.S. FDA approved Abbott's Epic</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Max stented tissue valve to treat people with aortic regurgitation or stenosis.</span></div><div style="text-align:justify"><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_85"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross profit margin percentage was 50.5 percent for the first quarter of 2023 compared to 53.8 percent for the first quarter of 2022. The decrease in the first quarter of 2023 reflects the unfavorable effects of lower sales of COVID-19 tests, foreign exchange, and higher costs for various manufacturing inputs, partially offset by the impact in 2022 of the voluntary product recall in the Nutritional business and the impact in 2023 of gross margin improvement initiatives. </span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development (R&amp;D) expenses decreased $43 million, or 6.2 percent, in the first quarter of 2023 compared to the prior year. The decrease in R&amp;D expenses in the first quarter of 2023 was primarily driven by the timing of spending on various projects and the favorable impact of foreign exchange.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses decreased $25 million, or 0.9 percent, in the first quarter of 2023 compared to the prior year as higher selling and marketing spending to drive growth across various businesses was offset by the favorable impact of foreign exchange and the nonrecurrence of 2022 expenses related to the product recall in the Nutritional segment.</span></div><div><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other (Income) Expense, net</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net increased from $78 million of income in the first quarter of 2022 to $111 million of income in the first quarter of 2023. Th</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e increase in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the first quarter of 2023 reflects higher income in 2023 related to the non-service cost components of net pension and post-retirement medical benefit costs.</span></div><div><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Interest Expense, net</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Interest expe</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">nse, net decreased $65 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in the first quarter of 2023  due to the impact of higher interest rates on interest income, partially offset by the impact of interest rate hedge contracts related to certain fixed-rate debt.</span></div><div style="text-align:justify"><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Taxes on Earnings</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Taxes on earnings reflect the estimated annual effective rates and include charges for interest and penalties. In the first three months of 2023 and 2022, taxes on earnings include approximately $3 million and $30 million, respectively, in excess tax benefits associated with share-based compensation. In the first three months of 2023 and 2022, taxes on earnings also include approximately $22 million and $30&nbsp;million, respectively, of tax expense as the result of the resolution of various tax positions related to prior years.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax authorities in various jurisdictions regularly review Abbotts income tax filings. Abbott believes that it is reasonably possible that the recorded amount of gross unrecognized tax benefits may decrease approximately $75 million to $80 million, including cash adjustments, within the next twelve months as a result of concluding various domestic and international tax matters.</span></div><div style="text-align:justify"><span><br></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_97"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Liquidity and Capital Resources March&nbsp;31, 2023 Compared with December&nbsp;31, 2022</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in cash and cash equivalents from $9.9 billion at December&nbsp;31, 2022 to $9.2 billion at March&nbsp;31, 2023 primarily reflects the payment of dividends, share repurchases and capital expenditures, partially offset by the cash generated from operations in the first three months of 2023. Working capital was $9.8 billion at March&nbsp;31, 2023 and $9.7 billion at December&nbsp;31, 2022. The increase in working capital in 2023 primarily reflects an increase in inventory and a decrease in accounts payable, partially offset by a decrease in cash and cash equivalents.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the Condensed Consolidated Statement of Cash Flows, Net cash from operating activities for the first three months of 2023 totaled approximately $1.1 billion, which reflects a decrease of $922 million from the prior year. The decrease is  primarily due to a decline in operating earnings, partially offset by the timing of the collection of trade receivables and a reduction in cash taxes paid. In the first three months of 2023, Net cash from operating activities includes $282 million of pension contributions and the payment of cash taxes of approximately $122 million. In the first three months of 2022, Net cash from operating activities includes $334 million of pension contributions and the payment of cash taxes of approximately $195 million.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 15, 2022, Abbott repaid the $750 million outstanding principal amount of its 2.55% Notes upon maturity.</span></div><div><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In September 2019, the board of directors authorized the early redemption of up to $5 billion of outstanding long-term notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March 31, 2023, $2.15 billion of the $5 billion authorization remains available.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&nbsp;31, 2023, Abbotts long-term debt rating was AA- by Standard &amp; Poors Corporation and A1 by Moodys Investors Service. Abbott expects to maintain an investment grade rating. Abbott has readily available financial resources, including lines of credit of $5.0 billion which expire in 2025.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the first quarter of 2023, Abbott repurchased approximately 3 million of its common shares for $300 million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March 31, 2023, $2.134 billion remains available for repurchase under the share repurchase program authorized by the board of directors in December 2021.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, Abbott declared a quarterly dividend of $0.51 per share on its common shares, which represents an increase of 8.5 percent over the $0.47 per share dividend declared in the first quarter of 2022.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Business Acquisition</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 27, 2023, Abbott completed the acquisition of Cardiovascular Systems, Inc. (CSI) for $20 per common share, which equated to a purchase price of approximately $850 million. The acquisition was funded with cash on hand. CSI sells an atherectomy system used in treating peripheral and coronary artery disease. The acquisition adds complementary technologies to Abbotts portfolio of vascular device offerings. The transaction will be accounted for as a business combination.</span></div><div style="text-align:justify"><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_100"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legislative Issues</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbotts primary markets are highly competitive and subject to substantial government regulations throughout the world. Abbott expects debate to continue over the availability, method of delivery, and payment for health care products and services. It is not possible to predict the extent to which Abbott or the health care industry in general might be adversely affected by these factors in the future. A more complete discussion of these factors is contained in Item 1, Business, and Item 1A, Risk Factors, in the 2022 Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Private Securities Litigation Reform Act of 1995  A Caution Concerning Forward-Looking Statements</span></div><div style="text-align:justify"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Abbott cautions that any forward-looking statements made by Abbott are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Abbott's operations are discussed in Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2022, and are incorporated herein by reference. Abbott undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law.</span></div><div style="text-align:justify"><span><br></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_103"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controls and Procedures</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluation of disclosure controls and procedures. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chief Executive Officer, Robert B. Ford, and Chief Financial Officer, Robert E. Funck, Jr., evaluated the effectiveness of Abbott Laboratories disclosure controls and procedures as of the end of the period covered by this report, and concluded that Abbott Laboratories disclosure controls and procedures were effective to ensure that information Abbott is required to disclose in the reports that it files or submits with the Securities and Exchange Commission (the Commission) under the Securities Exchange Act of 1934 (the Exchange Act) is recorded, processed, summarized and reported, within the time periods specified in the Commissions rules and forms, and to ensure that information required to be disclosed by Abbott in the reports that it files or submits under the Exchange Act is accumulated and communicated to Abbotts management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.</span></div><div style="padding-left:9pt;text-align:justify"><span><br></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">Changes in internal control over financial reporting. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the quarter ended March 31, 2023, there were no changes in Abbotts internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, Abbotts internal control over financial reporting.</span></div><div style="padding-left:9pt;text-align:justify"><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_106"></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PART II. OTHER INFORMATION</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_109"></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Proceedings</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott is involved in various claims, legal proceedings and investigations, including those described in our Annual Report on Form 10-K for the year ended December&nbsp;31, 2022.</span></div><div style="text-align:justify"><span><br></span></div><div id="i901bb95f381d40f69da02b9fef764f5e_112"></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br></span></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.91pt">Issuer Purchases of Equity Securities</span></div><div style="padding-left:9pt;text-align:justify"><span><br></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:40.415%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.375%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.379%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(a) Total<br>Number of<br>Shares (or<br>Units)<br>Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(b) Average<br>Price Paid per<br>Share (or<br>Unit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(c) Total Number<br>of Shares (or<br>Units) Purchased<br>as Part of<br>Publicly<br>Announced Plans<br>or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(d) Maximum<br>Number (or<br>Approximate<br>Dollar Value) of<br>Shares (or Units)<br>that May Yet Be<br>Purchased Under<br>the Plans or<br>Programs</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2023 - January 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,434,092,348&nbsp;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2023 - February 28, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.933&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600,000&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,373,532,278&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2023 - March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369,830&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.037&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369,830&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,134,092,391&nbsp;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,969,830&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.016&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,969,830&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,134,092,391&nbsp;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr></tbody></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">These shares do not include the shares surrendered to Abbott to satisfy tax withholding obligations in connection with the vesting of restricted stock or restricted stock units.</span></div><div style="text-align:justify"><span><br></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">On December 10, 2021, the board of directors authorized the repurchase of up to $5 billion of Abbott common shares, from time to time. </span></div><div style="text-align:justify"><span><br></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_115"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&nbsp;&nbsp;&nbsp;&nbsp; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibits</span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Exhibit</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1800/000110465923023291/tm236955d1_ex3-1.htm">By-Laws of Abbott Laboratories, as amended and restated, effective April 28, 2023, filed as Exhibit 3.1 to the Abbott Laboratories Current Report on Form 8-K filed on February 17, 2023.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="non-employedirectorsfeep.htm">Abbott Laboratories Non-Employee Directors' Fee Plan, as amended and restated.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="q1202310qex311.htm">Certification of Chief Executive Officer Required by Rule 13a-14(a) (17 CFR 240.13a-14(a)).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="q1202310qex312.htm">Certification of Chief Financial Officer Required by Rule 13a-14(a) (17 CFR 240.13a-14(a)).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits 32.1 and 32.2 are furnished herewith and should not be deemed to be filed under the Securities Exchange Act of 1934.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="q1202310qex321.htm">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="q1202310qex322.htm">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following financial statements and notes from the Abbott Laboratories Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline XBRL: (i) Condensed Consolidated Statement of Earnings; (ii) Condensed Consolidated Statement of Comprehensive Income; (iii) Condensed Consolidated Balance Sheet; (iv) Condensed Consolidated Statement of Shareholders Investment; (v) Condensed Consolidated Statement of Cash Flows; and (vi) Notes to the Condensed Consolidated Financial Statements.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document and included in Exhibit 101).</span></td></tr></tbody></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26</span></div></div></div><div id="i901bb95f381d40f69da02b9fef764f5e_118"></div><hr style="page-break-after:always"><div style="min-height:45pt;width:100%"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i901bb95f381d40f69da02b9fef764f5e_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURE</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tbody><tr><td style="width:1.0%"></td><td style="width:4.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.356%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABBOTT LABORATORIES</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ ROBERT E. FUNCK, JR.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Robert E. Funck, Jr.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Finance <br>and Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May&nbsp;4, 2023</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></tbody></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">27</span></div></div></div>
</div>


	</div>

	<div id="form-information-modal" data-test="form-information-modal" class="reboot dialog-box fixed-dialog-box d-none bg-white">
		<div class="reboot dialog-header bg-sec text-white px-1 d-flex justify-content-between">
			<p id="form-information-modal-title" data-test="form-information-modal-title" class="reboot lead mb-0"></p>
			<div class="reboot dialog-header-actions">
				<i id="form-information-modal-drag" title="Click and drag to move this Dialog Box." class="reboot fas fa-arrows-alt m-1 drag-icon d-none d-sm-inline-block" tabindex="14"></i>

				<i id="dialog-box-copy-content" title="Click to Copy all Dialog Box Content." class="reboot fas fa-copy m-1 click" tabindex="14"></i>

				<i id="dialog-box-close" data-name="Form Information Modal" title="Click to Close this Dialog Box." class="reboot fas fa-times m-1 click" tabindex="14"></i>

			</div>
		</div>
		<div class="reboot dialog-content">
			<div id="form-information-copy-paste" class="reboot form-group d-none">
				<label class="reboot">Copy and Paste Below Content.</label>
				<a id="dialog-content-copy-content" class="reboot float-right click color-inherit" tabindex="14">
					<i class="reboot fas fa-times-circle mt-2"></i>
				</a>
				<textarea class="reboot form-control" rows="5" tabindex="14"></textarea>
			</div>
			<div id="form-information-modal-carousel" class="reboot carousel pointer-event" data-interval="false" data-ride="carousel">
				<div class="reboot carousel-inner">
					<div class="reboot carousel-item table-responsive active">
						<table class="reboot table table-striped table-sm">
							<tbody class="reboot" id="form-information-modal-carousel-page-1" tabindex="14">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-bordered table-sm">
							<tbody class="reboot" id="form-information-modal-carousel-page-2" tabindex="14">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm">
							<tbody class="reboot" id="form-information-modal-carousel-page-3" tabindex="14">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm">
							<tbody class="reboot" id="form-information-modal-carousel-page-4" tabindex="14">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
				</div>
			</div>
		</div>
		<div class="reboot dialog-footer d-flex justify-content-around">
			<button id="form-information-prev" class="reboot btn btn-link text-dark" href="#form-information-modal-carousel" role="button" data-slide="prev" tabindex="14">
				<i class="reboot fas fa-chevron-left" title="Previous"></i>
				<span class="reboot sr-only">Previous</span>
			</button>
			<ol id="form-information-carousel-indicators" class="reboot carousel-indicators mx-0 my-3 p-initial">
			</ol>
			<button id="form-information-next" data-test="form-information-next" class="reboot btn btn-link text-dark" href="#form-information-modal-carousel" role="button" data-slide="next" tabindex="14">
				<i class="reboot fas fa-chevron-right" title="Next"></i>
				<span class="reboot sr-only">Next</span>
			</button>
		</div>
	</div>

	<div id="settings-modal" data-test="settings-modal" class="reboot dialog-box fixed-dialog-box d-none bg-white">
		<div class="reboot dialog-header bg-sec text-white px-1 d-flex justify-content-between">
			<p id="settings-modal-title" data-test="settings-modal-title" class="reboot lead mb-0">Settings</p>
			<div class="reboot dialog-header-actions">
				<i id="settings-modal-drag" title="Click and drag to move this Dialog Box." class="reboot fas fa-arrows-alt m-1 drag-icon d-none d-sm-inline-block" tabindex="15"></i>

				<i id="settings-modal-close" data-name="Settings Modal" title="Click to Close this Dialog Box." class="reboot fas fa-times m-1 click" tabindex="15"></i>
			</div>
		</div>
		<div class="reboot dialog-content">
			<form class="reboot">
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">Hover
						over Fact for quick information.</label>
					<select id="hover-option-select" class="reboot col-sm-8 form-control" tabindex="15">
						<option class="reboot" value="true">On</option>
						<option class="reboot" value="false">Off</option>
					</select>
				</div>
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">Auto
						Scrolling Position</label>
					<select id="scroll-position-select" class="reboot col-sm-8 form-control" tabindex="15">
						<option class="reboot" value="start">Top</option>
						<option class="reboot" value="center">Center</option>
					</select>
					<small class="reboot form-text text-muted col-sm-12" tabindex="15">Selecting
						a fact from the Sections Menu or the Fact Menu will automatically
						scroll that element to the (Top, or Middle) of the viewer window.
						This setting will have no use on IE 10, or Safari.</small>
				</div>
				<hr class="reboot">
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">
						<span class="reboot tagged-data-example-1">Tagged Data</span>
					</label>
					<div class="reboot col-sm-4">
						<div class="reboot" id="tagged-data-color-picker" tabindex="15"><div class="picker_wrapper layout_default no_alpha no_editor" tabindex="-1"><div class="picker_arrow"></div><div class="picker_hue picker_slider" style="color: rgb(255, 102, 0);"><div class="picker_selector" style="left: 6.66667%;"></div></div><div class="picker_sl" style="background-color: rgb(255, 102, 0); color: rgb(255, 102, 0);"><div class="picker_selector" style="left: 100%; top: 50%;"></div></div><div class="picker_alpha picker_slider" style="background-image: linear-gradient(rgb(255, 102, 0), rgba(255, 102, 0, 0)), url(&quot;data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E&quot;);"><div class="picker_selector" style="top: 0%;"></div></div><div class="picker_editor"><input aria-label="Type a color name or hex value"></div><div class="picker_sample" style="color: rgb(255, 102, 0);"></div><div class="picker_done"><button>Save</button></div><div class="picker_cancel"><button>Reset</button></div></div></div>
					</div>
				</div>
				<hr>
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">
						<span class="reboot search-results-example-1">Search
							Results</span>
					</label>
					<div class="reboot col-sm-4">
						<div class="reboot" id="search-results-color-picker" tabindex="15"><div class="picker_wrapper layout_default no_alpha no_editor" tabindex="-1"><div class="picker_arrow"></div><div class="picker_hue picker_slider" style="color: rgb(255, 215, 0);"><div class="picker_selector" style="left: 14.0523%;"></div></div><div class="picker_sl" style="background-color: rgb(255, 215, 0); color: rgb(255, 215, 0);"><div class="picker_selector" style="left: 100%; top: 50%;"></div></div><div class="picker_alpha picker_slider" style="background-image: linear-gradient(rgb(255, 215, 0), rgba(255, 215, 0, 0)), url(&quot;data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E&quot;);"><div class="picker_selector" style="top: 0%;"></div></div><div class="picker_editor"><input aria-label="Type a color name or hex value"></div><div class="picker_sample" style="color: rgb(255, 215, 0);"></div><div class="picker_done"><button>Save</button></div><div class="picker_cancel"><button>Reset</button></div></div></div>
					</div>
				</div>
				<hr>
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">
						<span class="reboot selected-fact-example-1">Selected Fact</span>
					</label>
					<div class="reboot col-sm-4">
						<div class="reboot" id="selected-fact-color-picker" tabindex="15"><div class="picker_wrapper layout_default no_alpha no_editor" tabindex="-1"><div class="picker_arrow"></div><div class="picker_hue picker_slider" style="color: rgb(0, 135, 255);"><div class="picker_selector" style="left: 57.8526%;"></div></div><div class="picker_sl" style="background-color: rgb(0, 135, 255); color: rgb(0, 55, 104);"><div class="picker_selector" style="left: 100%; top: 79.6078%;"></div></div><div class="picker_alpha picker_slider" style="background-image: linear-gradient(rgb(0, 55, 104), rgba(0, 55, 104, 0)), url(&quot;data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E&quot;);"><div class="picker_selector" style="top: 0%;"></div></div><div class="picker_editor"><input aria-label="Type a color name or hex value"></div><div class="picker_sample" style="color: rgb(0, 55, 104);"></div><div class="picker_done"><button>Save</button></div><div class="picker_cancel"><button>Reset</button></div></div></div>
					</div>
				</div>
				<hr>
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">
						<span class="reboot tag-shading-exmple-1">Tag Shading
							(hover)</span>
					</label>
					<div class="reboot col-sm-4">
						<div class="reboot" id="tag-shading-color-picker" tabindex="15"><div class="picker_wrapper layout_default no_editor" tabindex="-1"><div class="picker_arrow"></div><div class="picker_hue picker_slider" style="color: rgb(255, 0, 0);"><div class="picker_selector" style="left: 0%;"></div></div><div class="picker_sl" style="background-color: rgb(255, 0, 0); color: rgb(255, 0, 0);"><div class="picker_selector" style="left: 100%; top: 50%;"></div></div><div class="picker_alpha picker_slider" style="background-image: linear-gradient(rgb(255, 0, 0), rgba(255, 0, 0, 0)), url(&quot;data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E&quot;);"><div class="picker_selector" style="top: 70%;"></div></div><div class="picker_editor"><input aria-label="Type a color name or hex value"></div><div class="picker_sample" style="color: rgba(255, 0, 0, 0.3);"></div><div class="picker_done"><button>Save</button></div><div class="picker_cancel"><button>Reset</button></div></div></div>
					</div>
				</div>
				<hr>
				<div class="reboot form-group row">
					<label class="reboot col-sm-4 col-form-label" tabindex="15">
						<span class="reboot text-block-exmple-1">Text Block Indicators</span>
					</label>
					<div class="reboot col-sm-4">
						<div class="reboot" id="text-block-color-picker" tabindex="15"><div class="picker_wrapper layout_default no_alpha no_editor" tabindex="-1"><div class="picker_arrow"></div><div class="picker_hue picker_slider" style="color: rgb(0, 135, 255);"><div class="picker_selector" style="left: 57.8526%;"></div></div><div class="picker_sl" style="background-color: rgb(0, 135, 255); color: rgb(0, 55, 104);"><div class="picker_selector" style="left: 100%; top: 79.6078%;"></div></div><div class="picker_alpha picker_slider" style="background-image: linear-gradient(rgb(0, 55, 104), rgba(0, 55, 104, 0)), url(&quot;data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E&quot;);"><div class="picker_selector" style="top: 0%;"></div></div><div class="picker_editor"><input aria-label="Type a color name or hex value"></div><div class="picker_sample" style="color: rgb(0, 55, 104);"></div><div class="picker_done"><button>Save</button></div><div class="picker_cancel"><button>Reset</button></div></div></div>
					</div>
				</div>
			</form>
		</div>
		<div class="reboot dialog-footer d-flex justify-content-around"></div>
	</div>

	<div id="taxonomy-modal" class="reboot dialog-box fixed-dialog-box d-none bg-white">
		<div class="reboot dialog-header bg-sec text-white px-1 d-flex justify-content-between">
			<p id="taxonomy-modal-title" class="reboot lead mb-0"></p>
			<div class="reboot dialog-header-actions">

				<i id="taxonomy-modal-drag" title="Click and drag to move this Dialog Box." class="reboot fas fa-arrows-alt m-1 drag-icon d-none d-sm-inline-block" tabindex="16"></i>

				<i id="taxonomy-modal-jump" title="Click to see this in the Facts sidebar." class="reboot fas fa-directions m-1 click" tabindex="16"></i>
				<i id="taxonomy-modal-copy-content" class="reboot fas fa-copy m-1 click" tabindex="16"></i>

				<i id="taxonomy-modal-compress" class="reboot fas fa-compress m-1 click d-none" tabindex="16"></i>

				<i id="taxonomy-modal-expand" class="reboot fas fa-expand m-1 click d-none" tabindex="16"></i>

				<i id="taxonomy-modal-close" class="reboot fas fa-times m-1 click" tabindex="16"></i>
			</div>
		</div>
		<div class="reboot dialog-content">
			<p id="taxonomy-modal-subtitle" class="reboot text-center font-weight-bold"></p>
			<div id="taxonomy-copy-paste" class="reboot form-group d-none">
				<label>Copy and Paste Below Content.</label>
				<a id="taxonomy-copy-content" class="reboot float-right click color-inherit" tabindex="16">
					<i class="reboot fas fa-times-circle mt-2"></i>
				</a>
				<textarea class="reboot form-control" rows="5" tabindex="16"></textarea>
			</div>
			<div id="taxonomy-modal-carousel" class="reboot carousel" data-interval="false" data-keyboard="false">
				<div class="reboot carousel-inner">
					<div class="reboot carousel-item table-responsive active">
						<table class="reboot table table-striped table-sm" id="taxonomy-modal-carousel-page-1" tabindex="16">
							<!-- Below is populated dynamically VIA JS -->
							<tbody class="reboot">
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm" id="taxonomy-modal-carousel-page-2" tabindex="16">
							<!-- Below is populated dynamically VIA JS -->
							<tbody class="reboot">
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm" id="taxonomy-modal-carousel-page-3" tabindex="16">
							<!-- Below is populated dynamically VIA JS -->
							<tbody class="reboot">
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm" id="taxonomy-modal-carousel-page-4" tabindex="16">
							<!-- Below is populated dynamically VIA JS -->
							<tbody class="reboot">
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
				</div>
			</div>
		</div>
		<div class="reboot dialog-footer d-flex justify-content-around">
			<button data-test="modal-taxonomy-prev" class="reboot btn btn-link text-dark" href="#taxonomy-modal-carousel" role="button" data-slide="prev" tabindex="16">
				<i class="reboot fas fa-chevron-left" title="Previous"></i>
				<span class="reboot sr-only">Previous</span>
			</button>
			<ol id="taxonomy-modal-carousel-indicators" class="reboot carousel-indicators mx-0 my-3 p-initial">
			</ol>
			<button data-test="modal-taxonomy-next" class="reboot btn btn-link text-dark" href="#taxonomy-modal-carousel" role="button" data-slide="next" tabindex="16">
				<i class="reboot fas fa-chevron-right" title="Next"></i>
				<span class="reboot sr-only">Next</span>
			</button>
		</div>
	</div>

	<div id="taxonomy-nested-modal" class="reboot dialog-box fixed-dialog-box d-none bg-white">
		<div class="reboot dialog-header bg-sec text-white px-1 d-flex justify-content-between">
			<p class="reboot lead mb-0">
				Nested Facts
				<span class="reboot" id="nested-page"></span>
				<span class="reboot">/</span>
				<span class="reboot" id="nested-count"></span>
			</p>
			<div class="reboot dialog-header-actions">
				<i id="taxonomy-nested-modal-drag" title="Click and drag to move this Dialog Box." class="reboot fas fa-arrows-alt m-1 drag-icon d-none d-sm-inline-block" tabindex="17"></i>

				<i id="nested-taxonomy-modal-jump" title="Click to see this in the Facts sidebar." class="reboot fas fa-directions m-1 click" tabindex="17"></i>

				<i id="taxonomy-nested-modal-copy-content" class="reboot fas fa-copy m-1 click" tabindex="17"></i>

				<i id="taxonomy-nested-modal-compress" class="reboot fas fa-compress m-1 click d-none" tabindex="17"></i>

				<i id="taxonomy-nested-modal-expand" class="reboot fas fa-expand m-1 click d-none" tabindex="17"></i>

				<i id="taxonomy-nested-modal-close" class="reboot fas fa-times m-1 click" tabindex="17"></i>
			</div>
		</div>
		<div class="reboot dialog-content pt-0">
			<div id="modal-nested-fact-labels" class="reboot carousel" data-interval="false" data-keyboard="false">
				<div class="reboot d-flex">
					<button data-test="modal-taxonomy-nested-prev" class="reboot btn btn-link text-dark" href="#modal-nested-fact-labels" role="button" data-slide="prev" tabindex="17">
						<i class="reboot fas fa-chevron-left" title="Previous"></i>
						<span class="reboot sr-only">Previous</span>
					</button>
					<div id="modal-taxonomy-nested-label-carousel" class="reboot carousel-inner">
						<!-- Below is populated dynamically VIA JS -->
					</div>
					<button data-test="modal-taxonomy-nested-next" class="reboot btn btn-link text-dark" href="#modal-nested-fact-labels" role="button" data-slide="next" tabindex="17">
						<i class="reboot fas fa-chevron-right" title="Next"></i>
						<span class="reboot sr-only">Next</span>
					</button>
				</div>
			</div>
			<div id="taxonomy-nested-copy-paste" class="reboot form-group d-none">
				<label class="reboot">Copy and Paste Below Content.</label>
				<a id="taxonomy-nested-copy-content" class="reboot float-right click color-inherit" tabindex="17">
					<i class="reboot fas fa-times-circle mt-2"></i>
				</a>
				<textarea class="reboot form-control" rows="5" tabindex="17"></textarea>
			</div>
			<div id="modal-taxonomy-nested-content-carousel" class="reboot carousel" data-interval="false" data-keyboard="false">
				<div class="reboot carousel-inner">
					<div class="reboot carousel-item table-responsive active">
						<table class="reboot table table-striped table-sm">
							<tbody class="reboot" id="modal-taxonomy-nested-content-carousel-page-1" tabindex="17">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-bordered table-sm">
							<tbody class="reboot" id="modal-taxonomy-nested-content-carousel-page-2" tabindex="17">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm">
							<tbody class="reboot" id="modal-taxonomy-nested-content-carousel-page-3" tabindex="17">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
					<div class="reboot carousel-item table-responsive">
						<table class="reboot table table-striped table-sm">
							<tbody class="reboot" id="modal-taxonomy-nested-content-carousel-page-4" tabindex="17">
								<!-- Below is populated dynamically VIA JS -->
								<tr class="reboot">
									<td class="reboot text-center">
										<i class="reboot fas fa-spinner fa-spin"></i>
									</td>
								</tr>
							</tbody>
						</table>
					</div>
				</div>
			</div>
		</div>
		<div id="taxonomy-nested-nav-controls" class="reboot dialog-footer d-flex justify-content-around">
			<button data-test="modal-taxonomy-prev" class="reboot btn btn-link text-dark" href="#modal-taxonomy-nested-content-carousel" role="button" data-slide="prev" tabindex="17">
				<i class="reboot fas fa-chevron-left" title="Previous"></i>
				<span class="reboot sr-only">Previous</span>
			</button>
			<ol id="taxonomy-nested-modal-carousel-indicators" class="reboot carousel-indicators mx-0 my-3 p-initial">
				<!-- Below is populated dynamically VIA JS -->
			</ol>
			<button data-test="modal-taxonomy-next" class="reboot btn btn-link text-dark" href="#modal-taxonomy-nested-content-carousel" role="button" data-slide="next" tabindex="17">
				<i class="reboot fas fa-chevron-right" title="Next"></i>
				<span class="reboot sr-only">Next</span>
			</button>
		</div>
	</div>



</body></html>